Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,39746,-0.479877136805554,0.0111617818100647,-0.50175422915328,-0.458000044457827,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,37784,-0.301633218269724,0.00713590693680339,-0.315619595865859,-0.287646840673589,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,40122,-0.210324288000276,0.00464018714147345,-0.219419054797564,-0.201229521202989,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,40095,-0.182576990496679,0.00373289188118202,-0.189893458583795,-0.175260522409562,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37791,-0.167246127222576,0.00376164179656614,-0.174618945143846,-0.159873309301306,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,40248,-0.233498248185742,0.00603747919186451,-0.245331707401796,-0.221664788969687,1.11258799138765e-308
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,40065,-0.315445759645683,0.00837997451972667,-0.331870509704348,-0.299021009587019,6.64863405916589e-297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,40057,-0.136639002707578,0.00367260352012456,-0.143837305607022,-0.129440699808134,2.31334187489279e-290
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,40274,-0.177140357193649,0.00485332099040721,-0.186652866334847,-0.167627848052451,4.13538503903622e-280
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40186,0.08960377809117,0.00251039147226648,0.0846834108055277,0.0945241453768123,2.23972659191791e-268
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,37808,0.207637629179326,0.00605106373698761,0.195777544254831,0.219497714103822,2.23787402768238e-247
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39991,-0.0895356488838935,0.00269385633988925,-0.0948156073100764,-0.0842556904577105,4.52956399908431e-234
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,37362,-0.286165909844049,0.00871973320661699,-0.303256586929018,-0.269075232759079,5.9261217784825e-227
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37697,-0.162297603258066,0.00501099906543578,-0.17211916142632,-0.152476045089812,1.55192916478663e-221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,40115,-0.22209079518124,0.00703259831466018,-0.235874687877974,-0.208306902484506,2.93721315963811e-212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40262,0.340666283683775,0.0108434889588293,0.31941304532447,0.361919522043081,3.27888372263746e-210
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40174,0.0913309448285429,0.00290735188493778,0.0856325351340649,0.097029354523021,3.86619057638038e-210
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FURIN,Furin,40174,-0.0970065257736736,0.00309747374477547,-0.103077574313433,-0.0909354772339137,6.56452407558546e-209
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,40040,-0.223266166108908,0.00716482437404319,-0.237309221882032,-0.209223110335783,7.42060446476833e-207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,40178,-0.0983944789792897,0.00315971486841959,-0.104587520121392,-0.0922014378371873,1.22072975769994e-206
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,40095,-0.120400261790991,0.00391347247936399,-0.128070667850544,-0.112729855731438,7.41229876080411e-202
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,40100,-0.149652859869755,0.00494895510598315,-0.159352811877482,-0.139952907862028,2.85608806672667e-195
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,40126,0.126651543968024,0.00422974181269511,0.118361250015142,0.134941837920907,1.28896065126709e-191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,40185,0.077466260543372,0.00260724414748677,0.072356062014298,0.0825764590724461,8.47486695484147e-189
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39810,-0.183122607696593,0.00621596421774971,-0.195305897563383,-0.170939317829804,1.30562241857662e-185
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,37470,-0.0782511019748681,0.00266304601147744,-0.0834706721573639,-0.0730315317923723,8.18615186714212e-184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40233,-0.355362031318078,0.0122249458582561,-0.37932292520026,-0.331401137435896,5.09604067617697e-181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,40126,-0.157907634853096,0.00552891602792229,-0.168744310267824,-0.147070959438369,6.11433255865816e-175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,37782,0.0637939199386112,0.00223070018948314,0.0594217475672242,0.0681660923099981,1.25356252958069e-174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39889,0.139648590828441,0.00496476388622583,0.129917653611439,0.149379528045444,8.28073682922263e-170
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,37782,0.126447308824684,0.00452872914128787,0.11757099970776,0.135323617941609,8.85545129097981e-167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,40213,-0.297356224336598,0.0108612165607314,-0.318644208795632,-0.276068239877565,2.91315611894669e-161
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37587,-0.0657700462831259,0.00240663239662996,-0.0704870457805206,-0.0610530467857312,5.52232411231215e-160
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,40095,0.0669593032046544,0.00250031442478788,0.0620586869320701,0.0718599194772386,1.63122716575792e-154
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40258,0.158465818431752,0.00591804273665265,0.146866454667913,0.170065182195591,1.6524172572932e-154
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40095,0.0770158568740146,0.00290841647070725,0.0713153605914284,0.0827163531566008,3.43932129692387e-151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40185,-0.110998349510405,0.00429057221733877,-0.119407871056389,-0.102588827964421,1.48989525129047e-144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,37376,-0.186884663829376,0.00733814682538708,-0.201267431607134,-0.172501896051617,1.21649906769966e-139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,40137,-0.0707064962864999,0.00279010576165947,-0.0761751035793525,-0.0652378889936474,6.78016421833964e-139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,40164,-0.0802957871376221,0.0031733377107764,-0.0865155290507439,-0.0740760452245004,1.71859533055455e-138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,40133,-0.0424340889642071,0.001679156743305,-0.0457252361810849,-0.0391429417473293,3.8078132505672e-138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37737,-0.176095062457032,0.00701663467759284,-0.189847666425114,-0.16234245848895,7.67118381461042e-136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40248,-0.0856680565928434,0.00345632356395412,-0.0924424507781934,-0.0788936624074933,4.38317814016175e-133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37171,-0.0739646524827609,0.00298639743198547,-0.0798179914494524,-0.0681113135160694,2.68471693730435e-132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,37784,-0.207816045505739,0.00852143498805278,-0.224518058082322,-0.191114032929155,1.49104622405853e-128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,37791,0.13735470983743,0.00564277609848639,0.126294868684396,0.148414550990463,4.32890070926765e-128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,40181,-0.131772655666369,0.00546968067250502,-0.142493229784479,-0.121052081548259,5.81801977833656e-126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40213,-0.094207854305104,0.00392459483694356,-0.101900060185513,-0.0865156484246946,4.34665692883329e-125
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,39815,-0.171285445281574,0.00715789460108047,-0.185314918699692,-0.157255971863457,2.8026001346357e-124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,40100,-0.225134050846749,0.00941548291262443,-0.243588397355493,-0.206679704338005,3.92031318122721e-124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39810,-0.188037497098842,0.00786497839839942,-0.203452854759705,-0.172622139437979,4.60036265882444e-124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,40100,-0.184916956540432,0.00774326064650547,-0.200093747407583,-0.169740165673282,7.84324289821881e-124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,37782,0.120392061766852,0.00503613013546743,0.110521246701336,0.130262876832368,1.05364820222555e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40077,-0.122817970762855,0.00514760070359468,-0.132907268141901,-0.11272867338381,1.30507635590083e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37470,0.0680636723305851,0.00285234012462089,0.0624730856863281,0.073654258974842,3.26517968030915e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40065,-0.150446411255234,0.00632212674217871,-0.162837779669904,-0.138055042840563,5.52176780971411e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,39729,-0.131973991360392,0.00555636831864304,-0.142864473264932,-0.121083509455851,1.72756822745567e-122
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40065,-0.175286415561931,0.00740401488919649,-0.189798284744756,-0.160774546379106,9.1406356391484e-122
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,40248,0.0762746131195339,0.00323201666793782,0.0699398604503758,0.082609365788692,4.7841635646838e-121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,40248,-0.0741855020129235,0.00316669473810503,-0.0803922236996094,-0.0679787803262376,2.44797497888323e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40164,0.0823254879438611,0.00351738511470435,0.0754314131190406,0.0892195627686816,4.0823396067762e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,40297,-0.115020929520313,0.00493877812412358,-0.124700934643595,-0.105340924397031,5.40732385113063e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,40229,-0.0435666660563473,0.00187136784783328,-0.0472345470381005,-0.039898785074594,6.70646761266577e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40297,0.0752302964248831,0.00323826495041341,0.0688832971220729,0.0815772957276934,1.98368166081406e-117
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,39014,-0.0862628447709515,0.00373484183699773,-0.0935831347714671,-0.0789425547704359,5.9850482379469e-116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,37441,-0.0781049916329762,0.00339201631262819,-0.0847533436057275,-0.071456639660225,5.05062221487052e-115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37430,-0.110514909040372,0.00485568789590535,-0.120032057316347,-0.100997760764398,1.7961584310795e-112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFM,Afamin,37808,-0.0395414443819907,0.00174524748382173,-0.0429621294502813,-0.0361207593137001,1.49981301408941e-111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40065,-0.0874354066251177,0.00389457527997575,-0.0950687741738702,-0.0798020390763652,6.88684882747733e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,40095,0.0781455154539984,0.00351298913420244,0.0712600567509616,0.0850309741570352,5.94922056927246e-108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40164,0.0707636758859539,0.00318856546602861,0.0645140875725378,0.0770132641993699,1.78948775925006e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39810,-0.101804333614274,0.00459250836217545,-0.110805650004138,-0.0928030172244102,3.37417179203876e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37715,-0.173160815038657,0.00780226320380312,-0.188453250918112,-0.157868379159203,3.49312412921026e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,37756,-0.0950683622712193,0.00431911050512956,-0.103533818861273,-0.0866029056811654,1.70289946445934e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,40065,-0.114244089736091,0.00520111309116093,-0.124438271394767,-0.104049908077416,2.42080998019928e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39746,-0.154901086895125,0.00708351156976861,-0.168784769571872,-0.141017404218379,2.07933777800883e-104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,40222,0.0701137689831514,0.00321156829578767,0.0638190951234076,0.0764084428428952,4.02592012040564e-104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40065,-0.213292106842472,0.00983836833111733,-0.232575308771462,-0.194008904913482,1.03976109166259e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,39727,-0.101731665143213,0.00471039019225516,-0.110964029920033,-0.0924993003663931,6.33906818462987e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40174,-0.0697054337803986,0.00323041076082228,-0.0760370388716103,-0.0633738286891869,8.64269314894102e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39991,-0.0646601208923792,0.00300135044689581,-0.070542767768295,-0.0587774740164634,1.84233645164315e-101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39815,-0.111546203342925,0.00520587980370797,-0.121749727758193,-0.101342678927658,2.19559944029962e-100
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40248,-0.069820015508943,0.00326023417739426,-0.0762100744966358,-0.0634299565212502,2.53900827495586e-100
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39746,-0.160948604280697,0.00753236566565991,-0.175712040985391,-0.146185167576004,7.67008438855883e-100
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40065,-0.175135944002791,0.00823467687084431,-0.191275910669646,-0.158995977335936,5.65856557323488e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37784,-0.056432136106871,0.00265113755692772,-0.0616283657184493,-0.0512359064952926,6.71336824222663e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39923,-0.09165730246184,0.00431794464690867,-0.100120473969781,-0.083194130953899,1.36162222783346e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,37667,-0.050769571816292,0.00239304846122936,-0.0554599468003015,-0.0460791968322824,2.96701984267292e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40126,-0.0592751287265484,0.00280173543801833,-0.0647665301850643,-0.0537837272680325,5.60154699365446e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40207,-0.0611901610649075,0.00289519708322893,-0.0668647473480362,-0.0555155747817788,8.58975766131783e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39746,-0.115195836132378,0.00549508387357734,-0.12596620052459,-0.104425471740167,3.17855441433295e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40248,-0.0646224572309956,0.00308522581509321,-0.0706694998285783,-0.0585754146334129,4.13761472308459e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,40105,0.0891333006694277,0.00427182957090834,0.0807605147104473,0.097506086628408,2.18924755453029e-95
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40233,0.0426487136641572,0.00204661415086735,0.0386373499284571,0.0466600773998572,3.6797617568908e-95
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39904,-0.289064919226692,0.0138942403018626,-0.316297630218343,-0.261832208235042,7.80572527549768e-95
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,40139,0.0392601748230462,0.00188898363960008,0.0355577668894301,0.0429625827566624,1.14139710349844e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,40068,-0.058912334911828,0.00283896293659027,-0.064476702267545,-0.0533479675561111,2.22913544411363e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,40194,-0.0927282092651107,0.00447638304557362,-0.101501920034435,-0.0839544984957864,4.54648495011714e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37618,-0.0524646641519557,0.00254810658848101,-0.0574589530653785,-0.0474703752385329,9.74926143462651e-93
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37470,-0.0727693090034667,0.00353918449633825,-0.0797061106162897,-0.0658325073906437,1.79279800404987e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,40095,-0.108687523716245,0.00530143087034462,-0.119078328222121,-0.0982967192103698,3.38557270046945e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40100,-0.05262241789383,0.00258947182904971,-0.0576977826787674,-0.0475470531088926,1.21912998421259e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37756,-0.109372051969266,0.00539114292766638,-0.119938692107492,-0.0988054118310394,3.81983713920236e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,37696,-0.13012279998397,0.00642311502406655,-0.142712105431141,-0.1175334945368,6.83844547392383e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39810,-0.10318715808675,0.00510303879382622,-0.113189114122649,-0.0931852020508506,9.44965003060894e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,37777,-0.05176543009779,0.00256558704761033,-0.0567939807111063,-0.0467368794844738,3.34516085446092e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,37696,-0.209156536330422,0.0103827432779597,-0.229506713155223,-0.188806359505621,6.40678056708605e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,40153,-0.0609057505396457,0.00303056700319651,-0.0668456618659109,-0.0549658392133806,1.01760219585156e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37631,-0.0620693488721896,0.00308991522098903,-0.0681255827053281,-0.0560131150390511,1.97991511798859e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,40095,-0.0445066616769855,0.00222212254986577,-0.0488620218747224,-0.0401513014792486,3.91600548329557e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,40106,-0.0583097417830424,0.00292383817429421,-0.064040464604659,-0.0525790189614257,2.09870560581235e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,40065,-0.152096282766526,0.00767335912404221,-0.167136066649649,-0.137056498883404,2.24291768799629e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40133,0.054716034033195,0.00279520577466205,0.0492374307148574,0.0601946373515326,2.56118260710444e-84
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,40121,-0.0967859647397584,0.00495047549328155,-0.10648889670659,-0.0870830327729266,4.07116261482374e-84
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40233,-0.095433406172125,0.00490426735188917,-0.105045770181828,-0.0858210421624222,2.30271483017561e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,40126,-0.10847148361508,0.00558894695335344,-0.119425819643653,-0.0975171475865072,6.17414114047935e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39955,-0.132649073729983,0.00687695676508987,-0.146127908989559,-0.119170238470407,6.06072154667413e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,37430,-0.0988783733487379,0.00513239777037336,-0.10893787297867,-0.0888188737188061,1.43407204754806e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,40095,-0.0630876946240149,0.00328631847039419,-0.0695288788259875,-0.0566465104220423,3.35676491981255e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,40115,0.0975347904375734,0.00508288900839968,0.08757232798111,0.107497252894037,3.90750980765393e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,39914,-0.0648525930959414,0.00338249021290324,-0.0714822739132318,-0.058222912278651,5.40570033151241e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37430,-0.103483780973487,0.00539296946747551,-0.114054001129739,-0.0929135608172352,6.06017325276908e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40040,-0.0461065715117686,0.00241210154759517,-0.0508342905450551,-0.041378852478482,1.58703528621502e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40095,0.0485027124651322,0.00254207461085917,0.0435202462278482,0.0534851787024161,3.01679799960637e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39746,-0.110583562088376,0.00579873767581995,-0.121949087932983,-0.099218036243769,3.78993218907735e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39821,-0.132849955101607,0.00698243720835522,-0.146535532029983,-0.119164378173231,8.52275786997472e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,40264,0.0966189035245657,0.00510252824024527,0.086617948173685,0.106619858875446,4.35679030460954e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,37808,-0.0357239478072108,0.00189172061426584,-0.0394317202111718,-0.0320161754032498,1.61154768045003e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40024,0.109051602911111,0.00579720379061932,0.0976890834814967,0.120414122340724,4.49043935397243e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,40274,-0.0605532097333106,0.00322092791655705,-0.0668662284497624,-0.0542401910168588,5.34668355183097e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,37782,-0.0459241467630092,0.00244564067167579,-0.0507176024794937,-0.0411306910465246,1.14616034289057e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,40186,-0.0720909425652336,0.00384519556231356,-0.0796275258673682,-0.064554359263099,1.39802327331173e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,40133,-0.0593785894721369,0.00316742462663636,-0.0655867417403442,-0.0531704372039297,1.45098788920283e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,39991,-0.0715934639354837,0.00384195379824407,-0.0791236933800421,-0.0640632344909253,1.15063570629694e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40065,-0.135237045777416,0.00726568516852795,-0.149477788707731,-0.120996302847102,1.69007975713938e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40297,-0.0681469982873433,0.00367529600055898,-0.0753505784484389,-0.0609434181262477,6.02370825437777e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,40274,-0.0778222332001458,0.00419924306091748,-0.0860527495995441,-0.0695917168007476,7.17470855639961e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40251,-0.0364170969008305,0.00197302698615101,-0.0402842297936865,-0.0325499640079745,2.80587736583961e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39727,-0.0950210292934925,0.00514995210414399,-0.105114935417615,-0.0849271231693703,3.36390852460772e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,37430,-0.111600748420514,0.0060901484295559,-0.123537439342444,-0.0996640574985844,4.49650953916303e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,40248,-0.077623873535867,0.00425103884368642,-0.0859559096694923,-0.0692918374022416,9.87494447994485e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,40100,-0.0684718507633853,0.00376204267095745,-0.0758454543984619,-0.0610982471283086,2.90037623460777e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,40274,-0.0509029995076704,0.0028308453098187,-0.0564514563149151,-0.0453545427004258,1.40078039987291e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40274,-0.131557408881204,0.00731941931363643,-0.145903470735931,-0.117211347026476,1.60795258813871e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40174,-0.0361301355547522,0.0020153264062047,-0.0400801753109135,-0.032180095798591,3.66206914662868e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,40160,-0.108027056870399,0.00603074394092696,-0.119847314994616,-0.0962067987461821,4.77302656432588e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,37151,0.074617888412527,0.00418936227560331,0.0664067383523445,0.0828290384727094,4.10684541106255e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,40251,-0.0819499927716839,0.00461837454394201,-0.0910020068778102,-0.0728979786655575,9.05444416796155e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40233,-0.109101216441386,0.00618033455149602,-0.121214672162318,-0.096987760720454,4.4511896114032e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,40065,-0.0598856936113622,0.00339949820480533,-0.0665487100927806,-0.0532226771299437,8.58361688937647e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,40297,-0.0823771935206176,0.00471573400186092,-0.091620032164265,-0.0731343548769702,1.07054597514214e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37697,-0.0836797898757471,0.00481688142024339,-0.0931208774594241,-0.07423870229207,7.36997075398131e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,40126,-0.104486954912552,0.00602719494482625,-0.116300257004412,-0.092673652820693,1.05513087139071e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39991,-0.120729351983069,0.00696933265101842,-0.134389243979065,-0.107069459987072,1.33276718018674e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37782,-0.0362079187340348,0.00209565489506636,-0.0403154023283649,-0.0321004351397048,3.6396159047321e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,37579,-0.0390232391145147,0.00226113583150675,-0.043455065344268,-0.0345914128847615,5.18232679475707e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40140,0.0515929713460076,0.00299565137869153,0.0457214946437722,0.057464448048243,7.24199377584623e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39991,-0.0584733215446744,0.00339608161434469,-0.06512964150879,-0.0518170015805588,7.95272446426926e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,40177,-0.108288217713159,0.00630282244990746,-0.120641749714978,-0.0959346857113403,1.463343609793e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40126,0.0433843941708126,0.00253451307305722,0.0384167485476205,0.0483520397940048,4.29316955194551e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,40126,-0.0417169619746242,0.00243936705539945,-0.0464981214032071,-0.0369358025460413,5.6120208513436e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37784,-0.0898442621781742,0.0052625479343948,-0.100158856129588,-0.0795296682267604,1.15782267311492e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,40065,-0.0857645171341132,0.0050565850386067,-0.0956754238097823,-0.075853610458444,5.96825345545558e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37784,-0.116252207137327,0.00685281330200801,-0.129683721209263,-0.102820693065392,7.06713513421158e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37470,-0.0779998742143473,0.00459789503164234,-0.0870117484763663,-0.0689879999523283,7.31882246511151e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40065,-0.0950131645872374,0.00561517492030261,-0.106018907431031,-0.0840074217434443,1.1670054754251e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40100,-0.0991460253536426,0.00585994503029577,-0.110631517613022,-0.0876605330942629,1.19328805587146e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,37470,-0.0665354806172303,0.00393891442295231,-0.0742557528862168,-0.0588152083482438,2.43911004586723e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40066,-0.0769698332416904,0.00457732573779342,-0.0859413916877655,-0.0679982747956153,6.72138329459786e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,40186,0.0702060833209145,0.00417736028787777,0.0620184571566741,0.0783937094851549,7.74486293860639e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40079,-0.0321712630046395,0.00191728956938012,-0.0359291505606246,-0.0284133754486545,1.21673580421032e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39834,-0.066863734639064,0.00399395622073957,-0.0746918888317135,-0.0590355804464144,2.33749744418605e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,40297,0.0436529156690361,0.00260871623521688,0.038539831848011,0.0487659994900612,2.5604653834984e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,40174,-0.0938738690958704,0.00561124416466716,-0.104871907658618,-0.0828758305331228,2.7560989448216e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39661,-0.0291504802947712,0.00174519272441423,-0.0325710580346231,-0.0257299025549193,4.42976361773783e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40248,-0.0449718759382922,0.00269340083511286,-0.0502509415751134,-0.039692810301471,4.68501472658238e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40248,-0.204582490195148,0.012298264475107,-0.228687088566357,-0.180477891823938,1.2978297699531e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,37430,-0.0895116097725983,0.00537859060400878,-0.100053647356455,-0.0789695721887411,1.49539339685787e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37362,-0.107070244598448,0.00643551357929823,-0.119683851213873,-0.0944566379830236,1.62986166499116e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,40100,-0.0674707206678085,0.00406428632842866,-0.0754367218715287,-0.0595047194640883,2.29867315706913e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,40100,-0.0830955059184024,0.00501618077163518,-0.0929272202308074,-0.0732637916059975,4.10036934776675e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37462,-0.071537681249564,0.00431468630184408,-0.0799944664011784,-0.0630808960979496,4.11081907075276e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39810,-0.143018445944614,0.00867559266449191,-0.160022607567019,-0.12601428432221,1.55283453636323e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,40297,-0.0874030585653628,0.00531306147675987,-0.0978166590598121,-0.0769894580709135,2.62509191611171e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40274,-0.0503878635338646,0.00306804536601649,-0.0564012324512569,-0.0443744946164722,4.08500084921106e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39653,-0.0849604564661837,0.00518819643372956,-0.0951293214762937,-0.0747915914560738,9.25708412822938e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39746,-0.103779067199753,0.00634971030544899,-0.116224499398433,-0.0913336350010726,1.53596381829667e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,40133,0.0412906803672297,0.00252702845421558,0.0363377045969672,0.0462436561374923,1.59992797207074e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37697,-0.103925662328387,0.00641918128051424,-0.116507257638195,-0.0913440670185793,2.15942105998778e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40065,-0.0669489758216106,0.00414863281468824,-0.0750802961383996,-0.0588176555048217,4.09760928507522e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,40274,-0.0613753179730007,0.00380919746486873,-0.0688413450041434,-0.053909290941858,6.03480589542586e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,37791,-0.170522515812182,0.0105902308303054,-0.191279368239581,-0.149765663384784,8.6681999297078e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,40065,-0.116676722203789,0.00725888521280606,-0.130904137220889,-0.102449307186689,1.13308051942906e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40174,-0.0882623723437693,0.00549868701096431,-0.0990397988852594,-0.0774849458022793,1.59731498085597e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,39991,-0.134681135472937,0.00840586881096422,-0.151156638342426,-0.118205632603447,2.57021662581134e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,40074,-0.13782562230669,0.00861259664525403,-0.154706311731388,-0.120944932881992,3.47811897505401e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,40097,0.263876253026069,0.0165011568909911,0.231533985519726,0.296218520532411,4.15934638285036e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39746,-0.163519439901157,0.0102533620681004,-0.183616029554634,-0.14342285024768,8.45579883290789e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,40095,0.0437350193744241,0.0027478900304489,0.0383491549147443,0.0491208838341039,1.36768002366149e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40065,-0.10214995903693,0.00642293962154001,-0.114738920695149,-0.089560997378712,1.65292637416212e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,37791,0.0568995868041147,0.00357733098348684,0.0498880180764805,0.063911155531749,1.91236184329384e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,40216,-0.0878113076191175,0.00553743852655935,-0.0986646871311738,-0.0769579281070612,3.37873299310853e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40065,-0.0460280196082881,0.00290891034198459,-0.0517294838785779,-0.0403265553379983,5.86590551283116e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39967,-0.132487251856691,0.00839150845659887,-0.148934608431625,-0.116039895281757,1.01741221553753e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40174,-0.134624033050746,0.00859013495715173,-0.151460697566764,-0.117787368534729,6.12764346769556e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,40065,-0.101490574274748,0.00648637270072237,-0.114203864768164,-0.0887772837813323,9.11074744268602e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,37102,-0.0342389916013477,0.00218742232094438,-0.0385263393503987,-0.0299516438522968,1.03762765097525e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40126,-0.0499121309106278,0.00319498073640066,-0.0561742931539731,-0.0436499686672825,1.32958258594935e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,40248,-0.0396815415292892,0.00254248482408221,-0.0446648117844904,-0.0346982712740881,1.65523913129663e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,37403,-0.122829070177934,0.00787538131221644,-0.138264817549878,-0.10739332280599,2.39488039082414e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,40233,-0.0347383280285305,0.00223238755805986,-0.0391138076423278,-0.0303628484147331,3.38265913771317e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,37430,-0.089735259641473,0.00578905834887043,-0.101081814005259,-0.078388705277687,1.03659716369669e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40065,-0.179044914733915,0.0115596933854148,-0.201701913769328,-0.156387915698502,1.0371706454148e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39607,-0.147950698775147,0.00958904272240206,-0.166745222511055,-0.129156175039239,2.65002027724745e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40297,-0.0714364316833089,0.00463554230406437,-0.080522094599275,-0.0623507687673427,3.37834025220969e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,40274,-0.0396077244320511,0.00257412251781282,-0.0446530045669642,-0.034562444297138,4.85392280111317e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40100,-0.138187577842708,0.00899156478279557,-0.155811044816987,-0.120564110868429,6.47518325911849e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37403,-0.122315345302813,0.00795941328278569,-0.137915795337073,-0.106714895268553,7.91868602823314e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40164,-0.0609524177747661,0.00397576885720429,-0.0687449247348865,-0.0531599108146457,1.14210121519139e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37791,-0.0447961262842291,0.00292040439531386,-0.0505201188990442,-0.0390721336694139,1.1800623689512e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37784,-0.0946328319115791,0.00617853132300874,-0.106742753304676,-0.082522910518482,1.66235284031347e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40065,-0.140371109521545,0.00919028168441331,-0.158384061622995,-0.122358157420095,2.7266460597597e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37696,-0.0836139663490898,0.00547417540691968,-0.0943433501466524,-0.0728845825515272,3.16136259991133e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40274,-0.0548777735615661,0.00360085260635226,-0.0619354446700166,-0.0478201024531157,4.48058943020489e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,40100,-0.104498505263165,0.00685900919398554,-0.117942163283377,-0.0910548472429535,4.87681594476343e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,40097,-0.0425091818749516,0.00279896439177158,-0.0479951520828239,-0.0370232116670793,1.00090589453654e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40297,0.0347750741843358,0.00229088365113397,0.0302849422281132,0.0392652061405583,1.1119040773418e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEP,Leptin,40126,-0.0910290960148853,0.00601080352978285,-0.10281027093326,-0.0792479210965109,1.91196158370217e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37430,0.0913515321471983,0.00603060873663922,0.0795315390233855,0.103171525271011,2.14781535539936e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,40274,-0.0374859129704739,0.002480197465923,-0.0423471000036829,-0.0326247259372648,2.98068169975104e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,40248,-0.0937304303398261,0.00620627355213066,-0.105894726502002,-0.08156613417765,3.54778436493232e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40261,-0.0540155532006506,0.00358213557172743,-0.0610365389212364,-0.0469945674800649,5.0278985842972e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,40065,-0.161144193408371,0.0107318030278133,-0.182178527342885,-0.140109859473857,1.30948901306088e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39746,-0.0702561841915574,0.00468538646049254,-0.0794395416541227,-0.061072826728992,1.81446176294366e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40065,-0.0642987515695466,0.00428970654315522,-0.0727065763941309,-0.0558909267449624,1.94101541722034e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39621,-0.125651300231993,0.00838425400048887,-0.142084438072951,-0.109218162391035,2.0620208360474e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,37756,-0.0618027178912626,0.00412264120325009,-0.0698830946496328,-0.0537223411328925,2.16554973007127e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,40056,-0.0422381954022031,0.00283012246000472,-0.0477852354238123,-0.0366911553805938,5.05292775884372e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40297,0.0444793067947557,0.00298902679921732,0.0386208142682897,0.0503377993212216,9.5096403457417e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40233,-0.134891887708566,0.00908345456870132,-0.15269545866322,-0.117088316753911,1.49655452242385e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37737,-0.065556534490411,0.00441915339268104,-0.0742180751400658,-0.0568949938407561,2.17234301784673e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40100,-0.0525295410519041,0.0035592691520386,-0.0595057085898998,-0.0455533735139085,5.78624665937203e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40152,-0.0322553957269398,0.00218781988858625,-0.0365435227085688,-0.0279672687453107,7.2236469244982e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37430,-0.118125736317914,0.00800839726818142,-0.13382219496355,-0.102429277672279,7.61756766986844e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,40097,-0.0402618799578559,0.00273261493489412,-0.0456178052302484,-0.0349059546854634,8.30087738422823e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,40164,-0.0697683201533788,0.00473572376965082,-0.0790503387418944,-0.0604863015648632,8.4555717097244e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39979,-0.0522555127742261,0.00355479536512947,-0.0592229116898798,-0.0452881138585723,1.36698804833216e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40121,0.046931211107397,0.00319371540560613,0.040671528912409,0.053190893302385,1.46339048352356e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37725,-0.150694658882099,0.0102714374094717,-0.170826676204664,-0.130562641559535,2.35516483727578e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40065,-0.0479260066206321,0.00327261531668203,-0.0543403326413289,-0.0415116805999353,3.04857339375852e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40297,-0.0932706883531419,0.00637995925215807,-0.105775408487372,-0.0807659682189121,4.34917137747927e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,40297,-0.0788866012876709,0.00540514074726199,-0.0894806771523044,-0.0682925254230374,6.20907570785719e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39746,-0.0866940804970148,0.00594745882548014,-0.0983510997949559,-0.0750370611990737,8.27162722234443e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,40174,-0.0549536139002225,0.00377372665165346,-0.0623501181374632,-0.0475571096629817,9.99724987959539e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39746,-0.0961031804300037,0.00660371688536176,-0.109046465525313,-0.0831598953346947,1.16563399119789e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,40100,-0.0535725790450028,0.00368361898370293,-0.0607924722530605,-0.046352685836945,1.31362913100913e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40164,0.0380682621431442,0.00261941603147667,0.0329342067214499,0.0432023175648384,1.52063140408954e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40100,-0.0727307572776246,0.00500667753677947,-0.0825438452497124,-0.0629176693055368,1.6713044410732e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,37784,-0.125872910814648,0.00867288935228473,-0.142871773945126,-0.10887404768417,2.28883352634107e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,40174,-0.112957544923828,0.00779155648476471,-0.128228995633967,-0.0976860942136895,2.53994129963458e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37376,-0.163249443149124,0.0112745476089035,-0.185347556462575,-0.141151329835673,3.81897321790054e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37696,-0.143812394967319,0.00995003357938588,-0.163314460782916,-0.124310329151723,5.42943463825097e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,40207,-0.0506986667107689,0.0035114634161231,-0.0575811350063702,-0.0438161984151676,5.94527431388198e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37717,-0.114507709381816,0.00793247275271951,-0.130055355977147,-0.0989600627864862,7.02756876592471e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37737,-0.117951723042981,0.00817268252241104,-0.133970180786906,-0.101933265299055,7.31305015193396e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,39727,-0.0704601326701787,0.0048985074499084,-0.0800612072719992,-0.0608590580683582,1.3146336633581e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37697,-0.0524942883326065,0.00365359530339192,-0.0596553351272546,-0.0453332415379583,1.83986050316112e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40100,-0.0744993216374603,0.00518852893944135,-0.0846688383587653,-0.0643298049161552,1.8605904023857e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,40100,-0.120311186519815,0.00838757627977501,-0.136750836028174,-0.103871537011456,2.28680074882147e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39815,-0.0594367309951305,0.00414558135147931,-0.06756207044403,-0.0513113915462311,2.54348096969556e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,40065,-0.0693696231696227,0.00484082002335657,-0.0788576304154016,-0.0598816159238439,2.78820158388496e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39991,-0.0743228428348331,0.00519322730331239,-0.0845015683493254,-0.0641441173203408,3.6451145591273e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39815,-0.0942317241346139,0.00658686679733867,-0.107141983057398,-0.0813214652118301,3.97093039992192e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37696,-0.188581138041007,0.013195869504898,-0.214445042270607,-0.162717233811407,5.47618937406994e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,39726,-0.0531643010669172,0.00372919173329654,-0.0604735168641784,-0.045855085269656,8.06426296432562e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,40138,-0.0630692122910783,0.00442926981208943,-0.0717505811227736,-0.054387843459383,1.00845041003346e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,40072,-0.071630232132407,0.00503803598587365,-0.0815047826647193,-0.0617556816000946,1.36593056677076e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37808,-0.0236205871473189,0.00166049396368069,-0.026875155316133,-0.0203660189785048,1.37865085730795e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,40100,-0.123414023609472,0.00868890273572983,-0.140444272971503,-0.106383774247442,1.66793879502576e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,40100,-0.12602329619949,0.00888659245271701,-0.143441017406815,-0.108605574992164,2.2849364103898e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40186,-0.038112886337015,0.00268814259962169,-0.0433816458322735,-0.0328441268417565,2.37963574235403e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,37784,-0.0928453371639048,0.00655582066041427,-0.105694745658317,-0.0799959286694928,3.33453496260152e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,37470,-0.0354008739471415,0.00250581162885263,-0.0403122647396926,-0.0304894831545903,5.52385505017011e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,40297,-0.0593877311665402,0.00421404771227585,-0.0676472646826009,-0.0511281976504795,7.84448104925575e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39746,-0.109436859011605,0.00777659193703837,-0.1246789792082,-0.0941947388150097,1.06368373792838e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,37737,-0.174140109482882,0.0123700563441484,-0.198385419917413,-0.149894799048351,1.0929097710315e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,37470,-0.0605289927033608,0.00430689417791628,-0.0689705052920767,-0.0520874801146449,1.54051717737292e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40126,-0.115240840576698,0.00821598812909455,-0.131344177309724,-0.099137503843673,1.99439094468077e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37470,-0.110595705955196,0.0078841494638594,-0.12604863890436,-0.0951427730060316,2.22278968388545e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40126,-0.0467152204556149,0.00333627552459093,-0.0532543204838131,-0.0401761204274167,2.79283254112857e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40100,0.0512732807908944,0.00366216432793879,0.0440954387081344,0.0584511228736545,2.85032041839646e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,37784,-0.0572332662473828,0.00408764150369409,-0.0652450435946233,-0.0492214889001424,3.13679566072719e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37470,-0.0981777400908434,0.0070247366426684,-0.111946223910473,-0.0844092562712133,4.54536865237095e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,40065,-0.0436104675097842,0.00313037673229956,-0.0497460059050913,-0.0374749291144771,7.47388004054175e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,39955,-0.0721418004686021,0.00517868878312265,-0.0822920304835225,-0.0619915704536817,7.59607263025296e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40095,-0.0695226174417749,0.00499248229520355,-0.0793078827403738,-0.0597373521431759,8.10200413633079e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40065,-0.0722529397104624,0.00519912447925728,-0.0824432236898067,-0.0620626557311181,1.19946836380265e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37430,-0.0954421884626854,0.00686965094371079,-0.108906704312359,-0.0819776726130123,1.42598440802973e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40100,-0.139061990860193,0.0100156874945862,-0.158692738349582,-0.119431243370804,1.42754664971624e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,40100,-0.107205435415357,0.00772254371607876,-0.122341621098871,-0.0920692497318422,1.4730772631632e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,37678,-0.0470138655558056,0.00338841988537099,-0.0536551685311327,-0.0403725625804785,1.81347513658955e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39727,-0.0660527916946416,0.00476402639984825,-0.0753902834383442,-0.056715299950939,1.89468697363641e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39727,-0.0351496024498455,0.00253699736212009,-0.0401221172796009,-0.0301770876200901,2.17726952741791e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40095,-0.0299868525842261,0.00216561729095364,-0.0342314624744952,-0.0257422426939569,2.39688167896019e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39727,-0.103149677579304,0.00746727944373305,-0.117785545289021,-0.0885138098695876,3.83654921513006e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39991,-0.0672651787551908,0.00488265577282981,-0.0768351840699372,-0.0576951734404444,6.32285735786441e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,37808,-0.0269533648767225,0.00195611136538509,-0.0307873431528773,-0.0231193866005677,6.69465114589271e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,37782,-0.094530972625856,0.00686726861368976,-0.107990819108688,-0.081071126143024,8.07240491742281e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40186,0.0267936395027992,0.00194873334420656,0.0229741221481544,0.0306131568574441,9.09184326935046e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39815,-0.109954601172228,0.00800259016180892,-0.125639677889374,-0.0942695244550827,1.04758444609607e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37403,-0.102666054791366,0.00748636026843319,-0.117339320917495,-0.0879927886652369,1.66379361458813e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37362,-0.0826345191752665,0.00602769467396287,-0.0944488007362337,-0.0708202376142993,1.77504660827442e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40100,-0.0555986892134424,0.00406641605967739,-0.0635688646904101,-0.0476285137364747,2.5889544421778e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40126,-0.0543078427462075,0.00397477343810113,-0.0620983986848857,-0.0465172868075293,2.94359112201008e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,40100,-0.106363169443472,0.00779892370041537,-0.121649059896286,-0.0910772789906576,4.13225587435486e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37470,-0.0472366683101628,0.00346359800210117,-0.0540253203942811,-0.0404480162260445,4.62648423038488e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40040,-0.0977992370897185,0.00717544096055132,-0.111863101372399,-0.0837353728070379,4.64427011868966e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,37470,-0.0667801592428112,0.00490382499238029,-0.0763916562278766,-0.0571686622577458,6.06645799983762e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40065,-0.109836266439252,0.00807706957872804,-0.125667322813559,-0.0940052100649455,7.07537037421422e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37362,-0.0957570309722775,0.00703783699953415,-0.109551191491364,-0.0819628704531906,7.16614721105569e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40274,-0.0479761478138756,0.0035318318660202,-0.0548985382712752,-0.041053757356476,8.55604391307958e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37737,-0.0517880865208616,0.00381584474185082,-0.0592671422148892,-0.044309030826834,1.1148546686635e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39991,-0.0696182949437924,0.00513366637058227,-0.0796802810301336,-0.0595563088574511,1.17503499259692e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40229,-0.105203879030364,0.00776389767500153,-0.120421118473367,-0.0899866395873613,1.34674792124185e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37697,-0.102328835264888,0.00754817468530583,-0.117123257648088,-0.087534412881689,1.36831188742276e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40095,0.0518821417104312,0.00383139623234207,0.0443726050950407,0.0593916783258216,1.52879051160545e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,40095,-0.0571406072790341,0.00421977606598828,-0.0654113683683711,-0.0488698461896971,1.53224575919744e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,39815,-0.0609955931061803,0.00450499905946901,-0.0698253912627396,-0.0521657949496211,1.58116542759417e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,37544,-0.0361322930087843,0.00267465431714094,-0.0413746154703805,-0.030889970547188,2.61159715057593e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39746,-0.0818269738332755,0.00606747258997433,-0.0937192201096252,-0.0699347275569258,3.24485140030691e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39746,-0.077477008605976,0.00575220768288088,-0.0887513356644225,-0.0662026815475295,4.07881595334628e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37696,-0.120001227913578,0.00890614978347564,-0.13745728148919,-0.102545174337966,4.15097504533801e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37696,-0.0343542079947714,0.00255038969886467,-0.0393529718045462,-0.0293554441849967,4.36683166787729e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,40297,-0.0548527516149483,0.00407507265706359,-0.062839894022793,-0.0468656092071037,4.48795897111229e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,40233,-0.0467396685916018,0.0034750813696626,-0.0535508280761405,-0.039928509107063,5.18299161378295e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,37791,-0.0354845319226832,0.00263935254934226,-0.040657662919394,-0.0303114009259724,6.13303091317393e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37656,-0.13794656340507,0.0102667187731487,-0.158069332200442,-0.117823794609699,6.8770498741162e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,39967,-0.0658200296027307,0.00492831941819941,-0.0754795356624015,-0.0561605235430598,1.84099470491684e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,40174,-0.0659025610265874,0.00494024617971222,-0.0755854435388233,-0.0562196785143514,2.24741253770202e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40065,0.0298886821311089,0.00225283001605145,0.0254731352996481,0.0343042289625697,5.90493024064022e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,40228,-0.0771811579501899,0.00582339320612309,-0.0885950086341911,-0.0657673072661886,7.02258346132533e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40037,-0.13053477263037,0.0098800891443983,-0.149899747353391,-0.11116979790735,1.2235691305708e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40233,0.0565294736464241,0.0042795194234572,0.048141615576448,0.0649173317164002,1.25842686577259e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40194,-0.0903226173776941,0.00684057002686644,-0.103730134630352,-0.0769151001250358,1.35154102747828e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,40031,-0.0483050962721445,0.0036589960665747,-0.0554767285626309,-0.0411334639816581,1.39864539625848e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37737,-0.0803162875259597,0.00608263924629383,-0.0922382604486956,-0.0683943146032238,1.47282735041229e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,40233,-0.0742480708840799,0.00562905581101859,-0.0852810202736763,-0.0632151214944834,1.61833159418281e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,40195,-0.0861530321729554,0.0065380683940044,-0.098967646225204,-0.0733384181207068,1.92155709102448e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39815,-0.0858745011151864,0.00652788529991861,-0.0986691563030269,-0.073079845927346,2.59728242709557e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,39727,-0.0746247783786069,0.00568026771873082,-0.0857581031073193,-0.0634914536498945,3.27327234906924e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37430,-0.0934384878471192,0.00711655592391848,-0.107386937457999,-0.079490038236239,3.94915914604006e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,40229,-0.0415023803795503,0.00316296605903483,-0.0477017938552586,-0.035302966903842,3.98245050968076e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40100,-0.076049140671775,0.0057980153939275,-0.0874132508438729,-0.0646850304996771,4.26407430478825e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39746,-0.0829734660799084,0.0063274559999522,-0.0953752798398147,-0.0705716523200021,4.49261085743572e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37737,-0.110143561990281,0.00839989382417897,-0.126607353885672,-0.0936797700948901,4.87901163483392e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40143,-0.0367806536860399,0.00280931935728713,-0.0422869196263227,-0.0312743877457572,5.82586510684366e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,40233,-0.0721302050624156,0.00551359447888771,-0.0829368502410355,-0.0613235598837957,6.62921064661932e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37696,-0.0371824232938767,0.00284168519180037,-0.0427521262698054,-0.031612720317948,7.02123633244048e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40274,-0.0932349876920065,0.0071437457904694,-0.107236729441327,-0.0792332459426865,9.90454695281879e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40100,-0.105153501455202,0.00806172744241166,-0.120954487242329,-0.0893525156680754,1.1005860506489e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37515,-0.138473619738008,0.0106139149906839,-0.159276893119749,-0.117670346356268,1.16148799833853e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,40130,0.045740858367985,0.00351025893518213,0.038860750855028,0.052620965880942,1.30029587719949e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,39991,0.0411571601167683,0.00317447264635313,0.0349351937299162,0.0473791265036204,3.04927912505975e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37697,-0.0708458385481673,0.00546297268772343,-0.0815532650161052,-0.0601384120802294,3.15966205679249e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,37762,-0.0693646808930365,0.00535722355608057,-0.0798648390629545,-0.0588645227231186,4.102534707169e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40233,-0.0775983945942717,0.00599964019406793,-0.0893576893746448,-0.0658390998138986,4.52693329769961e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40174,0.0298056008318786,0.00230501843442163,0.0252877647004122,0.034323436963345,4.71895433223943e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,40164,-0.0706004606555482,0.00546170159443773,-0.0813053957806462,-0.0598955255304503,4.98781709133986e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,40126,0.0636660768103483,0.0049278107908134,0.0540075676603541,0.0733245859603426,5.44328379773962e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,39746,-0.089899212597242,0.00695906748377517,-0.103538984865441,-0.0762594403290426,5.60815516688912e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,37697,-0.120330824113301,0.00931721008070219,-0.138592555871477,-0.102069092355124,6.28290646718564e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40075,-0.0230771199471317,0.00179197504202995,-0.0265893910295104,-0.019564848864753,9.31255238814103e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37430,-0.085793478924336,0.00666209820596191,-0.0988511914080213,-0.0727357664406506,1.0208052122503e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37784,-0.0726492437099959,0.00565632043846053,-0.0837356317693785,-0.0615628556506133,1.55322446620008e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40274,-0.121428780274084,0.00946004771234372,-0.139970473790278,-0.102887086757891,1.58701699579344e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,40100,-0.100439099883584,0.00783691659971429,-0.115799456419024,-0.0850787433481438,2.05350375484292e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,39810,-0.0652041826779194,0.00509394979340047,-0.0751883242729843,-0.0552200410828544,2.53325294196435e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40121,-0.0338304754982117,0.00264611277243816,-0.0390168565321905,-0.0286440944642329,3.05362884119076e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,40274,-0.113582608996517,0.00888960600299438,-0.131006236762386,-0.0961589812306481,3.36524708659351e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,40100,-0.110021100923802,0.00861318510684191,-0.126902943733212,-0.0931392581143916,3.53248034714885e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40100,-0.125220479381367,0.00980501990210559,-0.144438318389494,-0.10600264037324,3.64702294085664e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39727,-0.0670690107553779,0.0052520057912437,-0.0773629421062156,-0.0567750794045402,3.72680543124003e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37763,0.0585758497808228,0.00459656750096348,0.0495665774789344,0.0675851220827113,5.57975846670578e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40020,-0.0538935248450372,0.00423172817068534,-0.0621877120595804,-0.0455993376304939,5.73484586915779e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,37470,-0.0754504075101954,0.00594317675849332,-0.0870990339568423,-0.0638017810635485,1.03615736822476e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37366,-0.0595024789605542,0.00469006128603943,-0.0686949990811915,-0.0503099588399169,1.15612139545382e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,39756,-0.0594749990063184,0.00470135411045558,-0.0686896530628113,-0.0502603449498254,1.69066681511431e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40097,-0.123183171174535,0.00975897117546733,-0.142310754678451,-0.104055587670619,2.38476723252521e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,40095,-0.0283637018966264,0.00224742767376473,-0.0327686601372052,-0.0239587436560475,2.44681225194387e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39727,-0.101674791290404,0.00807202537439248,-0.117495961024213,-0.0858536215565949,3.36381356573912e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39991,-0.112419085338034,0.0089628937475015,-0.129986357083137,-0.0948518135929312,6.50435946870453e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,37784,-0.0297963406648465,0.00237480017767659,-0.0344509490130927,-0.0251417323166004,6.5952330376011e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37696,-0.0605048154773658,0.00483385621042365,-0.0699791736497961,-0.0510304573049354,9.61484849700796e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,40233,0.0441064251675233,0.00353137697187544,0.0371849263026474,0.0510279240323992,1.24978860708081e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,40174,-0.0304155961989296,0.00243728150503856,-0.0351926679488051,-0.025638524449054,1.42720311632072e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37784,-0.0913754525492985,0.00732014094574236,-0.105722928802954,-0.0770279762956435,1.46539238535962e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,40174,-0.067965020354902,0.00545499585316553,-0.0786568122271065,-0.0572732284826976,1.83181866026104e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37697,-0.0564352022115973,0.00453015738070018,-0.0653143106777697,-0.047556093745425,2.00599187227142e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40182,-0.121993300935895,0.00981376969232392,-0.14122828953285,-0.102758312338941,2.60459665555666e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37403,-0.14300857599936,0.0114987660018916,-0.165546157363068,-0.120470994635653,2.62211243644248e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,40065,-0.110882150323637,0.00892421063825456,-0.128373603174616,-0.0933906974726584,2.81212780160622e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,39991,-0.0724137940148416,0.00583052308112605,-0.0838416192538486,-0.0609859687758345,3.00056228062601e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,40065,-0.120576963071008,0.00970988736233041,-0.139608342301175,-0.10154558384084,3.06334060943733e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,40233,-0.0486838226556282,0.00392099864052896,-0.0563689799910649,-0.0409986653201914,3.11880820814853e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,37784,-0.0879072372451313,0.00708213415456481,-0.101788220188078,-0.0740262543021843,3.49571381424953e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,40100,-0.099353684394518,0.0080124909557397,-0.115058166667768,-0.0836492021212682,3.82891437152808e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,39704,-0.0811308870505211,0.00654328621900546,-0.0939557280397718,-0.0683060460612704,3.90242339478841e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,40065,-0.0644972752547505,0.00520700691154885,-0.0747030088013862,-0.0542915417081147,4.51178896866847e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,40186,-0.0387712588286594,0.00313082293483223,-0.0449076717809306,-0.0326348458763882,4.6629081306843e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,39991,-0.0616136378739493,0.00497678607716837,-0.0713681385851993,-0.0518591371626993,4.89289429095034e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40094,-0.0228998520926837,0.00185051018348514,-0.0265268520523145,-0.0192728521330528,5.21183099595124e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40233,-0.0406809020297429,0.00329083605980197,-0.0471309407069548,-0.0342308633525311,6.0984985437527e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37784,-0.0931537776601977,0.00753404661484876,-0.107920509025301,-0.0783870462950941,6.32916423178326e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39955,-0.130537816070724,0.0105742651601943,-0.151263375784705,-0.109812256356743,7.56980655266091e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40164,0.0519088033883308,0.00420740130626007,0.043662296828061,0.0601553099486005,8.24617380107029e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39746,-0.0614455890302672,0.00499432466664386,-0.0712344653768891,-0.0516567126836452,1.27100207400506e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,37784,-0.034104542559869,0.00277178227115958,-0.0395372358113417,-0.0286718493083962,1.32482254544905e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40065,-0.0636147273396037,0.00517375570172921,-0.0737552885149929,-0.0534741661642144,1.38153138259649e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,39955,-0.093273085207929,0.0075957575756475,-0.108160770056198,-0.0783854003596599,1.68559033586001e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40100,-0.0631022513992569,0.00514193315847755,-0.0731804403898729,-0.0530240624086409,1.84230718879038e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39746,-0.0640166810315427,0.00521763023685715,-0.0742432362957827,-0.0537901257673027,1.9222032242217e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40143,0.0398294769361693,0.00325377118791407,0.0334520854078577,0.0462068684644808,2.69035227970544e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39810,-0.111981243564056,0.00914856745414933,-0.129912435774189,-0.0940500513539232,2.73510163666454e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40114,-0.0571903594474791,0.00467835026162502,-0.0663599259602642,-0.0480207929346941,3.29422347460678e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37697,-0.0838297919364941,0.00685980845940651,-0.0972750165169309,-0.0703845673560573,3.69279849899538e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37737,-0.0723289827880579,0.0059205011129854,-0.0839331649695093,-0.0607248006066065,3.85920784233196e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,37403,-0.0513045355436564,0.00420814700446587,-0.0595525036724095,-0.0430565674149033,5.28398306617631e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37697,-0.131827986246931,0.0108255689266635,-0.153046101343191,-0.11060987115067,6.22202926636189e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40065,-0.0319280911929936,0.00262436282805777,-0.0370718423359868,-0.0267843400500004,6.71196749218291e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,40100,-0.0771419335646956,0.00634163441500639,-0.0895715370181081,-0.0647123301112831,6.84428768763776e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNST,Consortin,40126,-0.124201195495477,0.0102103812945111,-0.144213542832719,-0.104188848158235,6.85311500672899e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39991,-0.0680696527870906,0.00560522138337631,-0.0790558866985082,-0.0570834188756731,8.78451977002688e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40065,-0.0372937526891231,0.00307202041097071,-0.0433149126946257,-0.0312725926836205,9.22296803434193e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,37470,0.0250806803921068,0.00206593550889614,0.0210314467946703,0.0291299139895432,9.84963006077234e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37696,-0.0974549018419848,0.00803007934811536,-0.113193857364291,-0.0817159463196787,1.02489416537549e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,40114,-0.0368995280802306,0.00304266019221497,-0.0428631420569719,-0.0309359141034893,1.07073778398073e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37430,-0.0710981126421058,0.00586020436271769,-0.0825841131930325,-0.0596121120911791,1.08298957711271e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40160,-0.0593846653502055,0.00490056747202564,-0.0689897775953758,-0.0497795531050352,1.19948154900786e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,37696,-0.119222321441348,0.00984090525598574,-0.13851049574308,-0.0999341471396162,1.32474163610522e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39746,-0.0412659208242724,0.00340845951886118,-0.0479465014812403,-0.0345853401673045,1.38277261901413e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37470,-0.0244428219659328,0.0020228726300789,-0.0284076523208874,-0.0204779916109781,1.95564895864555e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,39523,-0.106658902068893,0.00883453226383826,-0.123974585306016,-0.0893432188317695,2.09310028347505e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37737,-0.0443183622316783,0.0036717817811646,-0.0515150545227609,-0.0371216699405957,2.274308218609e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40095,-0.0595592458972916,0.00494278919311309,-0.0692471127157933,-0.0498713790787899,2.73254271558225e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37403,-0.0494864933981548,0.00410556039717982,-0.0575333917766272,-0.0414395950196823,2.79997318111581e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37362,-0.0494854058433279,0.00411296188860026,-0.0575468111449844,-0.0414240005416714,3.6478669894374e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,40133,-0.0319452074225378,0.00265771695802681,-0.0371543326602703,-0.0267360821848052,3.91088547893304e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40274,-0.0471073060583579,0.00392295820194064,-0.0547963041341616,-0.0394183079825543,4.48552810172967e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,39991,-0.0760486415050536,0.00633598093552445,-0.0884671641386815,-0.0636301188714257,4.81659013539893e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,40122,-0.0653000870674314,0.00544117255830589,-0.0759647852817109,-0.0546353888531518,4.89352497416606e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,40126,-0.0400691699933836,0.00334244282694792,-0.0466203579342015,-0.0335179820525656,5.72468529222327e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39991,-0.0427157730590783,0.00356328486251667,-0.049699811389611,-0.0357317347285457,5.75750064175157e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,40058,-0.0496269507392413,0.00414751327302722,-0.0577560767543746,-0.0414978247241079,7.50300515150721e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40065,-0.0863792656333726,0.00722152206253979,-0.100533448875951,-0.0722250823907946,7.87869815083699e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,40229,-0.0299670520584349,0.00250555862946231,-0.034877946972181,-0.0250561571446888,7.95920265386984e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40160,-0.0987331765219585,0.00826354775579655,-0.11492973012332,-0.0825366229205972,9.21807652701721e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39991,-0.0509170269077332,0.00426402147187928,-0.0592745089926166,-0.0425595448228498,1.00502728574793e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40126,0.0448331803251063,0.00375481192051044,0.0374737489609058,0.0521926116893067,1.01285352497601e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37403,-0.0507298694506349,0.00425036491126007,-0.0590605846767047,-0.0423991542245652,1.14773073760172e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40261,-0.0600337298337181,0.0050364911923173,-0.06990525257066,-0.0501622070967762,1.28833739680498e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,39746,-0.0701263999097007,0.00588348292955783,-0.0816580264516341,-0.0585947733677674,1.3109016024558e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,39727,-0.0401182244943691,0.00336779950596474,-0.04671911152606,-0.0335173374626782,1.42358951425848e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,40126,-0.136134864833031,0.0114321569440336,-0.158541892443336,-0.113727837222725,1.4844836558879e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,37723,0.0215521413882835,0.00180941078144373,0.0180056962566538,0.0250985865199132,1.51698911975755e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,37808,-0.024526414496247,0.00206864396125979,-0.0285809566603161,-0.0204718723321778,2.8978150630035e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40065,-0.0497128554634399,0.004198568540684,-0.0579420498031806,-0.0414836611236993,3.31287716517252e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),37533,0.197901301292164,0.0167256032045451,0.165119119011256,0.230683483573073,3.8783903613009e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37737,-0.0773647914772964,0.00654979171231428,-0.0902023832334324,-0.0645271997211604,4.90627272126541e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,40133,-0.0282733103183693,0.00239510037527999,-0.0329677070539181,-0.0235789135828205,5.04668704202554e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40274,-0.0625284965434583,0.00529862053791991,-0.0729137927977813,-0.0521432002891353,5.25974762038747e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39727,-0.0545807132841299,0.00462653790323201,-0.0636487275744647,-0.0455126989937952,5.54745340139357e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40065,-0.154118810428757,0.0130647625116401,-0.179725744951572,-0.128511875905943,5.56068536250393e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,40233,-0.0674766883025786,0.00572403272429321,-0.0786957924421933,-0.0562575841629639,6.10495053613234e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39991,-0.0780889634659381,0.00663203350400226,-0.0910877491337825,-0.0650901777980937,7.2150204618722e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37697,-0.0495799539440443,0.00420927667265233,-0.0578301362224429,-0.0413297716656457,7.24451984209464e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40213,-0.0656161928001336,0.00557602548758978,-0.0765452027558096,-0.0546871828444577,7.79552444761259e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40065,0.0467272599516134,0.00397921540350803,0.0389279977607376,0.0545265221424891,1.04497398439935e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,39967,-0.0327557612195989,0.00279039034893129,-0.0382249263035043,-0.0272865961356936,1.09799997587447e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37756,-0.0704562214753374,0.00600429761755443,-0.0822246448057441,-0.0586877981449307,1.21747599315816e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,37791,-0.0827879870951381,0.00706283348551369,-0.0966311407267449,-0.0689448334635313,1.41036702333449e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,40097,-0.0403162844124017,0.00344508289137797,-0.0470686468795025,-0.0335639219453009,1.67319122058528e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37756,-0.0684981199961655,0.00585408764311526,-0.0799721317766715,-0.0570241082156596,1.79833963496088e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37362,-0.0754482535905546,0.00644815863230274,-0.088086644509868,-0.0628098626712412,1.82119168802731e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40186,-0.138308789020613,0.0118266372449306,-0.161488998020677,-0.11512858002055,1.83127838172475e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37470,-0.0878034234748353,0.00751099365293418,-0.102524971034586,-0.0730818759150843,2.05827144635457e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,37756,-0.114388512374853,0.00979132975546306,-0.133579518695561,-0.0951975060541454,2.22518686692984e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40233,-0.0736194017385988,0.0063070480068894,-0.085981215832102,-0.0612575876450956,2.36846551024166e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37756,-0.106251078536661,0.00909991208424794,-0.124086906221787,-0.0884152508515347,2.40231277638342e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,37737,-0.0830878975293736,0.00712130901287491,-0.0970456631946084,-0.0691301318641388,2.65501727855452e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37403,-0.0538484043266971,0.0046239845534859,-0.0629114140515295,-0.0447853946018648,3.46126928347744e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37470,-0.0648124424130981,0.00558024740150313,-0.0757497273200442,-0.053875157506152,4.9398764065617e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37362,-0.0619328558310618,0.00533592805261098,-0.0723912748141793,-0.0514744368479443,5.42587524036208e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,40248,0.0505618053038745,0.00435992104175356,0.0420163600620375,0.0591072505457115,5.70020183641229e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,40100,-0.0676164726131671,0.00583383376920645,-0.0790507868008118,-0.0561821584255225,6.16631421411909e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40095,-0.0503041976846816,0.00434035392363805,-0.0588112913750122,-0.041797103994351,6.20391353433054e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37737,-0.118014136838893,0.0101816442069069,-0.137970159484431,-0.0980581141933558,6.45631740343584e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37784,-0.0317695685588949,0.00275410108016666,-0.0371676066760216,-0.0263715304417683,1.22310293654175e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,40186,-0.114028355795234,0.00989432036506878,-0.133421223710768,-0.0946354878796989,1.31557685033053e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,40248,-0.0397691494262675,0.00345484035935704,-0.0465406365306072,-0.0329976623219277,1.53475897843928e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,40144,0.0424537290774335,0.00368817418734874,0.03522490767023,0.0496825504846371,1.54412602053616e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40065,0.044902506390429,0.00390533064204482,0.0372480583320212,0.0525569544488369,1.79597955299607e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,39955,-0.0704297983270467,0.00612651208311222,-0.0824377620099467,-0.0584218346441468,1.83806057339919e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39810,-0.0412601167683969,0.00359582905935961,-0.0483079417247417,-0.0342122918120521,2.35762801787569e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,40164,-0.108773922305288,0.00949234356907504,-0.127378915700675,-0.0901689289099009,2.79196305068702e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39991,-0.0624619622506617,0.00545340524848476,-0.0731506365376919,-0.0517732879636316,2.9779980833037e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,37756,-0.0584282292031651,0.00510414601382104,-0.0684323553902544,-0.0484241030160759,3.36244650791257e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39810,-0.0792884130684852,0.00692961408417946,-0.0928704566734769,-0.0657063694634934,3.4189434085424e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,40121,0.0415287334525691,0.00363184511799816,0.0344103170212928,0.0486471498838455,3.69820583567795e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37410,-0.0876551406407247,0.0076662837427016,-0.10268105677642,-0.0726292245050296,3.95013152406441e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37696,-0.0430161150286856,0.00376307880062487,-0.0503917494779103,-0.0356404805794608,4.04721979775177e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37756,-0.0834736271044392,0.00730424476808375,-0.0977899468498834,-0.0691573073589951,4.1818715643792e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,37675,-0.0452781570095719,0.00396469209502942,-0.0530489535158296,-0.0375073605033143,4.57717641159255e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37430,-0.111710787759533,0.00978347613756495,-0.13088640098916,-0.0925351745299056,4.71304464369834e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,40065,-0.0535214776669018,0.00469260562958517,-0.0627189847008887,-0.0443239706329149,5.16081379830819e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,40100,-0.0575722074791367,0.00504986747197588,-0.0674699477242094,-0.047674467234064,5.44490287210198e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,40054,-0.044224957137638,0.00387994854065875,-0.0518296562773292,-0.0366202579979468,5.60030574834828e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,39815,-0.0551835616294585,0.00484344187875785,-0.0646767077118239,-0.0456904155470931,5.94508071772823e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40174,-0.037445352076879,0.0032884788782925,-0.0438907706783323,-0.0309999334754257,6.37087685032014e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37784,-0.0800962124954808,0.0070394730602543,-0.0938935796935793,-0.0662988452973824,7.37702523377588e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,37737,-0.0399221640502932,0.00351001449120585,-0.0468017924530567,-0.0330425356475297,7.76047301010011e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40274,-0.0732047332173641,0.00644551195250203,-0.085837936644268,-0.0605715297904601,8.87915042183214e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,37515,-0.139273998134315,0.0122696596899401,-0.163322531126597,-0.115225465142032,1.00921665873919e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,40274,-0.0403920559935671,0.00356175937370248,-0.0473731043660239,-0.0334110076211102,1.07670399132692e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40065,-0.0646277496355072,0.00569881195926186,-0.0757974210756604,-0.0534580781953539,1.07943237446899e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,40058,-0.0334464769569906,0.00295498871417087,-0.0392382548367655,-0.0276546990772157,1.38366324727043e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39991,-0.0835832057591376,0.00738546131166569,-0.0980587099300023,-0.0691077015882728,1.4071171102213e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37784,-0.0879666405941126,0.00777976131029935,-0.103214972762299,-0.0727183084259259,1.64870657663628e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40126,-0.0298858471087849,0.00264414590396294,-0.0350683730805523,-0.0247033211370176,1.65613946348366e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37714,-0.0640452347247314,0.00567832127421874,-0.0751747444222001,-0.0529157250272627,2.26957378319588e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,40083,-0.0888697967718522,0.00788886850737584,-0.104331979046309,-0.0734076144973955,2.52797315623897e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39727,-0.0653513244602001,0.00580973579253603,-0.0767384066135707,-0.0539642423068295,3.06643526755662e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,40100,-0.0349136227292332,0.0031102787959247,-0.0410097691692456,-0.0288174762892208,3.96117413379785e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40174,-0.101341797509536,0.00903046525539035,-0.119041509410102,-0.0836420856089714,4.09311066705143e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,37791,0.0426304064471793,0.00380213985751045,0.0351782123264588,0.0500826005678998,4.78994813565793e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,40100,0.0362086735179184,0.003231600987014,0.029874735583371,0.0425426114524659,4.994726769999e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,39967,-0.0561175701984524,0.00501725845376718,-0.0659513967678361,-0.0462837436290687,6.23721538077012e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,40186,-0.0500306625908903,0.00448303194816002,-0.058817405209284,-0.0412439199724967,8.20876273359877e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,37403,-0.0969694644783583,0.00868710961646002,-0.11399619932662,-0.0799427296300966,8.42420779553501e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,40057,-0.0500215696110031,0.00448316064956298,-0.0588085644841465,-0.0412345747378597,8.44400431746745e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,37697,-0.0217612974184218,0.00195391289785098,-0.0255909666982097,-0.0179316281386338,1.10738920501588e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37784,-0.0775552105834373,0.00696925405428113,-0.0912149485298284,-0.0638954726370463,1.22292790261262e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,37575,-0.115381416819383,0.0103861260847237,-0.135738223945441,-0.0950246096933246,1.5172067414879e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37403,-0.0572753380537198,0.00516077096025415,-0.067390449135818,-0.0471602269716217,1.72012795963854e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,40274,-0.0369902130338973,0.0033409944173436,-0.0435385620918907,-0.0304418639759039,2.18998961199058e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,40174,-0.0584031828729039,0.00528051024884948,-0.0687529829606489,-0.048053382785159,2.49043590414906e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,37759,-0.0467662584750986,0.00423789585533707,-0.0550725343515593,-0.0384599825986379,3.42287917802754e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,40126,-0.0560803711907333,0.00508426949714133,-0.0660455394051303,-0.0461152029763363,3.47042338587928e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37782,-0.0283821936274507,0.00257420521366463,-0.0334276358462334,-0.0233367514086681,3.80465010090862e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,37470,-0.0736699071194437,0.00668331294135982,-0.086769200484509,-0.0605706137543785,3.94359340662617e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40186,-0.10886030455294,0.00988062584633404,-0.128226331211755,-0.0894942778941256,3.985080920185e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37396,-0.0405680650805713,0.00368306040854022,-0.0477868634813101,-0.0333492666798324,4.32265962215942e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37430,-0.0813498224489995,0.00739166673114499,-0.0958374892420436,-0.0668621556559553,4.77707334483787e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40100,-0.0835233703612838,0.00759687948249934,-0.0984132541469825,-0.0686334865755851,5.14697286623687e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,40100,-0.0633598223578167,0.00576823752896195,-0.0746655679145821,-0.0520540768010513,5.75592922205835e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40070,-0.0681526401092299,0.00620715206824254,-0.0803186581629852,-0.0559866220554745,6.05467767830131e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39933,-0.0292913335783822,0.00266928168353707,-0.0345231256781148,-0.0240595414786495,6.49513821172534e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39810,-0.0959765023098253,0.0087515937928873,-0.113129626143884,-0.0788233784757662,7.00723851184861e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37737,-0.0792930717562274,0.0072292545065988,-0.0934624105891611,-0.0651237329232938,7.14332828646872e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39705,-0.0602111120427348,0.00549545305211278,-0.0709822000248758,-0.0494400240605937,7.85033761961662e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,39864,-0.0434327050816402,0.00396457437683086,-0.0512032708602287,-0.0356621393030517,7.94636007123752e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,37696,-0.0730863144724037,0.00667059934299631,-0.0861606891846765,-0.0600119397601309,8.14260878000293e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37756,-0.0789258729099324,0.00720366083018316,-0.0930450481370914,-0.0648066976827734,8.14397346252801e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39775,-0.0319673244316719,0.00291878409241871,-0.0376881412528126,-0.0262465076105312,8.21643593701555e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37430,-0.0559991827513318,0.00511589217463681,-0.0660263314136199,-0.0459720340890436,9.17116325477625e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39727,-0.0702015232328755,0.0064157402951533,-0.082776374211376,-0.057626672254375,9.19402813549022e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,39991,0.0294714983862496,0.00269385841261772,0.0241915358975189,0.0347514608749804,9.34166694361522e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37756,-0.0573349958728369,0.00523938832140671,-0.067604196982794,-0.0470657947628797,9.41811252236073e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37808,-0.0308472337800508,0.00282004825736612,-0.0363745283644884,-0.0253199391956132,9.8850358160118e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40095,-0.0448292196075197,0.00410417412649978,-0.0528734008954593,-0.0367850383195802,1.12850244242855e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,37764,-0.0476770990072445,0.00436581685937919,-0.0562341000516277,-0.0391200979628612,1.20436311763807e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39915,-0.0382646514000385,0.00350558462990887,-0.0451355972746599,-0.0313937055254171,1.22806092020356e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,37696,-0.0610075085166936,0.00559839494580063,-0.0719803626104628,-0.0500346544229244,1.55347238924561e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37696,-0.1125791280367,0.0103335304560705,-0.132832847730599,-0.0923254083428023,1.6011249290201e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40164,-0.0735039130602221,0.00675500268719711,-0.0867437183271284,-0.0602641077933158,1.77162746149692e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,37470,-0.052535750973823,0.00482846019521873,-0.0619995329564518,-0.0430719689911943,1.875457005337e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,37430,-0.0511071508894908,0.00471952478182265,-0.0603574194618632,-0.0418568823171184,3.28359417353923e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,40100,0.0438247090814296,0.00404927075039585,0.0358881384106538,0.0517612797522055,3.348842281421e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39815,-0.0617240255929473,0.00570650278696624,-0.0729087710554012,-0.0505392801304935,3.60496445300596e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40160,0.0466212200327168,0.00431130622835363,0.0381710598251437,0.0550713802402899,3.69466683546104e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,40100,-0.0491780543787298,0.00455141677822912,-0.0580988312640589,-0.0402572774934007,4.06327879682399e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37696,-0.0854365860509054,0.00791563754180234,-0.100951235632838,-0.0699219364689728,4.79250388105325e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40100,-0.062549511606129,0.00580570516982482,-0.0739286937389857,-0.0511703294732723,5.69129242448808e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40186,-0.087123334732773,0.00810212226262884,-0.103003494367525,-0.0712431750980204,7.10129792042545e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,40126,-0.0394717310424556,0.0036746581648713,-0.0466740610456033,-0.0322694010393078,8.04701459718871e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37515,-0.0539224247131817,0.00502005824946219,-0.0637617388821276,-0.0440831105442359,8.41733206329853e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37696,-0.104600856185055,0.0097412932866308,-0.123693791026851,-0.0855079213432584,8.71030586722717e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37362,-0.0377625475165343,0.00352167432292213,-0.0446650291894617,-0.0308600658436069,1.02962349589707e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40100,-0.0731901473944054,0.00683876767462385,-0.0865941320366682,-0.0597861627521427,1.22830584800021e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,40248,-0.111772696809834,0.0104472744722713,-0.132249354775486,-0.0912960388441826,1.27272088639497e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37609,-0.0315627284897684,0.00295023510794723,-0.037345189301345,-0.0257802676781918,1.33233344953998e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37376,-0.0732201067545697,0.00684618833409299,-0.086638635889392,-0.0598015776197475,1.38731574230259e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40126,-0.0779214531507878,0.00729258901034702,-0.092214927611068,-0.0636279786905076,1.47653714560866e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,40274,-0.0516081853227868,0.00483786883562681,-0.0610904082406153,-0.0421259624049583,1.77634476522908e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,40028,-0.0856386869935073,0.00803732687073811,-0.101391847660154,-0.0698855263268606,2.0349209870446e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,37784,0.0276916947411104,0.00259960512854613,0.02259646868916,0.0327869207930608,2.1725431848516e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40126,-0.0646058549491598,0.00607413568939561,-0.0765111609003751,-0.0527005489979444,2.48589059914287e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,39746,-0.09829416208038,0.00924747521541376,-0.116419213502591,-0.080169110658169,2.68979931261592e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40174,0.0428186581351977,0.00403040212433188,0.0349190699715072,0.0507182462988882,2.8320463826937e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37696,-0.0471381736472122,0.0044435937725758,-0.0558476174414608,-0.0384287298529636,3.47958960423378e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39746,-0.0859207983361601,0.00810873289146641,-0.101813914803434,-0.0700276818688859,3.82839585099482e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39919,-0.0353253050262202,0.00333592000915223,-0.0418637082441586,-0.0287869018082818,4.10121445241636e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,40095,0.0243815999580475,0.0023055613446637,0.0198626997225066,0.0289005001935883,4.75884669997845e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37784,-0.064855399651125,0.00613829914166014,-0.0768864659687789,-0.0528243333334711,5.44460925679663e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,40076,-0.114641150279412,0.0108731153965164,-0.135952456456584,-0.0933298441022395,6.64790835234701e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,39991,-0.0965345533301554,0.00916337674177228,-0.114494771744029,-0.0785743349162817,7.29682253570961e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37696,-0.0763447268363436,0.00724937665594946,-0.0905535050820045,-0.0621359485906827,7.84663835629121e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,40297,-0.0529485396076528,0.00503384719846152,-0.0628148801166374,-0.0430821990986683,8.63384701387184e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,37730,-0.0838312428404237,0.00796850633047378,-0.0994495152481523,-0.0682129704326951,8.79506693469147e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,40055,-0.0875512291091902,0.00833242212181886,-0.103882776467955,-0.0712196817504252,9.74488132546152e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40297,-0.0215869087823044,0.00205475562728115,-0.0256142298117754,-0.0175595877528333,9.86697645775521e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40233,-0.0656169243138851,0.00624899314451802,-0.0778649508771404,-0.0533688977506298,1.04552320125264e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40209,-0.0301288014735818,0.00287067766875592,-0.0357553297043434,-0.0245022732428202,1.10273826366034e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,37518,-0.0250635882484225,0.00238926686784538,-0.0297465513093994,-0.0203806251874455,1.2131943395818e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,37697,-0.0818118470285494,0.00780127517674126,-0.0971023463749623,-0.0665213476821366,1.24925040059811e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40083,0.0242848015273418,0.00232884662438669,0.0197202621435439,0.0288493409111397,2.24186455233349e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,39570,-0.0397568098006078,0.00381462979512271,-0.0472334841990483,-0.0322801354021673,2.3930827881499e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,40073,-0.0661156494857796,0.00634485667037518,-0.0785515685597149,-0.0536797304118442,2.42409647543516e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,40095,-0.0523167897007163,0.00502327895799267,-0.0621624164583819,-0.0424711629430507,2.56626593628274e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,37756,-0.0655526995959287,0.00629300975264336,-0.0778869987111097,-0.0532184004807477,2.60174976713806e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40069,-0.0671458470472981,0.00645017382306187,-0.0797881877404994,-0.0545035063540969,2.70287238523857e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,37376,-0.0271184104405147,0.0026052125481377,-0.0322246270348646,-0.0220121938461648,2.83052807946172e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,37470,-0.0561094581481715,0.0053906192793699,-0.0666750719357365,-0.0455438443606065,2.84259418616744e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39815,-0.0573485850447712,0.00551156798491284,-0.0681512582952004,-0.046545911794342,2.85046657318857e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40100,-0.0957581353843462,0.00921007455354837,-0.113809881509301,-0.0777063892593914,3.08825560049188e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37791,0.0209318246794543,0.00201295914334143,0.0169864247585051,0.0248772246004035,3.14352219256676e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37737,-0.0391993698525583,0.00377196295064741,-0.0465924172358272,-0.0318063224692894,3.35721815361708e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37222,-0.0531740199861124,0.00512021269164896,-0.0632096368617444,-0.0431384031104804,3.64980266357124e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40145,0.0301081110773438,0.00290080675664307,0.0244225298343234,0.0357936923203642,3.71841204282481e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELN,Elastin,37784,-0.0345834577634829,0.00333714459776343,-0.0411242611750992,-0.0280426543518666,4.5392284550404e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39792,-0.0378348828980583,0.00365267149472432,-0.0449941190277179,-0.0306756467683986,4.64885720108898e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40174,-0.0247577473369051,0.00239028298765121,-0.0294427019927015,-0.0200727926811088,4.65046038322092e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37737,-0.0313823013439828,0.00303124077481995,-0.0373235332626299,-0.0254410694253357,5.05122860856871e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,40138,-0.104470233658662,0.0100941133360146,-0.12425469579725,-0.084685771520073,5.05747818405262e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",37808,-0.0160573445155955,0.0015546563945623,-0.0191044710489376,-0.0130102179822534,6.49578033860991e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37756,-0.0465619016808171,0.0045102027867391,-0.0554018991428258,-0.0377219042188085,6.83667700139923e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,40126,0.0298951707044939,0.00289699667288426,0.0242170572256408,0.0355732841833471,6.91987956154523e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39746,-0.0905778627628531,0.00878086961104632,-0.107788367200504,-0.0733673583252023,7.2451205505407e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,37784,-0.0457031417184033,0.00442992228226261,-0.054385789391638,-0.0370204940451686,7.32838031829514e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37515,-0.0415151177196463,0.00402658854077143,-0.0494072312595583,-0.0336230041797343,7.88564929239754e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37784,-0.0983181533334974,0.00954485106360649,-0.117026061418166,-0.0796102452488287,8.66835854762751e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40095,-0.026660708052057,0.00259042286789447,-0.0317379368731301,-0.0215834792309838,9.18137806425938e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,40243,-0.0680030963393169,0.00660810254716461,-0.0809549773317595,-0.0550512153468742,9.27650722784138e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37489,-0.0629294465402445,0.00611536383650236,-0.0749155596597891,-0.0509433334206999,9.68212580231779e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40065,-0.0819337573804622,0.00796698061771907,-0.0975490393911916,-0.0663184753697328,9.96038976133781e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40100,-0.0499107395726972,0.00485668796975947,-0.0594298479934258,-0.0403916311519687,1.07524790637375e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37756,-0.0766008108796441,0.00745857567228548,-0.0912196191973237,-0.0619820025619646,1.18705688364816e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37515,-0.0650760470055166,0.00634005222383374,-0.0775025493642307,-0.0526495446468025,1.2660640646375e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37193,-0.033982019402736,0.00331533868676621,-0.0404800832287978,-0.0274839555766742,1.4748237476383e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,37697,-0.0379126744930644,0.00370133479768899,-0.0451672906965348,-0.030658058289594,1.57098428032037e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40121,-0.0900483329201698,0.00879483200627366,-0.107286203652466,-0.0728104621878734,1.58779178226457e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,37732,-0.07349235753852,0.00718636459725807,-0.0875776321491458,-0.0594070829278942,1.85628234655248e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,39810,0.0228808390738916,0.00224155835281824,0.0184873847023679,0.0272742934454154,2.19439895626031e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37403,-0.0682501275889982,0.00668461971543404,-0.0813519822312489,-0.0551482729467475,2.21190674259891e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,37808,-0.0405389163401875,0.00397283329539417,-0.0483256695991601,-0.032752163081215,2.33661474231528e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39746,-0.0554337594998538,0.00544328257389642,-0.0661025933446907,-0.0447649256550168,2.79734398115756e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37403,0.0312157358395396,0.00306606655189093,0.0252062453978334,0.0372252262812458,2.97371343232494e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39746,-0.0532602013251133,0.00523422245203598,-0.0635192773311038,-0.0430011253191227,3.0510146022187e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,40274,-0.052743457488029,0.00518566750990131,-0.0629073658074355,-0.0425795491686224,3.17144522737624e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39746,-0.0572321351241511,0.00563622467245273,-0.0682791354821585,-0.0461851347661438,3.78079754927184e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37791,0.0316914757130568,0.00312811427112284,0.0255603717416561,0.0378225796844576,4.90872016199705e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40126,-0.0761679683612544,0.00752602465689316,-0.090918976688765,-0.0614169600337438,5.30478311845608e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40174,-0.0232768596356626,0.002303000364586,-0.0277907403502511,-0.018762978921074,6.07547111889214e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,40065,-0.0573181075991946,0.00567306341850583,-0.068437311899466,-0.0461989032989232,6.31081678514917e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,39815,-0.0759596619233547,0.00752299964583844,-0.0907047412291981,-0.0612145826175114,6.7632222485385e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40297,-0.0688100696782362,0.00681627728911384,-0.0821699731648994,-0.0554501661915731,6.86775828531389e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40213,-0.0266121817389041,0.00263649172735578,-0.0317797055245214,-0.0214446579532868,6.95630780478096e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40107,-0.0540703139048607,0.00537872486828728,-0.0646126146467038,-0.0435280131630177,1.05559275826779e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37430,0.0346458829617055,0.00344608751855105,0.0278915514253455,0.0414002144980656,1.08048632970918e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37470,-0.0644776763728048,0.00641461281709012,-0.0770503174943014,-0.0519050352513081,1.10179912221924e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40100,-0.0956262959287251,0.00953810663511281,-0.114320984933546,-0.076931606923904,1.38441496634553e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,37770,0.0320667608785024,0.00319796631486344,0.02579874690137,0.0383347748556347,1.40282690564169e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39991,-0.0772147139804235,0.00770474997099232,-0.0923160239235685,-0.0621134040372786,1.44300348759815e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37441,-0.0816400502668741,0.00815183170833705,-0.0976176404152147,-0.0656624601185334,1.59499663742257e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,40065,-0.0861388051722539,0.00860712374018819,-0.103008767703023,-0.0692688426414851,1.65722012655801e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,39727,-0.0683136996038191,0.00682633234639018,-0.0816933110027438,-0.0549340882048943,1.67106245094587e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39746,-0.0582249169350699,0.00582373371282013,-0.0696394350121974,-0.0468103988579424,1.83805934302132e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40186,-0.0396561743026475,0.00397285065183224,-0.0474429615802387,-0.0318693870250563,2.14947496779696e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,39966,-0.0430575480985133,0.00431588053645651,-0.0515166739499681,-0.0345984222470585,2.27073697300262e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,40174,-0.0669016505936449,0.00670801924503652,-0.0800493683139165,-0.0537539328733733,2.33858463424558e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40297,-0.0295648697398769,0.00297240967429834,-0.0353907927015016,-0.0237389467782521,3.05786953496393e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37362,-0.058728370737904,0.00590847437437072,-0.0703089805116706,-0.0471477609641373,3.38868922342251e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40100,-0.105218666445143,0.0105991858887834,-0.125993070787158,-0.0844442621031271,3.7171301183153e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,40297,0.0154467855735541,0.00155608607257569,0.0123968568713058,0.0184967142758024,3.72324063337249e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39810,-0.0705270610669263,0.00710959153609138,-0.0844618604776654,-0.0565922616561872,3.99987013707739e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40233,-0.0443562518606661,0.00447343708648954,-0.0531241885501856,-0.0355883151711466,4.16582138880857e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,40065,-0.0737046379670227,0.00744324190195004,-0.0882933920948448,-0.0591158838392007,4.7606090137783e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39746,-0.092665547494186,0.00936051413528037,-0.111012155199336,-0.0743189397890365,4.90114517300906e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,37470,-0.0640140636227629,0.00646503163777359,-0.0766855256327992,-0.0513426016127267,4.94178229215413e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REN,Renin,40126,-0.0668627785758477,0.00675628356084924,-0.0801050943551122,-0.0536204627965832,5.04188327311839e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,40100,-0.0667794851917442,0.00675212059036794,-0.0800136415488654,-0.0535453288346231,5.36526360133084e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39746,-0.0425673140403184,0.00431075175943115,-0.0510163874888034,-0.0341182405918333,6.27714582684884e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39746,-0.0415804924656976,0.0042128559344739,-0.0498376900972665,-0.0333232948341288,6.58150243043541e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,37501,-0.0210538269355689,0.00213402289215561,-0.0252365118041939,-0.0168711420669439,7.04237736254163e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,40027,-0.0678515984854667,0.00688126262918793,-0.0813388732386751,-0.0543643237322584,7.21488981807047e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37756,-0.0743303430893286,0.00753764757867274,-0.0891041323435272,-0.05955655383513,7.34287431579042e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39746,-0.0592197844698356,0.00601076010594421,-0.0710008742774862,-0.0474386946621849,7.83472512400752e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37470,-0.0669150170299644,0.00679062072245943,-0.0802246336459849,-0.0536054004139439,7.91379062560435e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,40274,-0.0457003992467588,0.00464013637688241,-0.0547950665454484,-0.0366057319480693,8.05748814382405e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,37470,-0.0509033176077799,0.0051685078288354,-0.0610335929522973,-0.0407730422632625,8.338287200899e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37376,-0.0641622013557045,0.00651654215546299,-0.076934623980412,-0.0513897787309971,8.57451701610164e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37430,-0.0718282265149231,0.00729717134764739,-0.086130682356312,-0.0575257706735342,8.80397927565411e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,39881,0.0256376740693681,0.00260855421022367,0.0205249078173297,0.0307504403214065,9.91599107922088e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37756,-0.1064777131712,0.0108331243892662,-0.127710636974162,-0.0852447893682386,1.01019103988331e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37784,-0.0999990671926414,0.0101775994334883,-0.119947162082278,-0.0800509723030044,1.0451888602255e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39810,-0.0320076035010806,0.00326229756077246,-0.0384017067201946,-0.0256135002819666,1.17263816580365e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40233,-0.0598863177546939,0.0061073636866333,-0.0718567505804952,-0.0479158849288927,1.23620948264569e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40141,-0.0370244803830531,0.00377833321074711,-0.0444300134761175,-0.0296189472899888,1.31818397668828e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,40095,0.0272994268899709,0.00278734061181565,0.0218362392908122,0.0327626144891295,1.38633974783315e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,39727,-0.0578360086801541,0.00590503158219965,-0.0694098705812655,-0.0462621467790428,1.38743846704204e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,40095,0.0265936616448936,0.00271902092496923,0.0212643806319539,0.0319229426578333,1.58262247591709e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38272,0.0290281983805069,0.00296883026164606,0.0232092910676806,0.0348471056933331,1.66116746477377e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40100,-0.0604960660054265,0.00619077463620408,-0.0726299842923865,-0.0483621477184665,1.72248833196902e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,40174,-0.029173820714439,0.00299262687120187,-0.0350393693819947,-0.0233082720468834,2.16510172271254e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,40097,-0.0834674132297689,0.0085644937225807,-0.100253820926027,-0.0666810055335107,2.22720862619518e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39746,-0.0723827489932493,0.00742837556937176,-0.086942365109218,-0.0578231328772807,2.27130599733812e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37756,-0.060880176147383,0.00624937563196794,-0.0731289523860402,-0.0486313999087259,2.37504259219862e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40100,-0.0965386530177124,0.00992408787309366,-0.115989865248976,-0.0770874407864489,2.65677391986515e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37410,-0.0525727597209327,0.00540841648939158,-0.0631732560401402,-0.0419722634017252,2.93601110713892e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40274,-0.0499649997715267,0.00514638710219411,-0.0600519184918272,-0.0398780810512263,3.19172310511015e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,39727,-0.0620022180021391,0.00638632001639966,-0.0745194052342825,-0.0494850307699958,3.21284011346952e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,37782,-0.022330018038739,0.00229961974080469,-0.0268372727307162,-0.0178227633467618,3.228348779803e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,40095,-0.083475891814158,0.00860183358758767,-0.10033548564583,-0.0666162979824861,3.33452356644213e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40095,0.0485667404167916,0.00500767131029679,0.0387517046486099,0.0583817761849733,3.53396818398475e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37782,-0.04322825923146,0.00445999490122677,-0.0519698492378644,-0.0344866692250555,3.84142292139546e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,40100,-0.0768171933884442,0.00792990147752291,-0.0923598002843891,-0.0612745864924993,3.95005612376202e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37403,-0.0814816264606947,0.00842503021533918,-0.0979946856827595,-0.06496856723863,4.73697994707504e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37756,-0.0990313190910064,0.0102419618777466,-0.11910556437139,-0.078957073810623,4.81731172870721e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,37606,0.0981501014050267,0.0101532690022889,0.0782496941605405,0.118050508649513,4.93665474591238e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37403,-0.0897331107523205,0.00928768317836754,-0.107936969781921,-0.0715292517227201,5.2121827178906e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,37791,-0.0375071940450229,0.00388277514917543,-0.0451174333374067,-0.029896954752639,5.26873432655234e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,37697,-0.0327076714991587,0.00338901645725721,-0.0393501437553829,-0.0260651992429346,5.74508981159347e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,37715,-0.0271326659659755,0.00281201630510617,-0.0326442179239836,-0.0216211140079674,5.87038532574824e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37737,-0.0834405501465539,0.00864780847819673,-0.100390254763819,-0.0664908455292883,5.87324609502305e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37470,0.0263442560445902,0.00273088246667191,0.0209917264099133,0.0316967856792672,6.00595713880154e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,40186,-0.0842294979039881,0.00874771457372231,-0.101375018468484,-0.0670839773394924,6.94787754477239e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40095,-0.026405489370331,0.00274595690978823,-0.031787564913516,-0.0210234138271461,7.85488918231914e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37376,-0.0744104729542797,0.00773776564020023,-0.0895764936090722,-0.0592444522994873,8.05592837511763e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37756,-0.0624883978783923,0.00649941580274808,-0.0752272528517785,-0.0497495429050061,8.17914488018472e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37756,-0.047523999987221,0.00494780001773039,-0.0572216880219725,-0.0378263119524694,8.95418435530971e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,37737,-0.0568786598414371,0.00592751331912673,-0.0684965859469255,-0.0452607337359487,9.80283555181907e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40095,0.0392404946934883,0.00409097189636039,0.0312221897766219,0.0472587996103547,9.91710880250523e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,40100,-0.0710022162481246,0.00740570198607134,-0.0855173921408244,-0.0564870403554247,1.0352824019546e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,40194,-0.0546579448857413,0.00571102680459728,-0.065851557422752,-0.0434643323487306,1.2172562343362e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37737,-0.0274962794635036,0.00287798669225043,-0.0331371333803144,-0.0218554255466928,1.46361214983942e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40164,-0.024624502533855,0.00257949134461128,-0.0296803055692931,-0.0195686994984169,1.53818245511962e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37430,-0.028500697822278,0.00298673073225415,-0.0343546900574961,-0.0226467055870598,1.6412075127297e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,39746,-0.0377083416470592,0.00395275855358838,-0.0454557484120924,-0.029960934882026,1.64325700411826e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37756,-0.0651370441827328,0.00683190588990455,-0.0785275797269457,-0.0517465086385199,1.76820684970454e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37791,0.0234268679629189,0.00245739810706507,0.0186103676730714,0.0282433682527664,1.78519097571158e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,40297,0.0266534568108829,0.00279804802183411,0.021169282688088,0.0321376309336777,1.87055228891473e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,37784,-0.0580728356813889,0.00609724543446583,-0.070023436732942,-0.0461222346298359,1.9414410133565e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,40107,0.0249825271841623,0.00262581987699837,0.0198359202252455,0.0301291341430791,2.09246785470507e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40065,0.0179948553448232,0.00189277673634386,0.0142850129415892,0.0217046977480572,2.23937892778723e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,37696,-0.060769980032728,0.00639446140387249,-0.073303124384318,-0.0482368356811379,2.37295678588162e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,40143,-0.043756552098247,0.0046098872296141,-0.0527919310682906,-0.0347211731282033,2.58811180968526e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,37430,-0.066638584257101,0.00702015546989654,-0.0803980889780982,-0.0528790795361037,2.64551526892358e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40100,0.0309649132856103,0.00326511900385435,0.0245652800380558,0.0373645465331649,2.80346754954323e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,40233,0.0270347624004417,0.00285203739311315,0.0214447691099399,0.0326247556909434,2.92149365303696e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37430,-0.0273344816828703,0.00288740482255964,-0.0329937951350872,-0.0216751682306534,3.37748847635945e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39746,-0.0588710234709482,0.00622306013851251,-0.0710682213424327,-0.0466738255994636,3.51386272063295e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37430,-0.0401376962314899,0.00424453619415869,-0.0484569871720409,-0.0318184052909389,3.7309800321747e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37470,-0.0258986283622771,0.0027396997839599,-0.0312684399388385,-0.0205288167857157,3.84534466131495e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37737,-0.0733232283250411,0.00775683882798399,-0.0885266324278897,-0.0581198242221925,3.84682693140941e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,40274,-0.030491681651804,0.00322810175910235,-0.0368187610996446,-0.0241646022039634,4.01286862557808e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40095,-0.0523456530974608,0.00554723814184673,-0.0632182398554803,-0.0414730663394412,4.39186306801432e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40160,0.0758150011588952,0.00803924710843878,0.0600580768263552,0.0915719254914352,4.63489311090095e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39991,-0.071061048811188,0.00753730671341607,-0.0858341699694835,-0.0562879276528924,4.76164054900166e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,39691,-0.0400444935452694,0.00424854659506442,-0.0483716448715956,-0.0317173422189431,4.8859930550875e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37358,-0.0758048935309525,0.00805363434420303,-0.0915900168455904,-0.0600197702163145,5.6552095363781e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,40065,-0.0801086641861605,0.00851717590550227,-0.096802328960945,-0.063414999411376,5.88099409164196e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,40174,-0.0638288772645455,0.00679034404363969,-0.0771379515900793,-0.0505198029390117,6.19499853462288e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,37730,-0.086769722836398,0.00923372292752796,-0.104867819774353,-0.0686716258984432,6.5162837098219e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40160,-0.0681045815275912,0.00725001619830256,-0.0823146132762642,-0.0538945497789182,6.57150990410464e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,40297,0.0270828508721049,0.00288347887388004,0.0214312322793,0.0327344694649098,6.64497365833876e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,40070,-0.0613897048555972,0.00653822485781715,-0.0742046255769189,-0.0485747841342756,6.85271639973782e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37362,-0.0596306063720903,0.00635569321816163,-0.0720877650796871,-0.0471734476644936,7.52484527018381e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,40190,0.0228332798310091,0.00243573556561466,0.0180592381224043,0.0276073215396138,7.89182523852343e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,37470,-0.0275310694192871,0.00293642443565974,-0.0332864613131802,-0.021775677525394,7.99161375811334e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40243,0.0295836049475844,0.00315809532331166,0.0233937381138935,0.0357734717812752,8.40567507235595e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37696,-0.0577179516414997,0.00618071477348493,-0.0698321525975301,-0.0456037506854692,1.13202236113265e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40297,-0.0362990718178689,0.00388817676544165,-0.0439198982781345,-0.0286782453576032,1.13299460433548e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37403,-0.0510638688509906,0.00547169876913362,-0.0617883984384924,-0.0403393392634887,1.20186185909654e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39746,-0.0690232826921513,0.00740126959933641,-0.0835297711068507,-0.054516794277452,1.24857200277036e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39991,-0.0307731886274363,0.00330351607269658,-0.0372480801299216,-0.0242982971249509,1.37610340901372e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40233,-0.0592329130610163,0.0063619491235574,-0.0717023333431888,-0.0467634927788438,1.43647814767027e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,40100,-0.0431634998822566,0.00463704861296231,-0.0522521151636627,-0.0340748846008504,1.46648647030193e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,39969,-0.0453944347872332,0.00488178941291429,-0.0549627420365452,-0.0358261275379212,1.60701950565131e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,37737,-0.0502542359950514,0.00540676756111072,-0.0608515004148284,-0.0396569715752744,1.70340913517831e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37470,-0.0623133144308678,0.0067141047488128,-0.0754729597385409,-0.0491536691231947,1.94199716723018e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37696,-0.0801631624395183,0.00863827578239335,-0.0970941829730092,-0.0632321419060273,1.95464890597443e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,39647,-0.0751062504519018,0.00809595784849938,-0.0909743278349606,-0.059238173068843,1.97360932072419e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37430,-0.0791752748212241,0.0085343631735133,-0.0959026266413101,-0.062447923001138,2.01149146566841e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37470,-0.0198845749641289,0.00214483311806206,-0.0240884478755305,-0.0156807020527272,2.1324268435903e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40233,-0.0425113791166414,0.00458729908417012,-0.0515024853216148,-0.033520272911668,2.15288014937809e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40050,-0.078086905184013,0.00844348986801558,-0.0946361453253236,-0.0615376650427025,2.57344810787054e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37403,-0.067441782623054,0.00730445116517036,-0.0817585069067879,-0.0531250583393201,3.03673938074586e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37696,-0.0563604758294059,0.00611735578122774,-0.0683504931606123,-0.0443704584981995,3.63576222166227e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37784,-0.0412742059383291,0.00448297116403828,-0.0500608294198441,-0.0324875824568141,3.85139800134251e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40065,-0.101362799094377,0.0110235216739467,-0.122968901575313,-0.0797566966134417,4.20891124735492e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,37376,-0.114363765833868,0.0124348640546335,-0.13873609938095,-0.0899914322867867,4.23735239021948e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,40097,-0.0336903164925284,0.00366484055854078,-0.0408734039872684,-0.0265072289977885,4.29804568926723e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,39722,0.105804610934411,0.0115121635931682,0.0832407702918014,0.128368451577021,4.39752502098911e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,37403,-0.0381004838601712,0.00415272985371191,-0.0462398343734465,-0.0299611333468958,5.20072719633441e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37756,-0.0542447364146779,0.00591825469348262,-0.0658445156139039,-0.042644957215452,5.63711060622657e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,40248,0.0142535526067152,0.00155588262403248,0.0112040226636116,0.0173030825498189,5.75728063399461e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39810,-0.0312694321060629,0.00341632118689036,-0.037965421632368,-0.0245734425797577,6.22446026333163e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,37470,-0.0991795939853629,0.0108419572245206,-0.120429830145423,-0.0779293578253026,6.66685730896839e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37403,-0.0780477548821919,0.00853895935700337,-0.0947841152219185,-0.0613113945424653,7.15179172873501e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,37376,-0.0357594781593292,0.0039145655614116,-0.043432026659696,-0.0280869296589625,7.50485885793472e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37380,-0.0310160102074111,0.00339671514008166,-0.0376735718819711,-0.024358448532851,7.77112515635533e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,39727,0.0638056253389017,0.00698964065000831,0.0501059296648855,0.077505321012918,7.79221721943809e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40065,-0.0776208501444371,0.00850506247960676,-0.0942907726044664,-0.0609509276844079,7.92921300910388e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40248,-0.0467742919378067,0.00512764556012614,-0.056824477235654,-0.0367241066399595,8.24890543232938e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,37376,-0.0695394339655576,0.007621735611034,-0.0844780357631842,-0.0546008321679309,8.31333141057408e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,37644,-0.0805434402310656,0.00882927830594654,-0.0978488257107208,-0.0632380547514104,8.4066813802798e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37403,-0.0293664728183236,0.00322074714514078,-0.0356791372227995,-0.0230538084138476,8.77496202756844e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37430,0.0178014199023017,0.00195358243259443,0.0139723983344166,0.0216304414701868,9.24406980179536e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40126,-0.0587458709877327,0.00644889997606069,-0.0713857149408117,-0.0461060270346538,9.26282339507447e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,40090,-0.0886483692938975,0.0097368416475153,-0.107732578923028,-0.0695641596647675,9.7008483740171e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40092,-0.0313337563398692,0.00344269174809113,-0.0380814321661278,-0.0245860805136106,9.96183581150485e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,37777,0.0313205752361728,0.00344243730272219,0.0245733981228373,0.0380677523495083,1.04542524482347e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,39810,-0.0512166250205472,0.00563259976828905,-0.0622565205663937,-0.0401767294747007,1.08035089092571e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40297,-0.0295711726843812,0.00325591346409599,-0.0359527630740094,-0.0231895822947531,1.18617275587955e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C3,Complement C3,37162,-0.0405863048793465,0.00447092760486292,-0.0493493229848778,-0.0318232867738152,1.26928006635142e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39746,-0.0255010802660878,0.00281465306552153,-0.03101780027451,-0.0199843602576656,1.45816910295522e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37430,-0.0281560459696391,0.00310879166451407,-0.0342492776320867,-0.0220628143071915,1.53166034377014e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40095,-0.0665605476471584,0.00735290317023622,-0.0809722378608214,-0.0521488574334955,1.56220164077167e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,37470,-0.0637337392554072,0.00704055620114273,-0.077533229409647,-0.0499342491011675,1.59561473234562e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40065,0.022704737575987,0.00251099803109345,0.0177831814350438,0.0276262937169302,1.71408199212812e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37756,-0.079850731386499,0.00883126918633422,-0.0971600189917141,-0.0625414437812839,1.75151094382881e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39991,-0.0417516711207203,0.00461865953012182,-0.0508042437997591,-0.0326990984416816,1.75181782758838e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37696,-0.126672370208467,0.0140125165040896,-0.154136902556482,-0.0992078378604513,1.78264088658302e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,39991,0.0293427999481732,0.00324759141870784,0.0229775207675058,0.0357080791288405,1.8255441233001e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,40095,0.0218566454559607,0.00241946764552753,0.0171144888707267,0.0265988020411946,1.85080909199592e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,37782,0.0408319749453703,0.0045217798839616,0.0319692863728056,0.0496946635179351,1.94844350943539e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,40174,0.0352550028292007,0.00390606960041448,0.0275991064123883,0.0429108992460131,1.98864432334452e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,40248,-0.0350405263524596,0.00388368819401591,-0.0426525552127308,-0.0274284974921885,2.04647613261125e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40186,-0.0231839306517896,0.00257067263176851,-0.0282224490100559,-0.0181454122935234,2.12043374288883e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39815,-0.0468408347159175,0.00519524112411874,-0.0570235073191902,-0.0366581621126448,2.17511327736874e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,40274,-0.0540683404768904,0.00599711888872726,-0.0658226934987958,-0.042313987454985,2.17580738258732e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,37808,-0.031437227293592,0.00349472432193281,-0.0382868869645803,-0.0245875676226037,2.66190636652058e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37470,-0.0720314909553719,0.00801433015585264,-0.0877395780608431,-0.0563234038499008,2.86540462446764e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40100,-0.0521374742638853,0.00580314515627248,-0.0635116387701794,-0.0407633097575913,2.89463279403673e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40274,0.0219708546296087,0.00245079254861863,0.0171673012343161,0.0267744080249012,3.45006156806388e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37697,-0.0703025274743938,0.00784620349617276,-0.0856810863268924,-0.0549239686218952,3.67372832824549e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,37737,-0.116102674039399,0.0129624505973469,-0.141509077210199,-0.0906962708685993,3.78061444811926e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,37756,-0.0467120710704143,0.00521739242810243,-0.056938160229495,-0.0364859819113335,3.90811670401861e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37403,-0.0382264421622584,0.00427073649969963,-0.0465970857016696,-0.0298557986228471,4.0054591452499e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39997,-0.0250035022545629,0.00280300675151035,-0.0304973954875232,-0.0195096090216026,5.16267119360895e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37697,-0.0487817348907695,0.00546770627592072,-0.0594984391915741,-0.0380650305899648,5.18385405315021e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39991,-0.0803386240920237,0.00900874856515492,-0.0979957712797274,-0.0626814769043201,5.27530421402633e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37756,-0.0519154124218842,0.00582814656531683,-0.0633385796899052,-0.0404922451538632,5.87890559563739e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39810,-0.0413238233281595,0.00464429284609363,-0.050426637306503,-0.032221009349816,6.32431785073874e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,40094,0.0185318586277908,0.00208545349660964,0.0144443697744359,0.0226193474811457,6.99821427533716e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37376,-0.0415412571656731,0.00467717479166563,-0.0507085197573377,-0.0323739945740085,7.4458640628401e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40297,-0.0356905077192198,0.00402633819916764,-0.0435821305895884,-0.0277988848488512,8.50754656139149e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40100,-0.0811139408330476,0.00915102959076881,-0.0990499588309544,-0.0631779228351407,8.54450814896695e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40174,-0.0517096050035521,0.0058339592693846,-0.0631441651715459,-0.0402750448355583,8.56808472622266e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39810,-0.0483676769363938,0.00546107509969077,-0.0590713841317877,-0.0376639697409999,9.12150112242431e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40174,-0.0610488796733239,0.0069017827977214,-0.0745763739568578,-0.0475213853897899,1.00760658214129e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37756,-0.0630127762704846,0.00712766126586873,-0.0769829923515873,-0.0490425601893819,1.07052953733802e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,40204,-0.058669481668958,0.00664054614305171,-0.0716849521093394,-0.0456540112285767,1.10459427496574e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,40174,-0.0574543620133931,0.00651167031363415,-0.070217235828116,-0.0446914881986702,1.22650418424042e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37784,0.0274296953188701,0.00311000588392788,0.0213340837863714,0.0335253068513687,1.28733501512233e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37808,-0.0210272055651625,0.0023869471275076,-0.0257056219350774,-0.0163487891952476,1.41368690719185e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39991,-0.0845415878554846,0.00959916609083745,-0.103355953393526,-0.0657272223174432,1.41681321896558e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37756,-0.0704766337216455,0.00800243606278621,-0.0861614084047065,-0.0547918590385845,1.44408898550171e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,40233,-0.0187407824772428,0.0021287879571086,-0.0229132068731756,-0.0145683580813099,1.46164444340452e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,40095,-0.0447049513021636,0.00507972167283163,-0.0546612057809136,-0.0347486968234136,1.50007050123025e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40095,-0.0249999601529371,0.00284461166904556,-0.0305753990242664,-0.0194245212816078,1.67041527559301e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,37403,-0.0349623101998769,0.00398039532970973,-0.042763885046108,-0.0271607353536458,1.78002837580765e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,40077,-0.0389233942208195,0.00443275583044501,-0.0476115956484917,-0.0302351927931473,1.7880461481471e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,37737,-0.0773402618524321,0.00880727298355781,-0.0946025169002054,-0.0600780068046588,1.80997070241322e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,39991,0.0353636822001334,0.00402988677844022,0.0274651041143905,0.0432622602858762,1.87824201168657e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,39746,-0.0358795897500442,0.0040892777118588,-0.0438945740652875,-0.027864605434801,1.90272207999238e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39810,-0.0409318178651986,0.00467254070449423,-0.0500899976460073,-0.0317736380843899,2.15210351178226e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,37791,-0.0690250826586302,0.00788013101278391,-0.0844701394436866,-0.0535800258735737,2.19757217633051e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40186,-0.0318278089362835,0.00363551540704805,-0.0389534191340976,-0.0247021987384693,2.25164598847426e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,37696,-0.0566979619270236,0.00648004513545537,-0.0693988503925162,-0.0439970734615311,2.39689826912488e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37470,-0.0865366200894129,0.00990037935772983,-0.105941363630563,-0.0671318765482625,2.59705574008822e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,40095,-0.0629238880426203,0.00720206066850987,-0.0770399269528997,-0.048807849132341,2.63469301111662e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40065,-0.0466319810273059,0.00533927158242197,-0.0570969533288529,-0.0361670087257588,2.7094261564879e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39877,-0.0172097743381419,0.00197107849909267,-0.0210730881963635,-0.0133464604799203,2.77598234724e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,40034,-0.0653272649154739,0.00748419222779754,-0.0799962816819571,-0.0506582481489907,2.83364499134828e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39832,0.0248190631429267,0.00284454933308677,0.0192437464500767,0.0303943798357768,2.92766059479471e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37808,0.0212636775611564,0.00243756361194495,0.0164860528817443,0.0260413022405685,3.01785067911715e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,39746,-0.0800883355555891,0.00918382437037589,-0.0980886313215259,-0.0620880397896524,3.04861018105589e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37784,-0.0333185705449799,0.00382068969214168,-0.0408071223415776,-0.0258300187483822,3.09273670251719e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37470,-0.0453178093730635,0.00519689699629656,-0.0555037274858047,-0.0351318912603222,3.11182791707028e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40158,-0.0912183124089302,0.0104645126181116,-0.111728757140429,-0.0707078676774315,3.14051089019233e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37697,-0.0290979263349441,0.00333740138408279,-0.0356392330477463,-0.0225566196221418,3.14503412858383e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPART,Spartin,37470,-0.0641548305398043,0.0073586986680814,-0.0785778799292438,-0.0497317811503647,3.16518825455243e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37515,-0.0882534055207947,0.0101237236278498,-0.10809590383138,-0.0684109072102091,3.18473787201499e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40100,0.0436953259490023,0.00501754471075002,0.0338609383159323,0.0535297135820724,3.38246748230413e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40121,-0.0416276197655773,0.00478107270656634,-0.0509985222704473,-0.0322567172607073,3.43452480881917e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40065,-0.0294191552675633,0.00338052819687897,-0.036044990533446,-0.0227933200016805,3.56530386307199e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37746,-0.016428990703532,0.00188776521807763,-0.0201290105309642,-0.0127289708760999,3.61301790351385e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39815,-0.0760616014473513,0.00874630681517588,-0.093204362805096,-0.0589188400896066,3.76716428028229e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,37362,-0.0556369540834538,0.00640415547560773,-0.0681890988156449,-0.0430848093512626,4.14249153732888e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37696,-0.0737599912627614,0.00849872453700611,-0.0904174913552934,-0.0571024911702295,4.4567517964155e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,37697,-0.0523929630812763,0.00604279459011028,-0.0642368404778925,-0.0405490856846602,4.80569019114414e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,37737,-0.0881652225038227,0.0101736634427983,-0.108105602851707,-0.068224842155938,4.98769547995023e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,40186,-0.0348691299153071,0.00402929201348616,-0.04276654226174,-0.0269717175688743,5.45160526636652e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,40100,-0.0642325005537028,0.00744186464835334,-0.0788185552644753,-0.0496464458429302,6.64571402825769e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37784,-0.073867249777393,0.00857438086928741,-0.0906730362811964,-0.0570614632735897,7.78188445043684e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,40118,-0.0631499013261642,0.00733285716068859,-0.0775223013611138,-0.0487775012912146,7.86084390606774e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,39901,-0.0625473987845644,0.0072830660217633,-0.0768222081872205,-0.0482725893819084,9.67920303249013e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40248,0.0278964364399771,0.00325077012726832,0.0215249269905312,0.034267945889423,1.0225832288016e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,39727,-0.0372424272041333,0.00434165423807855,-0.0457520695107672,-0.0287327848974993,1.0576376317306e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37756,-0.0966296659112961,0.0112646159554751,-0.118708313184027,-0.0745510186385649,1.06982121310692e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37725,-0.0332342577474571,0.00387987371844157,-0.0408388102356026,-0.0256297052593116,1.19054264482219e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,40126,-0.10316430703197,0.0120543824154326,-0.126790896566218,-0.0795377174977221,1.25096934546349e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,40114,-0.0345818407316092,0.00404335546384237,-0.0425068174407403,-0.0266568640224782,1.31166437192578e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,37470,-0.0879460814953868,0.0102861149985094,-0.108106866892465,-0.0677852960983084,1.36742465296285e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,40100,-0.0549004286900172,0.00642499899007323,-0.0674934267105607,-0.0423074306694737,1.40475342944531e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,40028,-0.0458818816211718,0.00537048029257694,-0.0564080229946226,-0.035355740247721,1.42320004020419e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,40297,0.0189345813829441,0.00222029109341994,0.014582810839841,0.0232863519260472,1.62224537563763e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37403,-0.0430340887503168,0.00504569963963884,-0.052923660044009,-0.0331445174566247,1.64078256064361e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,37696,-0.0832143116922731,0.00976866115178129,-0.102360887549764,-0.0640677358347818,1.78949557003407e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,39990,-0.0582748891793208,0.00684486829813029,-0.0716908310436561,-0.0448589473149854,1.83767381692582e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39727,-0.0499921820004259,0.00587444002402588,-0.0615060844475166,-0.0384782795533351,1.8972402458297e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39746,-0.0478026360931971,0.00561768478456426,-0.058813298270943,-0.0367919739154511,1.91020488828617e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40143,0.0192885921918351,0.00227082998678475,0.014837765417737,0.0237394189659332,2.1721466247567e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,37782,-0.0552859160741462,0.00651042496154574,-0.0680463489987758,-0.0425254831495165,2.24622530902864e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39607,-0.097399775136341,0.0114785438123078,-0.119897721008464,-0.0749018292642178,2.34706529427611e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37784,0.0266475171569797,0.00314095002622911,0.0204912551055706,0.0328037792083887,2.40537845371758e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,40186,-0.0543016393875221,0.00640655439125419,-0.0668584859943803,-0.0417447927806639,2.53605313583253e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,37430,-0.0551259610552082,0.0065041125321853,-0.0678740216182914,-0.042377900492125,2.5902927679053e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40186,-0.105852568067807,0.0125074730652124,-0.130367215275623,-0.0813379208599904,2.82931426245411e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,40174,-0.0511855152415527,0.00605016693322975,-0.063043842430683,-0.0393271880524224,2.90199885692226e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,37362,-0.0481233588997322,0.00568689066346714,-0.0592696646001278,-0.0369770531993366,2.90570714015693e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37470,-0.0337410691465933,0.00398793968720883,-0.0415574309335226,-0.025924707359664,2.93762500816864e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37430,-0.0788137884810355,0.00931723821795713,-0.0970755753882315,-0.0605520015738395,2.9854020936118e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37782,-0.048504503736969,0.00574302435870737,-0.0597608314800355,-0.0372481759939026,3.32941515270137e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,40100,0.0208350905646921,0.0024721075150246,0.0159897598352439,0.0256804212941403,3.8168496429754e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37430,-0.0749624553379918,0.00890152607224751,-0.0924094464395969,-0.0575154642363867,4.11161559326209e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,37244,-0.0572750639470537,0.00681278355236678,-0.0706281197096925,-0.0439220081844148,4.64875991532778e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,40071,-0.0274758736887142,0.00327345361891658,-0.0338918427817906,-0.0210599045956377,5.11732074029945e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37737,-0.0771370486155908,0.0091975132596096,-0.0951641746044256,-0.059109922626756,5.49889461400256e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,40065,0.0359218260880739,0.00428851105787691,0.0275163444146352,0.0443273077615126,5.92182720653603e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,40100,-0.0527167912021994,0.00630078877065188,-0.065066337192677,-0.0403672452117217,6.42085305300446e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37696,-0.0819591807066618,0.0098064053548898,-0.101179735202246,-0.0627386262110778,7.02722992338378e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39955,-0.0607394497140154,0.00727181296669945,-0.0749922031287464,-0.0464866962992845,7.22973405178897e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,40140,-0.0535612754891978,0.00641399911098637,-0.066132713746731,-0.0409898372316645,7.34826082630108e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,37470,-0.0453685835824627,0.00543419812049578,-0.0560196118986344,-0.0347175552662909,7.593263982618e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,37737,-0.0298039891541135,0.00357089831899064,-0.0368029498593352,-0.0228050284488919,7.73091109850191e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40297,0.0205906973334256,0.0024699571998189,0.0157495812217806,0.0254318134450706,8.27708917544421e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40065,-0.0440852096368549,0.00529492707518248,-0.0544632667042125,-0.0337071525694972,9.05374107007243e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37756,-0.0383581922418456,0.0046069305027796,-0.0473877760272937,-0.0293286084563976,9.15817771059138e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,40065,-0.0651791886142608,0.00783301965975726,-0.0805319071473851,-0.0498264700811366,9.43055580403364e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,39746,-0.0300245666010802,0.00361030485449633,-0.037100764115893,-0.0229483690862674,9.82864414828092e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,37441,-0.0811983244303669,0.00977899380975059,-0.100365152297478,-0.0620314965632558,1.11177513175742e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39923,0.029831717659387,0.00359615414966676,0.0227832555260402,0.0368801797927339,1.17008599399985e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,37696,-0.060612340526091,0.00730630561703719,-0.0749326995354839,-0.0462919815166981,1.18117934215406e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37756,-0.0531957470269924,0.00642262152987661,-0.0657840852255506,-0.0406074088284343,1.3199900559977e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39727,-0.0524347252118568,0.00633296482694052,-0.0648473362726602,-0.0400221141510534,1.33682270520198e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,37737,-0.0553084905822981,0.00668122874601253,-0.0684036989244827,-0.0422132822401136,1.36923211557273e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,39815,-0.0385292054221817,0.00465553669276291,-0.047654057339997,-0.0294043535043664,1.37763984170256e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,37376,-0.0540819212359921,0.0065373492754286,-0.0668951258158322,-0.0412687166561521,1.43636966951637e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37696,-0.0417301487691011,0.00504801522891096,-0.0516242586177666,-0.0318360389204357,1.50818646713314e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37430,-0.0578858585191296,0.00700349179816176,-0.0716127024435266,-0.0441590145947326,1.52820121375516e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,40248,-0.0443112229798172,0.00536392008935521,-0.0548245063549534,-0.033797939604681,1.55836863837568e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,40126,-0.0518197553934798,0.00627757867573324,-0.064123809597917,-0.0395157011890427,1.64259177563185e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,37808,0.0181971736537055,0.00220541552763017,0.0138745592195504,0.0225197880878606,1.7150474972484e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37586,-0.0440812317351386,0.00535042535809702,-0.0545680654370087,-0.0335943980332684,1.90276396680774e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37768,0.0576191418771578,0.006996103914307,0.0439067782051161,0.0713315055491996,1.94741409135221e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37403,-0.0723771985545349,0.00879121759827167,-0.0896079850471473,-0.0551464120619224,2.00140682144401e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,39584,-0.0606157874908184,0.00737679633910773,-0.0750743083154695,-0.0461572666661672,2.25262028912165e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,40196,-0.0465659073273857,0.00566793724476871,-0.0576750643271324,-0.035456750327639,2.27245549695102e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,39727,-0.0245942724295223,0.00299580113945901,-0.0304660426628619,-0.0187225021961826,2.39562911865011e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,36873,-0.0192267950196229,0.00234257333947935,-0.0238182387650024,-0.0146353512742434,2.47914528378524e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,40174,0.0213635744342149,0.00260679791514628,0.0162542505205282,0.0264728983479016,2.69000589121499e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40297,0.0225685642667666,0.00275669408443685,0.0171654438612704,0.0279716846722628,2.88461044866424e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40233,-0.0445236770382656,0.00544129767219449,-0.0551886204757668,-0.0338587336007644,2.98926679017811e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40126,-0.0652214664876199,0.00797680854453837,-0.0808560112349151,-0.0495869217403246,3.14696014038881e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,37700,-0.0749036962178884,0.00916657967185223,-0.0928701923747188,-0.0569372000610581,3.32350974611128e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37470,-0.0641119877730222,0.00784849866160671,-0.0794950451497713,-0.048728930396273,3.40338260789693e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37696,-0.0457630902369218,0.00560245472274847,-0.0567439014935088,-0.0347822789803348,3.40657372334685e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,37343,-0.0305083697390842,0.00373510151530756,-0.037829168709087,-0.0231875707690814,3.42541827654788e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,40277,0.0323844318274301,0.00396891893083502,0.0246053507229934,0.0401635129318667,3.61469861301104e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39727,-0.0496846683922548,0.00608923773438055,-0.0616195743516407,-0.0377497624328689,3.62661955360525e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39991,0.0902338072925782,0.0110786601213007,0.0685196334548289,0.111947981130328,4.08461823312572e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39955,-0.0572401168377208,0.00703582839747635,-0.0710303404967744,-0.0434498931786671,4.4104448256993e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,37697,-0.0248114180048212,0.00305131567860958,-0.030791996734896,-0.0188308392747464,4.61940565131894e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37143,-0.0382654826296938,0.00470926849008857,-0.0474956488702674,-0.0290353163891202,4.86305704241088e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39815,-0.051157732583507,0.00630064465684866,-0.0635069961109304,-0.0388084690560836,5.03613218402134e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,39991,-0.0258288132831549,0.00318246136080125,-0.0320664375503254,-0.0195911890159845,5.17676451823773e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,40160,-0.0662492729768203,0.0081868457898914,-0.0822954907250074,-0.0502030552286332,6.28732508660429e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,40095,-0.0214124092620931,0.00264828610071282,-0.0266030500194902,-0.0162217685046959,6.64741004479849e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37515,-0.0340564889204419,0.00421169799405481,-0.0423114169887894,-0.0258015608520945,6.69697277195564e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,37403,-0.0357538014135678,0.00442242252769329,-0.0444217495678467,-0.027085853259289,6.78449646806663e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,37430,-0.031892328159663,0.00394716212293436,-0.0396287659206143,-0.0241558903987116,7.05731717461268e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37376,-0.0333202423466378,0.0041250170094405,-0.0414052756851412,-0.0252352090081344,7.18827913069765e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37696,-0.0591639102493052,0.00732708953429156,-0.0735250057365167,-0.0448028147620938,7.34656767468704e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,39800,-0.0332568911832634,0.00412036470213333,-0.0413328059994447,-0.025180976367082,7.46459145172902e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37430,-0.0430686097722604,0.00534099673119126,-0.0535369633653953,-0.0326002561791255,8.04270322344058e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37745,-0.0521542307185776,0.00648347835818822,-0.0648618483006265,-0.0394466131365287,9.41456881854001e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,37737,-0.0511599909288045,0.00636669241430291,-0.0636387080608382,-0.0386812737967708,1.00966068382284e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,40065,-0.0229852398883497,0.00286327852080017,-0.0285972657891181,-0.0173732139875814,1.06434764163771e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37697,-0.082459964260111,0.0102759697154801,-0.102600864902452,-0.06231906361777,1.10438083784146e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39727,-0.0574928410073299,0.00716692677463508,-0.0715400174856146,-0.0434456645290451,1.1157551733282e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37362,-0.0517572083047417,0.00645077188742594,-0.0644007212040966,-0.0391136954053869,1.11686321858702e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,37470,0.0411265984527491,0.00513000861881711,0.0310717815598676,0.0511814153456307,1.17688547997257e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,39911,-0.035316413436192,0.00441010663224634,-0.0439602224353948,-0.0266726044369892,1.24775758507152e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,40274,0.0296718514953667,0.00371060270534799,0.0223990701928846,0.0369446327978488,1.36793746627058e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37697,-0.0659711985234764,0.00825355773880384,-0.0821481716915319,-0.0497942253554209,1.42474902664769e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,40137,-0.0224347920025377,0.00280849272398357,-0.0279394377415455,-0.0169301462635299,1.46377515996684e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,39973,-0.0513898174491605,0.00644122285770097,-0.0640146142502544,-0.0387650206480666,1.58699686470749e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40174,-0.0250998776637279,0.00314894980653355,-0.0312718192845337,-0.0189279360429222,1.6831062770121e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,40164,0.0230244496437453,0.00289119919953899,0.0173576992126488,0.0286912000748417,1.78426761775929e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,40160,-0.0434095621910409,0.00545117579322531,-0.0540938667457625,-0.0327252576363193,1.7885245814051e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAX,Protein max,39727,-0.0790626427902579,0.00993879143693024,-0.0985426740066412,-0.0595826115738746,1.91692583040643e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40229,-0.0462169602283049,0.00581227377864795,-0.0576090168344549,-0.034824903622155,1.96492684165488e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37470,-0.0524660509054936,0.00660026813555317,-0.0654025764511778,-0.0395295253598094,2.03316268008313e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,37696,-0.0621741363973339,0.007827426640349,-0.077515892612418,-0.0468323801822499,2.13006752581552e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39746,-0.0435627237866335,0.00549539776311021,-0.0543337034023295,-0.0327917441709375,2.39670247552583e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,40095,-0.0187142858918548,0.00236280589401393,-0.0233453854441221,-0.0140831863395875,2.52645164518238e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37515,-0.025428006958986,0.00321128931793642,-0.0317221340221414,-0.0191338798958306,2.60113938243454e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40097,-0.0549322096421084,0.00693922951943745,-0.0685330995002058,-0.041331319784011,2.61249041499784e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37362,-0.050650340279376,0.00640748864382294,-0.0632090180212689,-0.038091662537483,2.89912642025235e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,40100,-0.0280963472072977,0.00355992957766307,-0.0350738091795173,-0.0211188852350781,3.15986696603857e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37470,-0.0311905084237387,0.003952652153172,-0.0389377066439558,-0.0234433102035216,3.23552246448823e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39746,-0.0386412187459938,0.00490472717466337,-0.048254484008334,-0.0290279534836536,3.5391027928494e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,40297,-0.0659643608949211,0.00837580035087942,-0.0823809295826447,-0.0495477922071974,3.61007054546716e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39741,-0.0366703260408587,0.00465645073030799,-0.0457969694722623,-0.027543682609455,3.63045069393283e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37737,0.0274127841273204,0.00348105603658418,0.0205899142956154,0.0342356539590253,3.67530504785065e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39810,-0.0305260261984286,0.00388636676730733,-0.038143305062351,-0.0229087473345063,4.27315331712583e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,39810,-0.0284625313204894,0.00362541356425154,-0.0355683419064224,-0.0213567207345564,4.40435072986417e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39746,-0.0628589932526682,0.00802569146459138,-0.0785893485232673,-0.0471286379820691,5.10664010828496e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,37694,-0.0212149511337186,0.00270853711178055,-0.0265236838728084,-0.0159062183946287,5.14046432026666e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,37362,-0.0295338615212984,0.00377187414003775,-0.0369267348357724,-0.0221409882068244,5.25724116924741e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37696,-0.0652371673681722,0.0083428051403874,-0.0815890654433315,-0.0488852692930129,5.69968779358918e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,37697,-0.0359721969331781,0.00460028850722984,-0.0449887624073486,-0.0269556314590076,5.70055125591865e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,39955,0.0377480531951663,0.00482829479441443,0.028284595398114,0.0472115109922186,5.70626135976907e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,37696,-0.0772750795366806,0.00988379840311528,-0.0966473244067865,-0.0579028346665746,5.75464564346497e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40126,-0.0538079505888632,0.00688660764711586,-0.0673057015772103,-0.0403101996005161,5.91711263152923e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37403,-0.0677674473966325,0.00867954037506861,-0.0847793465317669,-0.050755548261498,6.26929586321597e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,40164,0.0351269634748575,0.00450290336339889,0.0263012728825957,0.0439526540671193,6.528290824348e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37756,0.0198260190060045,0.00254242357459559,0.0148428687997971,0.0248091692122119,6.75183842738618e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40126,-0.0229255473992906,0.00294072009228148,-0.0286893587801623,-0.0171617360184189,6.79542441173364e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39746,-0.0389901725468801,0.00500331059101675,-0.0487966613052729,-0.0291836837884872,6.96976797462016e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,39991,-0.0274925728166749,0.00353994771351267,-0.0344308703351597,-0.02055427529819,8.57822414166349e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,37362,-0.0349292895788074,0.00449846872351051,-0.043746288276888,-0.0261122908807268,8.79864770244401e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37737,-0.0393141706460757,0.00506383302244126,-0.0492392833700606,-0.0293890579220908,8.84916473173771e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39746,-0.0388380155901204,0.00501242623758462,-0.0486623710157862,-0.0290136601644545,9.89237407403054e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39991,-0.0303963607462887,0.00392336001416378,-0.0380861463740497,-0.0227065751185277,9.94620214331002e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37515,-0.0365216233415133,0.00471390460033982,-0.0457608763581794,-0.0272823703248473,1.00508715026776e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,37737,-0.0617571061176702,0.00797566682853967,-0.0773894131016079,-0.0461247991337324,1.03949408733203e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,37782,-0.0667358938546574,0.00863445116273216,-0.0836594181336124,-0.0498123695757024,1.16108621383913e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,40095,-0.0263000313145023,0.00340753658722903,-0.0329788030254712,-0.0196212596035334,1.25091448644579e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,37756,-0.0558919614401496,0.00726499231084951,-0.0701313463694147,-0.0416525765108846,1.53419887131245e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37697,-0.0318437465220222,0.00414324767355093,-0.0399645119621821,-0.0237229810818624,1.62852717107543e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,40071,-0.0490550071362755,0.00639166930784378,-0.0615826789796493,-0.0365273352929016,1.75393183161565e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40065,-0.0751719745393621,0.00979495460064719,-0.0943700855566306,-0.0559738635220936,1.75771169883642e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37705,-0.029995663290923,0.0039183748842132,-0.0376756780639808,-0.0223156485178651,2.06455521739453e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37362,-0.0495011554695436,0.00648651577952309,-0.0622147263974089,-0.0367875845416783,2.48499640592718e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37430,-0.0563890557546306,0.0073894130353564,-0.0708723053039291,-0.041905806205332,2.4905235748531e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37756,-0.0620928185395119,0.00814067709866834,-0.0780485456529018,-0.0461370914261219,2.55621226276922e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40174,-0.0605727894838305,0.00794410657857323,-0.076143238377834,-0.0450023405898269,2.58205299130902e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDK,Midkine,40116,-0.0365807582270166,0.00480998438267956,-0.0460083276170685,-0.0271531888369646,3.00639497884946e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37697,-0.0506398864310777,0.00666066891226734,-0.0636947974991217,-0.0375849753630337,3.09211636160364e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,40274,0.00625083458262022,0.000822357732420967,0.00463901342707512,0.00786265573816531,3.10015174387219e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,40233,0.0212390057037251,0.00279665216828425,0.015757567453888,0.0267204439535622,3.26403155998106e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,39494,0.0227742043390716,0.00300077921493628,0.0168926770777965,0.0286557316003467,3.4012718153204e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39915,-0.0838363997186226,0.0110506807237717,-0.105495733937215,-0.0621770655000301,3.47238853520705e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39746,-0.0290027650443188,0.00382683766433383,-0.0365033668664131,-0.0215021632222245,3.68779632004261e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40065,0.0236150219190327,0.00311909639189417,0.0175015929909201,0.0297284508471452,3.90698755497766e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37403,-0.0408412162191793,0.00539343672586617,-0.051412352201877,-0.0302700802364816,3.91208203042986e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,40126,0.026171825250394,0.00345986821713483,0.0193904835448097,0.0329531669559782,4.11241201531726e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,37737,-0.0330522129963952,0.0043708509151445,-0.0416190807900784,-0.024485345202712,4.23055887839272e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39746,-0.0549196773020466,0.00726414176823509,-0.0691573951677874,-0.0406819594363058,4.2466740746748e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39746,-0.0411275628487886,0.00544452863324939,-0.0517988389699574,-0.0304562867276198,4.46184439630849e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40278,-0.0170503800259508,0.00225940858080102,-0.0214788208443208,-0.0126219392075808,4.71790593898198e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39810,0.0150087383972951,0.00198986213386956,0.0111086086149107,0.0189088681796794,4.8643566492971e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37421,-0.0206621400401478,0.00274031697362111,-0.0260331613084452,-0.0152911187718504,5.00970375569185e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40274,-0.032668636794782,0.00433951515654176,-0.0411740865016039,-0.0241631870879602,5.42219842982711e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40251,-0.0229251221323013,0.00304561954171297,-0.0288945364340587,-0.0169557078305438,5.46132229305426e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,37678,-0.0329743413409564,0.0043922508983747,-0.0415831531017708,-0.024365529580142,6.41747295498651e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,39757,-0.0640968812095027,0.0085436235472536,-0.0808423833621198,-0.0473513790568857,6.61468077309121e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40233,0.0211821904479263,0.00282558725426848,0.01564403942956,0.0267203414662925,6.89879558211374e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40164,-0.0295153966344247,0.00393734059736873,-0.0372325842052674,-0.021798209063582,6.91531261664805e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,37784,-0.0383695313558283,0.00512000872395775,-0.0484047484547855,-0.0283343142568712,7.09925761461998e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40174,0.0201045549164812,0.00268651610818181,0.0148389833444449,0.0253701264885175,7.61923519696798e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40065,-0.0230630197734124,0.00308319294699955,-0.0291060779495316,-0.0170199615972933,7.81308317979296e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40072,-0.0276783168976291,0.00370627450933298,-0.0349426149359218,-0.0204140188593365,8.57448903185083e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37784,-0.0439360274105087,0.00588836608063214,-0.0554772249285477,-0.0323948298924697,9.08371655609752e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,40095,-0.0522796884800789,0.00700787801149008,-0.0660151293825994,-0.0385442475775583,9.09722224478981e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39810,-0.0623244745741573,0.00835483465907035,-0.0786999505059351,-0.0459489986423794,9.13627868292179e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37430,-0.0405479777949406,0.00543803362516312,-0.0512065237002603,-0.0298894318896209,9.45814856211048e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,37430,0.0302051309705503,0.0040522517074013,0.0222627176240438,0.0381475443170569,9.63513546685214e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37784,-0.0637993967834383,0.00856492729451405,-0.0805866542806858,-0.0470121392861908,9.98954052349871e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,40020,-0.0411089081799387,0.00552077957041384,-0.0519296361379498,-0.0302881802219275,1.01084166453594e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37737,-0.0325279122884637,0.00436845587585963,-0.0410900858051486,-0.0239657387717789,1.02068106294027e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,40071,0.0219876855915335,0.00295486803094975,0.0161961442508719,0.027779226932195,1.0498630802956e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,40233,-0.0164872659180671,0.00221701300209752,-0.0208326114021782,-0.0121419204339559,1.08530718226559e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37756,-0.0351671640194626,0.00472901124555737,-0.044436026060755,-0.0258983019781701,1.0973412620335e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40121,-0.0270569338726884,0.0036399995691356,-0.0341913330281941,-0.0199225347171826,1.11453594057472e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,37808,-0.0184978468542809,0.00248956095158521,-0.0233773863193879,-0.0136183073891739,1.15047800772832e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37430,-0.0358257413547435,0.00482199411406549,-0.0452768498183119,-0.0263746328911752,1.15689641719946e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40065,-0.0432762312499457,0.00582589746914141,-0.0546949902894628,-0.0318574722104285,1.15729564441427e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39810,-0.0778026988762054,0.0105198122300537,-0.0984215308471106,-0.0571838669053001,1.47789176169684e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39991,-0.020665668726937,0.00279881303225893,-0.0261513422701645,-0.0151799951837095,1.61722114177741e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,39700,-0.0628478711614096,0.00851275807920412,-0.0795328769966496,-0.0461628653261695,1.63017821649919e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,37566,-0.0230902464574355,0.00312897269616057,-0.0292230329419102,-0.0169574599729607,1.6844898906416e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40100,-0.0567267752638596,0.0077036918071338,-0.0718260112058419,-0.0416275393218774,1.87950448072401e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,40074,-0.0614454399082297,0.00835075223308018,-0.0778129142850668,-0.0450779655313925,1.95860550455258e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37737,-0.025203596430086,0.00343315091806053,-0.0319325722294847,-0.0184746206306874,2.23923506453025e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,40140,-0.0641416184732407,0.00874842025491664,-0.0812885221728773,-0.046994714773604,2.38171771659424e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,37681,-0.0617723716269544,0.0084330015457046,-0.0783010546565354,-0.0452436885973733,2.52584669051037e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,40297,-0.0389706021463053,0.00532176113802182,-0.0494012539768281,-0.0285399503157826,2.54375765972899e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37737,-0.0203272340933574,0.00277606040821043,-0.0257683124934499,-0.014886155693265,2.57723111952573e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37791,-0.0575583838473252,0.00786317037145567,-0.0729701977753783,-0.0421465699192721,2.62168610449029e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37403,-0.0339713688598731,0.00464994144209522,-0.0430852540863797,-0.0248574836333664,2.9183486550677e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40248,-0.0437194170840549,0.00599277617693385,-0.0554652583908452,-0.0319735757772645,3.12024005043891e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37403,-0.0553485967023411,0.00758956531065879,-0.0702241447112323,-0.0404730486934499,3.21403286631681e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,40126,-0.0167773940555882,0.00230132919651832,-0.0212879992807641,-0.0122667888304123,3.24014417930843e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40065,-0.0654565164865341,0.00898678349877633,-0.0830706121441357,-0.0478424208289324,3.40441458259981e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,39947,-0.0401015169574522,0.00551970880300522,-0.0509201462113424,-0.029282887703562,3.9037173166622e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,40065,0.0198565739794587,0.00273345934087906,0.0144989936713357,0.0252141542875816,3.92790661086041e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,40054,-0.0486564774702893,0.00670558870249946,-0.0617994313271883,-0.0355135236133904,4.17136154588852e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37737,0.0452591065885679,0.00623778526530762,0.033033047468565,0.0574851657085709,4.21947053141915e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,39886,-0.046619364146462,0.00643092306335295,-0.0592239733506338,-0.0340147549422902,4.38955875816232e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,40065,-0.0503671398517483,0.00695241897293846,-0.0639938810387077,-0.0367403986647889,4.5415606676751e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40095,-0.0260937242647393,0.00360428218816857,-0.0331581173535497,-0.0190293311759289,4.70784155996237e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37737,-0.068843919569564,0.00950832242703848,-0.0874802315265594,-0.0502076076125686,4.72015317423808e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37470,-0.0818830359056847,0.0113107365999044,-0.104052079641497,-0.059713992169872,4.75936953972211e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37784,-0.0674922624910799,0.00933312591926339,-0.0857851892928361,-0.0491993356893236,5.0382723063893e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39727,-0.0412532619689471,0.00570835777640965,-0.05244164321071,-0.0300648807271842,5.17838896533811e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37697,-0.064909536796602,0.00899061829310538,-0.0825311486510885,-0.0472879249421154,5.49448848093511e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,37808,-0.044737085546279,0.00620579385841039,-0.0569004415087634,-0.0325737295837947,5.94272933748518e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40065,-0.0369102107202749,0.00512549641427285,-0.0469561836922497,-0.0268642377483002,6.23644392934981e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37697,-0.034732118766028,0.00483084503730237,-0.0442005750391407,-0.0252636624929154,6.84372989509249e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40100,-0.0685456619115147,0.00955871623554596,-0.0872807457331848,-0.0498105780898447,7.77775570021733e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,40258,0.0324662900515806,0.00452772067963182,0.0235919575195022,0.0413406225836589,7.79998278900308e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,39746,-0.040189332202143,0.00561079708906554,-0.0511864944967114,-0.0291921699075745,8.26165099121673e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37470,-0.0249407639336404,0.00348236123167596,-0.0317661919477253,-0.0181153359195555,8.37649538507173e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37756,-0.032453385832945,0.00453420352505418,-0.0413404247420512,-0.0235663469238388,8.64932728483442e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,40174,-0.0393615279091738,0.00550100587964209,-0.0501434994332723,-0.0285795563850754,8.71554292959647e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37403,-0.0597059014001231,0.0083430743054836,-0.076058327038871,-0.0433534757613753,8.73197903776598e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37515,-0.0500140696157802,0.00698977498328207,-0.0637140285830131,-0.0363141106485473,8.79321145329535e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,40065,-0.0508601995654141,0.0071127500812518,-0.0648011897246676,-0.0369192094061605,9.02522939566155e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40164,-0.0353533014468293,0.00494509649646762,-0.0450456905799058,-0.0256609123137527,9.11524693394119e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37696,-0.0310643842405339,0.00434465524573045,-0.0395799085221656,-0.0225488599589022,9.13139434624939e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,37282,-0.0385701241999486,0.00540702445623105,-0.0491678921341615,-0.0279723562657357,1.03222796866553e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37696,-0.0521893874962244,0.00731941459289248,-0.0665354400982937,-0.0378433348941552,1.05369384608799e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,39991,0.0170373546741033,0.00239046692157755,0.0123520395078113,0.0217226698403953,1.06930158978618e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39904,-0.0200754595057969,0.00281793892150606,-0.0255986197919488,-0.014552299219645,1.09338168165901e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37697,-0.0446891307989942,0.00627460935399638,-0.0569873651328271,-0.0323908964651613,1.11687591115027e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,40071,-0.0264139649544853,0.00371027496946524,-0.0336861038946371,-0.0191418260143334,1.13333044009808e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,37430,-0.0345507274612808,0.00485944319172899,-0.0440752361170696,-0.025026218805492,1.22102359894032e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,37421,-0.0448260658046495,0.00631331215309309,-0.0572001576247119,-0.032451973984587,1.3102391216738e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37403,-0.0382480854068423,0.00539621053284693,-0.0488246580512223,-0.0276715127624623,1.43162636132972e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40233,-0.0534792049745989,0.00755201525620681,-0.0682811548767643,-0.0386772550724336,1.48674595752576e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37430,-0.0691384582165751,0.00978407403767397,-0.0883152433304161,-0.0499616731027342,1.67091588199078e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,40095,-0.0178613553539125,0.00252820320925597,-0.0228166336440542,-0.0129060770637708,1.67580635467645e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37756,-0.0393773300931448,0.00557688973976641,-0.0503080339830869,-0.0284466262032026,1.73757813096919e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,40065,-0.0913487147691468,0.0129681175488956,-0.116766225164982,-0.0659312043733115,1.94459633596767e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37343,-0.0416583039870579,0.00591460584049011,-0.0532509314344185,-0.0300656765396973,1.97277316425621e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40174,-0.0176895328878188,0.00251631511341086,-0.0226215105101041,-0.0127575552655335,2.15128573979436e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,40186,-0.0509563019030143,0.00726910597202933,-0.0652037496081917,-0.0367088541978368,2.48034770402611e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,37784,-0.047881440748882,0.00683528105788098,-0.0612785916223287,-0.0344842898754353,2.58755655059728e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40148,-0.0794801056315578,0.0113607032761202,-0.101747084052753,-0.0572131272103621,2.7391026079203e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37791,-0.0402900026698705,0.00575914165047444,-0.0515779203048004,-0.0290020850349407,2.76262383563656e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37696,-0.0311424961335713,0.00445595152137297,-0.0398761611154623,-0.0224088311516803,2.90172144269721e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40099,-0.0624453440752852,0.00894168702479901,-0.0799710506438913,-0.0449196375066792,2.99250261195521e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,39810,-0.0560231081853499,0.00804161615637046,-0.071784675851836,-0.0402615405188638,3.37769792338706e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,39975,-0.015256271762294,0.00219011008017046,-0.0195488875194281,-0.0109636560051599,3.39218349432562e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37696,0.0193671423469266,0.00278055069486263,0.0139172629849959,0.0248170217088574,3.43375938463028e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37470,-0.0579167632239832,0.00832235768271063,-0.074228584282096,-0.0416049421658704,3.58654030350325e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40186,-0.07303378904447,0.0104963444701568,-0.0936066242059774,-0.0524609538829626,3.58697607597879e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,40126,-0.0280720798032829,0.00403927935145331,-0.0359890673321314,-0.0201550922744344,3.8029150804322e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,37737,-0.0145666921936812,0.00210005475307543,-0.0186827995097091,-0.0104505848776534,4.21016115931524e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39955,-0.0627448389980966,0.00905097960199977,-0.0804847590180162,-0.0450049189781771,4.30144534925957e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40065,0.0415295203661823,0.00599165168110781,0.029785883071211,0.0532731576611536,4.335283341926e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,37730,-0.0170097923726372,0.00245744793280224,-0.0218263903209296,-0.0121931944243448,4.66648081688509e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37470,-0.0402876160197185,0.00583476493940177,-0.051723755300946,-0.028851476738491,5.26240025364392e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37772,-0.0318211532372861,0.00461125655536591,-0.0408592160858033,-0.0227830903887689,5.40659388239919e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,40095,-0.0793218509370526,0.0115001104752401,-0.101862067468523,-0.056781634405582,5.49591910627061e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39955,-0.015550652796816,0.0022558851989491,-0.0199721877867563,-0.0111291178068758,5.65877420933223e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37696,-0.0624311505549235,0.00906773418097458,-0.0802039095496336,-0.0446583915602133,6.04014393291872e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39810,-0.0609318037828737,0.00885447208673293,-0.0782865690728703,-0.0435770384928772,6.15286032954174e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37403,-0.0282998539702197,0.00411284514941846,-0.0363610304630799,-0.0202386774773596,6.2235149502512e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,39727,-0.0402540252269466,0.00585995082970315,-0.0517395288531647,-0.0287685216007284,6.69884026396161e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37631,-0.0385455091156596,0.00561105429345867,-0.0495431755308386,-0.0275478427004806,6.72884639572103e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40186,-0.0178620357254479,0.00260219868543181,-0.0229623451488943,-0.0127617263020016,6.93590583655549e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37552,-0.00884194197748025,0.00128965120837199,-0.0113696583458893,-0.00631422560907115,7.39516001742963e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,37777,-0.0145923990989838,0.00212910730854461,-0.0187654494237312,-0.0104193487742363,7.50956361650104e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37784,-0.019974790838108,0.00291721330391457,-0.0256925289137805,-0.0142570527624354,7.85984838112828e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40261,-0.03314167289914,0.00484224717259212,-0.0426324773574205,-0.0236508684408594,7.96893437342469e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39727,-0.0729605767893063,0.0106870656617741,-0.0939072254863836,-0.0520139280922289,8.99773395361163e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37362,-0.0400307064028798,0.00587191171267311,-0.0515396533597191,-0.0285217594460405,9.68785733710752e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40069,-0.0408747848415165,0.00600614961890507,-0.0526468380945705,-0.0291027315884626,1.04370710523767e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,36981,-0.0800263907068473,0.0117797437603423,-0.103114688477118,-0.0569380929365764,1.1434624441101e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37370,-0.0184496261738613,0.00271816872861917,-0.0237772368819549,-0.0131220154657677,1.19058606225462e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,37808,0.0177510772464094,0.00262376038142906,0.0126085068988084,0.0228936475940103,1.38375320887179e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37784,-0.0478665782506135,0.00707929641461386,-0.0617419992232567,-0.0339911572779704,1.42269309028479e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37756,-0.0241453781855595,0.00357268801940022,-0.031147846703584,-0.0171429096675351,1.45413385657028e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40164,-0.0293730945072794,0.00435118200956609,-0.0379014112460289,-0.0208447777685299,1.52388835074611e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSG,Basigin,40261,-0.0129690207474115,0.00192160944241076,-0.0167353752545366,-0.00920266624028641,1.53999190457343e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,40100,-0.0215758110920553,0.003197275615619,-0.0278424712986686,-0.0153091508854421,1.54960634081366e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37756,-0.0514279247677212,0.00762628523991293,-0.0663754438379505,-0.0364804056974918,1.609900874917e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37403,-0.0232887962055504,0.00345466670166479,-0.0300599429408133,-0.0165176494702874,1.6367693708606e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39700,-0.0446982453332222,0.00663381877892497,-0.0577005301399151,-0.0316959605265293,1.66408017825876e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,37403,-0.0369651778362186,0.00548730695895123,-0.047720299475763,-0.0262100561966742,1.69118015328208e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40054,-0.0185094907882317,0.0027543740660368,-0.0239080639576638,-0.0131109176187996,1.87972595390469e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,37784,-0.0194368631420204,0.00289215002817083,-0.0251054771972353,-0.0137682490868056,1.88387652853309e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37343,-0.0639123689909669,0.00951600326474253,-0.0825637353898623,-0.0452610025920716,1.94212269365889e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,37784,-0.0359685732907087,0.00536127461299441,-0.0464766715321778,-0.0254604750492397,2.03929953320198e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39746,-0.0223323362590396,0.00333858250453978,-0.0288759579679376,-0.0157887145501416,2.32232242334488e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39312,-0.0241867955485218,0.00362400002741327,-0.0312898356022518,-0.0170837554947918,2.5763110998636e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,40229,-0.0382404753050697,0.00573584139055182,-0.0494827244305513,-0.0269982261795882,2.69869021504615e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,37289,-0.0346760013176177,0.00521548029968353,-0.0448983427049975,-0.024453659930238,3.07724203941519e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,37515,-0.0347051997859521,0.00522351006073109,-0.0449432795049851,-0.0244671200669192,3.173035582642e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,37376,-0.0308818130536149,0.00465132638826759,-0.0399984127746193,-0.0217652133326104,3.27647780230606e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,40126,-0.0433581630199381,0.00653505164939914,-0.0561668642527604,-0.0305494617871158,3.35796927916379e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,37376,-0.0285958106985304,0.00431620358776458,-0.037055569730549,-0.0201360516665118,3.60464866291688e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40274,-0.0207604616177822,0.00313555306146999,-0.0269061456182633,-0.014614777617301,3.68288163888269e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40248,-0.0195781604040529,0.00296483290670778,-0.0253892329012002,-0.0137670879069057,4.14480195909211e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,40095,0.0148551793502757,0.00225178796061467,0.0104416749474709,0.0192686837530804,4.32852440969288e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37362,-0.0175105208940626,0.00265501756746701,-0.022714355326298,-0.0123066864618273,4.41062536531276e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37515,-0.0219072346893788,0.00332453069671406,-0.0284233148549384,-0.0153911545238193,4.58019102242901e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39815,-0.0415134488963872,0.00630371002015804,-0.053868720535897,-0.0291581772568774,4.67890805470492e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,40095,0.0287094482737128,0.00436187864331378,0.0201601661328178,0.0372587304146078,4.79246018894939e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,37609,-0.0627476646540251,0.00953367484381777,-0.0814336673479079,-0.0440616619601422,4.82771373101474e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,40114,-0.0579586915504008,0.00882600633318519,-0.0752576639634438,-0.0406597191373578,5.30231520876832e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,40100,-0.0332043076711903,0.00505682827803928,-0.0431156910961473,-0.0232929242462333,5.32295652782273e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,40065,0.0177008985154425,0.00269608170920111,0.0124165783654084,0.0229852186654767,5.35247297402389e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,37430,-0.0326936172847506,0.00498323624572442,-0.0424607603263704,-0.0229264742431307,5.55809165550396e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,40274,-0.047654475519392,0.00726669843917729,-0.0618972044601795,-0.0334117465786045,5.62516403707253e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,37430,-0.0733708389692399,0.01119392484237,-0.0953109316602851,-0.0514307462781947,5.79305210776053e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39746,-0.0421737573835065,0.00644635629240121,-0.0548086157166129,-0.0295388990504002,6.25198146816393e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,40065,-0.0534605892255405,0.008177615971498,-0.0694887165296766,-0.0374324619214044,6.45263521940975e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_E,,40100,-0.0179069592280628,0.00274116242649629,-0.0232796375839955,-0.0125342808721301,6.66254356876431e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37756,-0.0616541891175963,0.00943754512719002,-0.0801517775668887,-0.0431566006683038,6.68719610899088e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40065,-0.0231737334545302,0.00354905516825437,-0.0301298815843088,-0.0162175853247516,6.80039935012375e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40171,0.0150328553217241,0.00230636236845972,0.0105123850795431,0.0195533255639052,7.3423302608643e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40164,0.0170884310916082,0.002622162654922,0.0119489922879611,0.0222278698952553,7.39488335253924e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37791,-0.0143491398089588,0.00220203470138584,-0.0186651278236751,-0.0100331517942426,7.46468624946309e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,40065,-0.025640288884514,0.00394068086656094,-0.0333640233829735,-0.0179165543860546,7.9230220986298e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,37791,-0.0153512814278817,0.00236504909235674,-0.0199867776489009,-0.0107157852068624,8.83470321719422e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,40025,-0.0479209051249224,0.00738530634178307,-0.0623961055548172,-0.0334457046950276,8.92045578566866e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37737,-0.0385597346959089,0.00594681430810629,-0.0502154907397972,-0.0269039786520206,9.24205913302268e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37784,-0.0200331140008062,0.00309425269430746,-0.0260978492816489,-0.0139683787199636,9.85906383066871e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,40160,0.0187174736393257,0.00289237647516175,0.0130484157480086,0.0243865315306427,1.00031681018791e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37470,-0.0583657469853212,0.00902422117286839,-0.0760532204841432,-0.0406782734864992,1.03078270251157e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,39746,-0.0499275369043901,0.00773363615134268,-0.0650854637610218,-0.0347696100477585,1.10823810575405e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37403,-0.0218644484360791,0.0033876282317576,-0.028504199770324,-0.0152246971018342,1.12664868274706e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37674,-0.0432185782969299,0.00670846414502025,-0.0563671680211696,-0.0300699885726902,1.21676286201717e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,37403,0.0185749053524302,0.00288518437467135,0.0129199439780743,0.024229866726786,1.25303850864626e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37784,-0.0543195883392394,0.00844714601567011,-0.0708759945299528,-0.037763182148526,1.31499780287435e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37430,-0.0224489365704877,0.00349414382161167,-0.0292974584608465,-0.0156004146801288,1.36715197387029e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37784,-0.0433872921558545,0.00676389343666688,-0.0566445232917216,-0.0301300610199874,1.46014090252071e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,37362,-0.0491836612632675,0.00767212215364278,-0.0642210206844073,-0.0341463018421276,1.49895757355271e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37782,0.0362659112822622,0.00565901674013473,0.0251742384715981,0.0473575840929263,1.51884529096841e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40297,0.0153916704354735,0.00240286778421553,0.010682049578411,0.0201012912925359,1.54059549262645e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,40100,-0.0391942356913547,0.00612035068308248,-0.0511901230301964,-0.0271983483525131,1.55756153888973e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37470,-0.0765626677775422,0.0119564541866482,-0.0999973179833726,-0.0531280175717118,1.57113672923966e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39991,-0.03557596513738,0.00556442630002368,-0.0464822406854264,-0.0246696895893336,1.6679547078087e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,40143,0.0202860155934133,0.00317301271133916,0.0140669106791885,0.026505120507638,1.66932068790226e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39815,-0.026550818914158,0.00415619606504356,-0.0346969632016434,-0.0184046746266726,1.7262289938289e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39727,-0.0319146204991899,0.00501166593059678,-0.0417374857231596,-0.0220917552752202,1.96897225024887e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,37376,-0.0269839185221602,0.00423803503002591,-0.035290467181011,-0.0186773698633094,1.99176045665155e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,37791,0.031619242483024,0.00497809403521409,0.0218621781740044,0.0413763067920436,2.1989292975421e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,40131,0.017103302935775,0.00269748498532724,0.0118162323645336,0.0223903735070164,2.35343697404177e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37470,-0.0527372452940378,0.00834469237233644,-0.0690928423438172,-0.0363816482442584,2.70346288356276e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37791,-0.021041248191598,0.00332956124067882,-0.0275671882233285,-0.0145153081598675,2.70712231648257e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37430,-0.052354791865094,0.00828728036938949,-0.0685978613890974,-0.0361117223410906,2.74532865985429e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37756,-0.0542806327950026,0.00859810716879192,-0.0711329228458348,-0.0374283427441704,2.82204373083646e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37430,-0.0496713017213365,0.00786897654176818,-0.0650944957432021,-0.0342481076994709,2.83877977559512e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37782,-0.0145431328961024,0.00230428950834749,-0.0190595403324635,-0.0100267254597413,2.85406632637222e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37430,-0.0337486571222406,0.00534833111638113,-0.0442313861103477,-0.0232659281341336,2.8786812077137e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37452,-0.0328806533751708,0.00521235448842024,-0.0430968681724745,-0.0226644385778671,2.91422119349337e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,37779,-0.0218404194109327,0.00346268630095826,-0.0286272845608108,-0.0150535542610545,2.927969087785e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39946,-0.0178795538217771,0.00283503964073571,-0.0234362315176191,-0.0123228761259351,2.92902665642487e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37376,-0.0368159061363517,0.00583889893000073,-0.0482601480391531,-0.0253716642335503,2.97032765997182e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40126,-0.0383009380297318,0.00607558188291486,-0.0502090785202449,-0.0263927975392186,2.97671850569143e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,37696,-0.0202888802882621,0.00322500698327596,-0.026609893975483,-0.0139678666010412,3.25119405048006e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,40126,-0.0200908726107536,0.00320030443738398,-0.0263634693080262,-0.013818275913481,3.52432693253046e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37470,-0.0669076240509813,0.0106578478665042,-0.0877970058693294,-0.0460182422326331,3.54348079882517e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37470,-0.0253571404463389,0.00404314725529931,-0.0332817090667256,-0.0174325718259523,3.68580374549116e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37697,-0.0172418122313781,0.00275119419803021,-0.0226341528595173,-0.0118494716032389,3.79408964071221e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37430,-0.0369715794891933,0.00590687993918452,-0.0485490641699949,-0.0253940948083916,3.99470305804319e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37756,-0.0237030547024811,0.00378935225194934,-0.0311301851163018,-0.0162759242886604,4.0923514311409e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40230,-0.0567204979592785,0.00907318093693098,-0.0745039325956632,-0.0389370633228938,4.17125381647613e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39725,0.0278146912218458,0.00445427154594779,0.0190843189917882,0.0365450634519035,4.36408787400302e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40116,0.0296092202426716,0.00474481692523415,0.0203093790692127,0.0389090614161305,4.47879580614265e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,39934,-0.0346967191337938,0.00556554786775958,-0.0456051929546025,-0.023788245312985,4.65873552301213e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37362,-0.0419578031380005,0.00673027831433155,-0.0551491486340903,-0.0287664576419106,4.68283076214378e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37737,0.0241515255396522,0.00387631883540129,0.0165539406222656,0.0317491104570387,4.78891677947636e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,40126,-0.045204751632258,0.00726344506553762,-0.0594411039607117,-0.0309683993038043,4.98240927851075e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,37782,-0.0404608855823107,0.0065035638901495,-0.0532078708070037,-0.0277139003576177,5.07670729628589e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,37727,-0.0381928615116472,0.00614437355493631,-0.0502358336793224,-0.026149889343972,5.25562789709201e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39746,-0.0287014961362502,0.00461965709356935,-0.0377560240396462,-0.0196469682328543,5.33601864381516e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39815,-0.040209729571568,0.00648059522513154,-0.0529116962128258,-0.0275077629303102,5.62294910516018e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40099,0.010412450986988,0.00167838656018497,0.00712281332902547,0.0137020886449505,5.64859086781736e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,40100,0.0245614215161743,0.00395973235333921,0.0168003461036295,0.0323224969287192,5.68621566433493e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,37403,-0.0226659664628021,0.00365584890054305,-0.0298314303078665,-0.0155005026177377,5.82087505450817e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,37403,-0.0257157670756936,0.00415457450321658,-0.0338587331019981,-0.0175728010493891,6.20797772737114e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40186,-0.0511805440609789,0.00827214422819353,-0.0673939467482383,-0.0349671413737196,6.27996381833709e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39691,-0.0389231454752657,0.00629234455886774,-0.0512561408106465,-0.026590150139885,6.33689311581414e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,40160,-0.0334371268446759,0.00540722191380566,-0.044035281795735,-0.0228389718936168,6.41285804434578e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFP,Properdin,37808,-0.0128737088072533,0.00208164007626913,-0.0169537233567408,-0.00879369425776583,6.4154244916411e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37362,-0.0399125306422336,0.0064582504257395,-0.052570701476683,-0.0272543598077842,6.59957567818027e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37515,-0.0438929909509602,0.00711390462792889,-0.0578362440217008,-0.0299497378802195,7.029548275226e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40143,-0.0277770119218355,0.00450990957599692,-0.0366164346907894,-0.0189375891528815,7.49400362463218e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,40248,-0.0225812884956271,0.00367322986316026,-0.0297808190274212,-0.015381757963833,8.05906294662987e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,37784,-0.0379978584000478,0.00618071234884007,-0.0501120546037743,-0.0258836621963213,8.08007784153672e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40100,-0.0264322775001548,0.00430016268272989,-0.0348605963583054,-0.0180039586420042,8.09747514704362e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37756,-0.0277249993134923,0.00451720665751952,-0.0365787243622306,-0.0188712742647541,8.61346367865813e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39979,-0.0282385902878525,0.00460460461216189,-0.0372636153276898,-0.0192135652480152,8.85011402140118e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40181,-0.0185563801338032,0.00302652533100818,-0.0244883697825792,-0.0126243904850271,8.9274604764318e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,37696,-0.0205850051169727,0.00335889032259453,-0.027168430149258,-0.0140015800846875,9.12206631273546e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,40174,0.0159464518097472,0.00260561759883055,0.0108394413160393,0.0210534623034551,9.57788545223985e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37404,0.0199692182502416,0.00327158056716695,0.0135569203385943,0.0263815161618888,1.06504714212172e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,40174,0.0158437002072187,0.00259684997760468,0.0107538742511135,0.0209335261633238,1.0779467553879e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,37737,-0.0413563766722094,0.00678375029255227,-0.0546525272456118,-0.0280602260988069,1.114972234177e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37696,-0.0675991469188972,0.0110971798063904,-0.0893496193394225,-0.045848674498372,1.1491268274781e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37362,-0.0404201818750938,0.00664799509948816,-0.0534502522700906,-0.027390111480097,1.23530713936712e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37545,-0.0322073862679472,0.00532014626153368,-0.0426348729405532,-0.0217798995953412,1.45288788814051e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37515,-0.044570412625811,0.00737290830123462,-0.0590213128962309,-0.0301195123553912,1.53329860822558e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,37343,-0.0315745719499107,0.00522532006354649,-0.0418161992744618,-0.0213329446253596,1.55822794655026e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,40194,-0.0355682280827591,0.00589117266202693,-0.0471149265003319,-0.0240215296651863,1.59989864111017e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40065,-0.03999117306151,0.00663137690725961,-0.0529886717997388,-0.0269936743232811,1.67036364926034e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37756,-0.0392924104841588,0.00652211940703614,-0.0520757645219496,-0.026509056446368,1.74127311013914e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39746,-0.0438742845869544,0.00728346899718162,-0.0581498838214304,-0.0295986853524784,1.74255278115121e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37697,-0.0225431051252149,0.00374415069885937,-0.0298816404949793,-0.0152045697554506,1.78053624602298e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37737,-0.0215969481244752,0.00359232486246778,-0.0286379048549121,-0.0145559913940384,1.88088296920506e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,37808,-0.0181679409107625,0.00302249523346641,-0.0240920315683566,-0.0122438502531683,1.89294943791844e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39991,-0.0275876225145662,0.00459006565411456,-0.0365841511966308,-0.0185910938325017,1.89332665929905e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,40075,-0.034961827017997,0.00581734718043605,-0.0463638274916516,-0.0235598265443423,1.89733741578507e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,37475,0.0180675929088918,0.00300608396237901,0.012175668342629,0.0239595174751547,1.90079940987922e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,40094,-0.055324188176061,0.0092073175160063,-0.0733705305074333,-0.0372778458446886,1.91142682196427e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37784,-0.0310044702438333,0.00516665703262064,-0.0411311180277698,-0.0208778224598969,2.01345617265653e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,39727,-0.0402624482535966,0.0067318153445768,-0.0534568063289671,-0.0270680901782261,2.26831470264956e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40126,0.043851212558272,0.00734388322048615,0.0294572014461192,0.0582452236704249,2.4071865515634e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,40186,-0.0200654360244315,0.00336750807179904,-0.0266657518451576,-0.0134651202037054,2.59929664357602e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40186,-0.0671161625070444,0.0112777579243744,-0.0892205680388183,-0.0450117569752705,2.71840258223247e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40212,-0.0241707575169448,0.00406616633020953,-0.0321404435241555,-0.0162010715097341,2.83395591728397e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,40105,0.0338111056804855,0.00569324838906738,0.0226523388379134,0.0449698725230576,2.93181121285464e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,40126,0.0394640358820628,0.0066474706917666,0.0264349933262003,0.0524930784379253,2.96956945358898e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37470,-0.0225198285661309,0.00380290853264835,-0.0299735292901217,-0.0150661278421402,3.26588962500182e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,40126,-0.0382191004922888,0.00645897686779627,-0.0508786951531695,-0.0255595058314081,3.34279941395924e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCN,Decorin,39810,0.0128254990591407,0.00217004381850976,0.00857221317486156,0.0170787849434198,3.48824753412549e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37788,-0.0109149739646864,0.00184732664249429,-0.0145357341839752,-0.00729421374539759,3.53606117711308e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,37403,-0.0291029495578637,0.0049265728641613,-0.0387590323716198,-0.0194468667441075,3.56400345928876e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40297,0.016495609463905,0.00279307847669485,0.0110211756495831,0.0219700432782269,3.57927989051583e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40036,-0.0151668051637297,0.00256874364112175,-0.0202015427003284,-0.0101320676271311,3.61361180090859e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37376,-0.0388210372977132,0.00657865273151236,-0.0517151966514774,-0.025926877943949,3.70217573592219e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40233,-0.0299964343742856,0.00510092299820424,-0.0399942434507659,-0.0199986252978053,4.17065752532475e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,40126,-0.031885608217436,0.00542241367839313,-0.0425135390270866,-0.0212576774077855,4.17763489597246e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,40100,0.0274742218101934,0.00468050858297534,0.0183004249875617,0.0366480186328251,4.44818944911943e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37362,-0.0446472641087662,0.00760610730963502,-0.0595552344356508,-0.0297392937818816,4.4670714264688e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37430,-0.029639446915788,0.00505073910523821,-0.0395388955620549,-0.0197399982695211,4.50927458006775e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40074,-0.0487720239140132,0.008312040317361,-0.0650636229360407,-0.0324804248919856,4.50996723504168e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37782,0.0145274253772128,0.00247587237454164,0.00967471552311122,0.0193801352313145,4.52650634105263e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37737,-0.036281862426012,0.00618741828485454,-0.0484092022643269,-0.0241545225876971,4.63107906112476e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40095,-0.0147389212757184,0.00251570038572667,-0.0196696940317426,-0.00980814851969409,4.75660608536642e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,40248,-0.0252533150554436,0.00431394415802413,-0.0337086456051709,-0.0167979845057163,4.89752436221943e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37696,-0.0544786270570713,0.00931034680477915,-0.0727269067944385,-0.0362303473197042,4.98956012169107e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37515,-0.0375083482634579,0.00641976195593271,-0.050091081697086,-0.0249256148298298,5.26049218807287e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37737,-0.0122508838442761,0.00210159999411375,-0.0163700198327391,-0.00813174785581316,5.69484104390475e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,37791,0.0171084472668202,0.00293581864955083,0.0113542427137006,0.0228626518199398,5.75675726254646e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37737,-0.0265441166982786,0.00456293943464127,-0.0354874779901755,-0.0176007554063818,6.11728945895377e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40058,-0.0238979248658176,0.00411226512530703,-0.0319579645114193,-0.0158378852202158,6.31691416944064e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40065,-0.0303806401083635,0.00522821975228662,-0.0406279508228453,-0.0201333293938817,6.3350242634415e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40095,-0.0232700151236361,0.00400872283080379,-0.0311271118720115,-0.0154129183752607,6.56733400075961e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,40233,0.0128562157258153,0.00221533560362724,0.0085141579427059,0.0171982735089247,6.6276631966598e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37697,-0.0271633191836425,0.00468507487536737,-0.0363460659393625,-0.0179805724279224,6.87056860277557e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,37430,-0.0166468416128318,0.00287243518967592,-0.0222768145845966,-0.011016868641067,6.9752228952963e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37784,-0.026237435496105,0.00452956276834653,-0.0351153785220642,-0.0173594924701458,7.09166356894627e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,37697,-0.0209277141859416,0.00361524254337046,-0.0280135895709477,-0.0138418388009355,7.25215369238399e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,39746,-0.0336061766965802,0.00581227198740841,-0.0449982297919007,-0.0222141236012597,7.5287053223122e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,40233,-0.0361385176291778,0.00625050440574612,-0.0483895062644402,-0.0238875289939154,7.53487521803083e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37376,0.0173039611900179,0.00299676482085895,0.0114303021411344,0.0231776202389015,7.90913621535333e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,37784,-0.053468892511801,0.00927303742975624,-0.0716440458741233,-0.0352937391494788,8.29447570508942e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,39746,-0.0412601874659128,0.00715983415801059,-0.0552934624156135,-0.027226912516212,8.43580767739105e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,40095,0.0173255728560335,0.00300796124824314,0.011429968809477,0.0232211769025901,8.57420819061236e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,37697,-0.0219354585800319,0.00380896055540565,-0.029401021268627,-0.0144698958914368,8.65389696772295e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39815,0.0222515221367752,0.00386621912346754,0.0146737326547788,0.0298293116187716,8.81010271671887e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40126,0.0172358228645928,0.00299569241306651,0.0113642657349825,0.0231073799942032,8.90275482247732e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,39717,-0.0606561004299988,0.0105447414356106,-0.0813237936437955,-0.039988407216202,8.97447206468253e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,40121,-0.0139436541949651,0.00242671529899009,-0.0187000161809857,-0.00918729220894452,9.3133974909364e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39746,-0.0403335356702595,0.00702664057953934,-0.0541057512061566,-0.0265613201343624,9.64215307317755e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37430,-0.0259992959205864,0.00452944832364212,-0.0348770146349249,-0.0171215772062478,9.67618836820382e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,40012,-0.0156057050599148,0.00272768202746254,-0.0209519618337414,-0.0102594482860882,1.07698958969046e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37791,0.0177927867126021,0.00311383951173623,0.0116896612695991,0.0238959121556051,1.12644909018873e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,40197,-0.0240849101407892,0.00421710470790788,-0.0323504353682887,-0.0158193849132898,1.14178651145672e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,40065,-0.0158730927862989,0.00278491681608261,-0.0213315297458209,-0.010414655826777,1.22211439174905e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36960,0.0604891731393326,0.0106279582590649,0.0396583749515654,0.0813199713270998,1.2874630292603e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37756,-0.0681209058271405,0.0119722736276902,-0.0915865621374134,-0.0446552495168677,1.29802265262876e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40100,-0.0178015963235118,0.00313157682363483,-0.0239394868978361,-0.0116637057491876,1.33498990559289e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,37407,-0.0225447119838885,0.00397193800525606,-0.0303297104741903,-0.0147597134935866,1.40839960881809e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40126,0.0528825017338725,0.0093179890903771,0.0346192431167334,0.0711457603510116,1.40884850123453e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40274,-0.0373988419304104,0.00659624537579996,-0.0503274828669784,-0.0244702009938425,1.45531061652437e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37430,-0.0287747740033818,0.00507497498610877,-0.038721724976155,-0.0188278230306086,1.4589826969191e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37662,-0.0234667147401841,0.00413942184553571,-0.0315799815574341,-0.0153534479229341,1.46571160023822e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37470,-0.034267747266834,0.00604774988226885,-0.0461213370360809,-0.0224141574975871,1.49096274640818e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,37343,-0.0347022107556497,0.00612468589624116,-0.0467065951122824,-0.022697826399017,1.49335613273324e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39531,-0.0166168808182041,0.00293459013728708,-0.0223686774872868,-0.0108650841491214,1.51974626887505e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37784,-0.0160635073319062,0.00284401581822666,-0.0216377783356304,-0.0104892363281819,1.65471832883491e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,40126,-0.0461402634073584,0.00817777378302783,-0.0621687000220929,-0.0301118267926239,1.70839095422425e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39746,-0.0255168455892504,0.00453162605563781,-0.0343988326583005,-0.0166348585202003,1.82491353651672e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37696,-0.0161792586522973,0.00287600389021361,-0.021816226277116,-0.0105422910274787,1.88604752108019e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,40095,-0.0249850777594493,0.00444542676321571,-0.0336981142153521,-0.0162720413035465,1.9376685912057e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37696,0.0370294075044719,0.00658860882074268,0.0241157342158163,0.0499430807931276,1.94567219489227e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,37697,-0.0220397494131427,0.00392486743495964,-0.0297324895856636,-0.0143470092406218,2.00037706843573e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,40065,0.0406235568393286,0.00723655008925799,0.026439918664383,0.0548071950142743,2.01458505913305e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39727,-0.0448448853430543,0.00799003014674462,-0.0605053444306737,-0.0291844262554348,2.02767823729872e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37362,-0.0274557794289956,0.00491375958382622,-0.037086748213295,-0.0178248106446962,2.34983443376596e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37756,-0.0232792944300283,0.00416916026564249,-0.0314508485506876,-0.015107740309369,2.40080594724528e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,39815,-0.0232276225200918,0.00417505795118158,-0.0314107361044077,-0.0150445089357759,2.68947961619944e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37515,-0.0295223692776652,0.00530710585477478,-0.0399242967530237,-0.0191204418023066,2.70698073497774e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37362,-0.0648561420029033,0.0116781461950937,-0.0877453085452869,-0.0419669754605196,2.85321487517238e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,39746,-0.0243117613532287,0.00437933455006411,-0.0328952570713544,-0.0157282656351031,2.87983363180842e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37808,-0.00991249618743892,0.00178609703716963,-0.0134132463802914,-0.00641174599458645,2.91429817025547e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,37282,-0.0274050187042428,0.00494115262604234,-0.0370896778512858,-0.0177203595571998,2.9758364157417e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39727,-0.038699303047964,0.00697850790608875,-0.0523771785438979,-0.02502142755203,2.9798006384262e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,37784,-0.0276878387582069,0.00499267257472943,-0.0374734770046765,-0.0179022005117372,2.98359399967778e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,37756,0.0233846327379962,0.00423465347465338,0.0150847119276756,0.0316845535483169,3.4104531864464e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,37716,-0.0167418300546678,0.0030367165589201,-0.0226937945101512,-0.0107898655991844,3.59083945050179e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40100,-0.0196650092765013,0.00356872691831642,-0.0266597140364015,-0.0126703045166011,3.6373262454279e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39775,-0.0271270541680326,0.00492713925795878,-0.0367842471136318,-0.0174698612224334,3.73742433932496e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40261,-0.01985659081174,0.00361384411599286,-0.026939725279086,-0.012773456344394,3.97672263213058e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,40081,-0.0211069648407414,0.00384308437985075,-0.0286394102252489,-0.0135745194562339,4.03166836419961e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37430,-0.0123498573563921,0.00224868320658849,-0.0167572764413056,-0.00794243827147869,4.04795128370175e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40133,0.0141190521147769,0.00257546098277546,0.00907114858853698,0.0191669556410168,4.26687989660329e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,40126,-0.0351619284765299,0.00643047828028275,-0.047765665905884,-0.0225581910471757,4.62074348590729e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37674,-0.0216776045334845,0.0039659955244582,-0.0294509557614226,-0.0139042533055464,4.68999501614762e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37430,-0.0167629847626653,0.00307639651892085,-0.0227927219397502,-0.0107332475855804,5.16063785477171e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37403,-0.0183784874833207,0.00337364349879549,-0.0249908287409599,-0.0117661462256815,5.19670682415398e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40047,-0.0166711153500256,0.00306674568392071,-0.0226819368905101,-0.010660293809541,5.52798840301599e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,40233,-0.0675171852525502,0.0124300046850509,-0.09187999443525,-0.0431543760698503,5.66171952557942e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,39746,-0.0354868265017233,0.00653610074298859,-0.0482975839579809,-0.0226760690454657,5.74198950718068e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39727,-0.0193035662807442,0.00355615824136826,-0.026273636433826,-0.0123334961276624,5.77912020093213e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40274,-0.0378416911633232,0.00697753596789358,-0.0515176616603946,-0.0241657206662518,5.93473007899544e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40143,-0.0170605629421566,0.00314896104953148,-0.0232325265992383,-0.0108885992850749,6.12129851925469e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40099,-0.0230988497397285,0.0042713503152421,-0.0314706963576031,-0.014727003121854,6.47195531966826e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,37430,-0.0481034150170846,0.008901415373963,-0.0655501891500521,-0.0306566408841172,6.63154047832444e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37652,-0.0247809051977455,0.0045859325245938,-0.0337693329459493,-0.0157924774495416,6.64215275254684e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37362,-0.0185457776440585,0.00343236346285774,-0.0252732100312597,-0.0118183452568574,6.66209805034673e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39815,-0.0195582539154602,0.00362380385876224,-0.0266609094786342,-0.0124555983522862,6.87078184264535e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,37737,-0.0372939836150027,0.0069114328162507,-0.0508403919348541,-0.0237475752951514,6.93180217323602e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,40059,0.0326835089843115,0.00605961733836394,0.0208066590011182,0.0445603589675049,7.00426434549884e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40081,-0.0561117936911546,0.010410427094501,-0.0765162307963766,-0.0357073565859327,7.14952095291357e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,39942,-0.0531623187644754,0.00987658234325452,-0.0725204201572543,-0.0338042173716966,7.44601103530348e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,40126,0.0194170619753973,0.00360867972175403,0.0123440497207594,0.0264900742300352,7.52812523377588e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37376,-0.031703776285995,0.00590856716304837,-0.0432845679255698,-0.0201229846464202,8.20136390611776e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,37696,-0.0286211883732406,0.00533857082213376,-0.0390847871846228,-0.0181575895618585,8.40544762029137e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,39931,-0.019810352956739,0.00369712318365713,-0.0270567143967069,-0.012563991516771,8.52037125251001e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37756,-0.0292629939536328,0.00547754540083556,-0.0399989829392705,-0.0185270049679951,9.3258215388981e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40126,-0.0337415512762638,0.00631832425832111,-0.0461254668225732,-0.0213576357299544,9.41033793537767e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39664,-0.029087766737575,0.00544840308015455,-0.039766636774678,-0.0184088967004721,9.49234462240775e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,37403,-0.02552194019148,0.00479012885912329,-0.0349105927553616,-0.0161332876275984,1.00948097572765e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,39700,-0.0315826498221226,0.00593279092342729,-0.0432109200320401,-0.0199543796122051,1.03285232301236e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37756,-0.0339283667661109,0.00637350256650043,-0.0464204317964518,-0.0214363017357701,1.03530397328647e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,37622,-0.0225797899728055,0.00424724596640989,-0.0309043920669688,-0.0142551878786421,1.07606187528057e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39689,-0.0383063249773069,0.00722320329138808,-0.0524638034284275,-0.0241488465261863,1.15359122133574e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39815,0.019438071770416,0.0036677754085382,0.0122492319696811,0.0266269115711509,1.17602346794023e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,40049,-0.0361182676138637,0.00683203178655482,-0.0495090499155111,-0.0227274853122162,1.26285312141685e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37430,-0.0253939542874632,0.00480430369458768,-0.0348103895288551,-0.0159775190460714,1.27276445963157e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40174,0.0224876785271991,0.00425982765699661,0.0141384163194858,0.0308369407349125,1.3160962267538e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,37203,-0.0398416132474973,0.00754679020059837,-0.0546333220406701,-0.0250499044543245,1.31822220751018e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37515,-0.0352834703805483,0.00669430024459932,-0.048404298859963,-0.0221626419011336,1.38088207901296e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40065,-0.0103243561850772,0.00196214915147567,-0.0141701685219695,-0.00647854384818492,1.44569808433084e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40126,-0.0287805553310323,0.00547415439477033,-0.0395098979447821,-0.0180512127172824,1.4791601600858e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,37279,0.0310828683938064,0.00591289001857143,0.0194936039574064,0.0426721328302064,1.48937918490858e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39991,-0.0304754930879052,0.00580343703252126,-0.0418502296716468,-0.0191007565041635,1.53033752879881e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,37808,-0.0103872061075008,0.00197906886669715,-0.0142661810862272,-0.00650823112877439,1.55664348108846e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,37696,-0.0356051904097072,0.00679984729862318,-0.0489328911150087,-0.0222774897044058,1.66447716400331e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,40213,-0.0258070396040696,0.00493044419450063,-0.0354707102252909,-0.0161433689828484,1.67806883296963e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39727,-0.0319880278227362,0.00613336006936288,-0.0440094135586874,-0.0199666420867849,1.85799164538836e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39815,-0.035680686980672,0.00684973954775206,-0.0491061764942661,-0.022255197467078,1.92254501449311e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37696,-0.0210719306323878,0.00404915079562483,-0.0290082661918125,-0.0131355950729631,1.97919141049857e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40100,-0.0744421994482652,0.0143154375779043,-0.102500457100958,-0.0463839417955727,2.01653465936658e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39810,-0.0173284465444185,0.00333788388950413,-0.0238706989678466,-0.0107861941209904,2.11327749614577e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37782,-0.0355438854422186,0.00689117347818283,-0.0490505854594569,-0.0220371854249802,2.53335557683665e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,37737,-0.0472356888791027,0.00916215311557699,-0.0651935089856336,-0.0292778687725718,2.5655728571814e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,40274,-0.0298436542077689,0.00579003936980252,-0.0411921313725819,-0.018495177042956,2.57631942889922e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,39810,-0.0231535865490893,0.00450181848188157,-0.0319771507735771,-0.0143300223246014,2.73473804808936e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,37430,-0.0145139098362299,0.00282425076464943,-0.0200494413349427,-0.008978378337517,2.80170916562974e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAT,Catalase,37587,-0.0266026402625489,0.00518599800567516,-0.0367671963536722,-0.0164380841714256,2.94331203538655e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40126,0.0138839913334025,0.00270906581114949,0.00857422234354948,0.0191937603232555,3.01057298681477e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,40100,-0.0149859073832038,0.00292815122891032,-0.020725083791868,-0.00924673097453955,3.12659049894304e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37756,-0.0191268646839966,0.00374887502230642,-0.0264746597277172,-0.011779069640276,3.40661642275923e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40248,0.0297719736276572,0.00583643291688221,0.018332565110568,0.0412113821447463,3.41674717356582e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,39978,-0.0218353128361187,0.00428252570884938,-0.0302290632254635,-0.013441562446774,3.46017359733387e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37784,-0.0133502142824952,0.00261953067054556,-0.0184844943967645,-0.00821593416822589,3.50883897985066e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37343,-0.0375930606845744,0.00737865719827233,-0.0520552287931882,-0.0231308925759607,3.53975443828973e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40186,0.0136601334036552,0.00268384895024115,0.00839978946118255,0.0189204773461279,3.62659651788007e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37697,-0.0161433052923749,0.00317790290382615,-0.0223719949838742,-0.00991461560087565,3.82848990999641e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39810,-0.0268093083811251,0.00529607545232841,-0.0371896162676888,-0.0164290004945614,4.19440174002027e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,40095,-0.0318718817329035,0.0063065193178046,-0.0442326595958005,-0.0195111038700065,4.37992944606636e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,37782,0.0118672680748441,0.00235295411080686,0.00725547801766262,0.0164790581320255,4.62952973859952e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37430,-0.0222965865252782,0.00442365483906588,-0.0309669500098473,-0.0136262230407091,4.71041576605132e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,40204,-0.03500637899293,0.00696760520556404,-0.0486628851958355,-0.0213498727900245,5.11171413820716e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37403,-0.0194573787571962,0.00387713998790217,-0.0270565731334845,-0.011858184380908,5.27710918741694e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39810,-0.0252039916610377,0.00502415623058431,-0.0350513378729829,-0.0153566454490924,5.31916771738556e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37403,-0.0168570702324287,0.00336105217352424,-0.0234447324925362,-0.0102694079723212,5.36199161164725e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39978,-0.0449010716910971,0.00895523881136341,-0.0624533397613693,-0.0273488036208248,5.39131180102408e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37645,0.0138388472967934,0.00276159773836398,0.00842611572959997,0.0192515788639868,5.47997242851155e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37737,-0.0503982287482276,0.0100596923321039,-0.0701152257191512,-0.030681231777304,5.51531780579347e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,40197,-0.0190260560308647,0.00379814491796702,-0.02647042007008,-0.0115816919916493,5.52193141721845e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37430,-0.0199451011290019,0.00398283074281542,-0.0277514493849201,-0.0121387528730837,5.57875009974783e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40065,-0.0348110409751606,0.00698498749464623,-0.0485016164646673,-0.021120465485654,6.30495908049638e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37362,-0.0169527651538423,0.00341843560626659,-0.0236528989421248,-0.0102526313655598,7.16777072023888e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,37362,-0.0190897454023937,0.00385002879889978,-0.0266358018482373,-0.0115436889565501,7.20020856778303e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40143,-0.0125426290461208,0.00253230077761528,-0.0175059385702468,-0.00757931952199486,7.38166631696088e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40121,0.0179368928276546,0.00362671829980863,0.0108285249600297,0.0250452606952795,7.66313767289539e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37430,-0.0282659764450448,0.00571989212876704,-0.0394769650174282,-0.0170549878726614,7.8411539277635e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37696,0.0238295773215586,0.00482502132594823,0.0143725355227001,0.0332866191204172,7.95835754049235e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37756,-0.0325125600846471,0.00661999924517775,-0.0454877586051955,-0.0195373615640988,9.15665778208233e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,40100,-0.0262565061648305,0.0053539060508543,-0.036750162024505,-0.0157628503051561,9.47613465470551e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37737,0.0144845325291185,0.00295468507647499,0.00869334977922747,0.0202757152790094,9.58764116892928e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39727,-0.0214653431180089,0.00437964468999725,-0.0300494467104035,-0.0128812395256142,9.62494793296991e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,37430,-0.0136283090543618,0.00278407798619941,-0.0190851019073126,-0.00817151620141094,9.94430817042436e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37344,-0.0190992916553521,0.00390551278695645,-0.0267540967177868,-0.0114444865929175,1.01875290468248e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,40233,-0.0138483173608956,0.0028351566771928,-0.0194052244481935,-0.00829141027359775,1.0470880174152e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37791,-0.0231389716351891,0.00474071233160645,-0.0324307678051378,-0.0138471754652405,1.06821207186793e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,37737,-0.012729670316,0.00261344684283038,-0.0178520261279475,-0.00760731450405243,1.12407795337786e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37362,-0.029063911886035,0.0059766415362227,-0.0407781292970315,-0.0173496944750385,1.17031570767725e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37784,-0.0116739150500708,0.00240218954212773,-0.0163822065526411,-0.00696562354750041,1.18903210509338e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37515,-0.017197747377721,0.00354307033234826,-0.0241421652291236,-0.0102533295263184,1.22449994601555e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40095,-0.016783656327489,0.00346088093431123,-0.023566982958739,-0.010000329696239,1.24942442608818e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37362,-0.0311452288226835,0.00642264363391323,-0.0437336103451534,-0.0185568473002136,1.25351907609263e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,40095,0.0182151351782671,0.00375885669550132,0.0108477760550845,0.0255824943014497,1.27231859462921e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39991,-0.0104432533163296,0.00215736047431203,-0.0146716798459812,-0.00621482678667802,1.30590199719307e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,39815,-0.0522662659504282,0.0108125223523199,-0.0734588097609753,-0.0310737221398811,1.35202758467779e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37470,0.0123467089743565,0.00255479176328235,0.00733931711832308,0.0173541008303899,1.36185806141457e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40095,0.011084488478459,0.00229629578437418,0.00658374874108556,0.0155852282158324,1.39832104148942e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,39698,-0.0312184624217152,0.00646909131885576,-0.0438978814066725,-0.0185390434367579,1.40801001228258e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37696,-0.0364140166414939,0.00754869299991704,-0.0512094549213313,-0.0216185783616565,1.42357221395678e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37515,-0.0246455872630146,0.00511520550147802,-0.0346713900459115,-0.0146197844801177,1.46558150242177e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37343,0.0131701318487165,0.00273408319523634,0.00781132878605324,0.0185289349113797,1.47376520001307e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40123,-0.0266664691115154,0.00553644309474217,-0.03751789757721,-0.0158150406458207,1.47438508056728e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,37403,-0.028682428474302,0.00595667222168939,-0.0403575060288132,-0.0170073509197908,1.48732930048165e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40056,0.0265134315992156,0.00551359328204802,0.0157067887664015,0.0373200744320297,1.5330243062923e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,40095,0.0152661377103531,0.00317771898596481,0.00903780849786211,0.0214944669228442,1.56876246167124e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37403,-0.0239154886288578,0.00500216183497337,-0.0337197258254056,-0.01411125143231,1.7631754210831e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40100,-0.0556365713381229,0.0116492694873615,-0.0784691395333514,-0.0328040031428944,1.80462930080084e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40199,-0.036948499645365,0.00773681261392994,-0.0521126523686677,-0.0217843469220623,1.80718172923159e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,39936,-0.03185542553533,0.00670017631600815,-0.0449877711147059,-0.018723079955954,2.00811968112553e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40100,0.0213635924583557,0.00449422499973866,0.012554911458868,0.0301722734578435,2.0163893480614e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39810,0.0144948545115088,0.00305594207623311,0.0085052080420919,0.0204845009809257,2.12290713308173e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37403,-0.0287155207439959,0.00606333619748074,-0.0405996596910582,-0.0168313817969337,2.203683256461e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,40164,0.0262320994835544,0.0055417345359896,0.0153702997930148,0.037093899174094,2.22545973222739e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37662,-0.0240665462656508,0.00508568854731318,-0.0340344958183846,-0.0140985967129169,2.24390682701324e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,40121,0.0161121404809265,0.00340629138476067,0.00943580936679554,0.0227884715950574,2.26352269792072e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,39727,-0.0326865100910995,0.00691072690219169,-0.0462315348193952,-0.0191414853628038,2.26725997241901e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37756,-0.0270644067570401,0.00572357301908219,-0.0382826098744412,-0.015846203639639,2.28409157615047e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40233,-0.0200687088294158,0.00424804049418499,-0.0283948681980183,-0.0117425494608132,2.32982053580497e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39949,0.0296998041972437,0.0062947490638081,0.0173620960321798,0.0420375123623076,2.40033054224031e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,40164,-0.0136719754851448,0.00290632767350218,-0.0193683777252091,-0.00797557324508054,2.57020454149209e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37430,-0.0188504529752621,0.00400723843874709,-0.0267046403152064,-0.0109962656353178,2.5761701574018e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37403,0.011970020267005,0.00255023637849474,0.00697155696515531,0.0169684835688547,2.71069169693e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,40233,0.034199359322993,0.00729851848559876,0.0198942630912194,0.0485044555547665,2.81203878803483e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37470,0.0181158280090868,0.0038659687640426,0.0105385292315633,0.0256931267866103,2.81454259106443e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40186,-0.0114910812479796,0.002454352485076,-0.0163016121187286,-0.00668055037723069,2.86573004645658e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,37496,0.0137268717371477,0.00293779914802366,0.00796878540702128,0.019484958067274,3.00527601603446e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,40186,0.0277123310305711,0.00593349020219042,0.0160826902342779,0.0393419718268644,3.02960649838989e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37755,0.00655864272504257,0.00140491355444371,0.00380501215833289,0.00931227329175224,3.06578821899187e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,39983,0.0127347293186188,0.00272983448932191,0.00738425371954784,0.0180852049176897,3.111622059675e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37403,-0.0178887314145771,0.00384386083489257,-0.0254226986509666,-0.0103547641781877,3.29032575831952e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,40274,-0.0391728312934214,0.00842475676219301,-0.0556853545473197,-0.0226603080395231,3.35058800971216e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,39727,-0.0298204877534909,0.00642430475882982,-0.0424121250807973,-0.0172288504261844,3.48220833523773e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40297,0.0121420055204337,0.00261747781089272,0.00701174901108397,0.0172722620297834,3.53208597768243e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40100,-0.0525368078988277,0.0113548717136431,-0.0747923564575682,-0.0302812593400871,3.743227910632e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,37372,-0.0188843972154288,0.00408489972479873,-0.0268908006760343,-0.0108779937548232,3.81936305539949e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,39967,0.0137496112705219,0.0029746864804341,0.00791922576887107,0.0195799967721727,3.82741277863087e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,40126,0.0148912182579293,0.00323665162643721,0.0085473810701124,0.0212350554457463,4.24148676871005e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,40065,-0.0123417351863191,0.00268605076869049,-0.0176063946929525,-0.00707707567968577,4.36656016378655e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40028,-0.0116543646735599,0.00253842915179972,-0.0166296858110874,-0.00667904353603248,4.44210855001619e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40100,0.0148794317919234,0.00324631218851498,0.00851665990243408,0.0212422036814128,4.6082056859763e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40297,0.00677587185422969,0.00147879876555062,0.00387742627375049,0.0096743174347089,4.64039145822336e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39792,-0.0184592731948618,0.00402927262977624,-0.0263566475492232,-0.0105618988405004,4.65752029137141e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37282,-0.0181353367923023,0.00395896967836058,-0.0258949173618891,-0.0103757562227156,4.67513008468696e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40100,-0.0358996175757054,0.00783796533203964,-0.0512620296265031,-0.0205372055249077,4.68066173908851e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37782,-0.0230146715919414,0.00503310837779602,-0.0328795640124216,-0.0131497791714612,4.85916046556274e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39815,-0.0244529637098401,0.00535054023435313,-0.0349400225691723,-0.013965904850508,4.91087892746994e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40248,0.0251326658371105,0.00551312686124298,0.0143269371890743,0.0359383944851468,5.18585842238378e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,37470,-0.0155400659025909,0.00342192457368479,-0.0222470380670131,-0.00883309373816874,5.64040752403351e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40100,-0.0396305247707812,0.00873520981089076,-0.0567515360001271,-0.0225095135414353,5.75194259096509e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39810,0.0147515052185297,0.00325191033345943,0.00837776096494917,0.0211252494721101,5.76946853821772e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37697,-0.0236515045536407,0.00522407548278033,-0.0338906924998901,-0.0134123166073912,6.02331453080695e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40174,-0.0376372757672368,0.00836174686880676,-0.054026299630098,-0.0212482519043755,6.80797437726607e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39746,-0.0220164927538033,0.00489338189207895,-0.0316075212622781,-0.0124254642453286,6.86998427733069e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37791,-0.0266560577819074,0.00592709458329886,-0.0382731631651732,-0.0150389523986417,6.93951892396504e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI3,Elafin,39842,-0.0229155034651098,0.00509864124208447,-0.0329088402995953,-0.0129221666306242,7.02641751234671e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40100,-0.0155047654046754,0.00345068999195155,-0.0222681177889005,-0.0087414130204504,7.06515237907736e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,37696,-0.0149295239452112,0.00332484293740634,-0.0214462161025276,-0.00841283178789473,7.17256921269887e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,37362,0.0158972089152799,0.00354420574519352,0.00895056565470065,0.0228438521758592,7.34027243206399e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37670,0.0115774239692745,0.00258122091805291,0.00651823096989078,0.0166366169686582,7.34419928173294e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37362,-0.0163940123099354,0.00366660677517237,-0.0235805615892732,-0.00920746303059754,7.8457183402162e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37282,-0.0261811059037851,0.00588308129042445,-0.037711945233017,-0.0146502665745532,8.64984672490665e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,40126,-0.0190955574582764,0.00429895724143596,-0.0275215136514909,-0.0106696012650619,8.97764900162154e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37697,-0.0231826102590142,0.00523962629410683,-0.0334522777954636,-0.0129129427225649,9.74476058544106e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,40124,0.0262207612697796,0.00595032191534501,0.0145581303157034,0.0378833922238558,1.05697108762579e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37343,0.0140514719331844,0.00319115545461923,0.00779680724213066,0.0203061366242381,1.07497362983445e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37470,0.00918398247715329,0.00209189559095918,0.0050838671188733,0.0132840978354333,1.1410361836607e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RETN,Resistin,40046,-0.0172144673844789,0.00392977178847654,-0.0249168200898929,-0.00951211467906484,1.19165482576015e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37697,-0.0256492872302791,0.0058596273930588,-0.0371341569206744,-0.0141644175398839,1.21084819206089e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,40126,0.0147897048473131,0.00340029592468545,0.00812512483492965,0.0214542848596966,1.37288403677963e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40186,-0.0108661165567852,0.00249927632217653,-0.0157646981482512,-0.00596753496531923,1.38433530987421e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39746,-0.0217899733516337,0.00501256644079235,-0.0316146035755867,-0.0119653431276807,1.38859846260925e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40185,0.00869059927749527,0.00200138102890507,0.00476789246084133,0.0126133060941492,1.41879593702078e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40122,-0.0411106498204184,0.00947710232020398,-0.0596857703680182,-0.0225355292728186,1.44755111773517e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37376,-0.0250752708337502,0.00578352790857565,-0.0364109855345585,-0.013739556132942,1.46439668195616e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39727,-0.0168924640804734,0.00391427746572307,-0.0245644479132906,-0.00922048024765616,1.60169637698602e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,40174,-0.016686161218057,0.00386696250385803,-0.0242654077256187,-0.00910691471049526,1.60536762008331e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,37808,0.00929833388462516,0.00215570598923181,0.00507315014573081,0.0135235176235195,1.61947491581768e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40164,0.0136278333280835,0.00316339956359535,0.0074275701834366,0.0198280964727304,1.65759706080872e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37362,0.021492156891148,0.00499467717865832,0.0117025896209777,0.0312817241613183,1.69732137441616e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40054,-0.0116817873262702,0.0027179651634015,-0.0170089990465371,-0.00635457560600327,1.73398759171691e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,39815,-0.0193189754398114,0.0045010630332553,-0.0281410589849918,-0.010496891894631,1.78081862821097e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,39675,-0.0466053497181662,0.010879383332359,-0.0679289410495899,-0.0252817583867426,1.84836509054301e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39746,-0.0244753878222697,0.00571426704424895,-0.0356753512289976,-0.0132754244155417,1.85343215810184e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37362,-0.0479325371241753,0.0112114773380716,-0.0699070327067956,-0.025958041541555,1.92242926703894e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39746,-0.0217521550256189,0.00509834363297854,-0.0317449085462568,-0.0117594015049809,1.99744957449891e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,37470,-0.0120425236831847,0.00282680663825461,-0.0175830646941637,-0.00650198267220562,2.05756836838692e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39746,-0.0177431236502251,0.00416533465261729,-0.025907179569355,-0.0095790677310952,2.0591445150828e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39746,-0.0178850758767163,0.00420122714070224,-0.0261194810724927,-0.00965067068093994,2.08323630649865e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40297,0.0133739441419286,0.00314181836400211,0.00721598014848452,0.0195319081353728,2.08610852477271e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39991,-0.0103278954558227,0.00242799720541397,-0.0150867699784341,-0.00556902093321133,2.11526889396613e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39967,-0.016044860851765,0.00377561195273067,-0.0234450602791171,-0.0086446614244129,2.15397773147993e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,40297,0.00690364994584923,0.00162573850854296,0.00371720246910502,0.0100900974225934,2.18402743864494e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37756,0.0183323583277269,0.00432489237314271,0.00985556927636722,0.0268091473790866,2.26232517926567e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39691,-0.0176992954620341,0.00418218817848096,-0.0258963842918567,-0.00950220663221138,2.32909608484078e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39746,-0.016300532241287,0.00385952537769165,-0.0238652019815627,-0.00873586250101138,2.41977150030806e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40126,0.0103284499250263,0.00244965174245288,0.00552713250981869,0.015129767340234,2.49743685232307e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37696,-0.0350776513251404,0.00832501118662452,-0.0513946732509245,-0.0187606293993564,2.53079782672151e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,40027,-0.0118984273375886,0.00282439286333532,-0.0174342373497259,-0.00636261732545141,2.53712961838873e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37027,-0.0434909877377835,0.0103300701174902,-0.0637379251680643,-0.0232440503075027,2.56993435578149e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40274,-0.0106588652302411,0.0025347116507661,-0.0156269000657427,-0.00569083039473959,2.62333760872134e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,40065,0.00851972830481813,0.00202722917312375,0.00454635912549557,0.0124930974841407,2.65279087238994e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCT,Secretin,37376,-0.0184746100924296,0.00439996518744465,-0.0270985418598211,-0.00985067832503812,2.70120563517773e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39746,0.0123342374346834,0.0029434648142363,0.0065650463987803,0.0181034284705866,2.80050665797107e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39630,-0.0150771639049414,0.00359811843672235,-0.0221294760409172,-0.00802485176896559,2.80172748129573e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37362,0.0161548564397427,0.00386871491245569,0.00857217521132956,0.0237375376681559,2.98932127169858e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37362,0.0080795919359624,0.00193662330884401,0.00428381025062814,0.0118753736212967,3.03913633633339e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,37697,0.046694903879639,0.0112282314546057,0.0246875702286118,0.0687022375306662,3.22073164973202e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39746,-0.01851736000545,0.00445377895103579,-0.0272467667494802,-0.00978795326141986,3.23256673613742e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39957,0.011265686486988,0.0027174901110022,0.00593940586942367,0.0165919671045523,3.40694215358552e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39691,-0.0186102250298351,0.0044914225994002,-0.0274134133246594,-0.00980703673501068,3.43886410999681e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FST,Follistatin,40160,-0.0204478314560475,0.00493598278709583,-0.0301223577187553,-0.0107733051933396,3.45178505577354e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,37470,-0.0134056560863779,0.00324164155673112,-0.0197592735375709,-0.00705203863518494,3.5647815503133e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37706,-0.0225882023171969,0.00546501459936636,-0.033299630931955,-0.0118767737024389,3.59888981688066e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2,Complement C2,40133,-0.00937884911238731,0.00228083271443456,-0.0138492812326791,-0.00490841699209557,3.94196514387713e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40100,-0.0183980861254368,0.00447435723381777,-0.0271678263037197,-0.00962834594715399,3.94428930863313e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40274,-0.0172922614221056,0.00420841506645227,-0.0255407549523521,-0.00904376789185918,3.99425053963746e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37362,-0.039806802611698,0.00969040375959336,-0.058799993980501,-0.020813611242895,4.0180880292549e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39815,-0.0137203539120047,0.0033406839625618,-0.0202680944786258,-0.00717261334538352,4.0282058614048e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37661,-0.0121906419785068,0.00297498677813002,-0.0180216160636417,-0.006359667893372,4.19744007676363e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37791,0.0139249101519965,0.00340357512733919,0.00725390290241169,0.0205959174015813,4.31558159082981e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,37403,-0.0460227400951989,0.0112655902656114,-0.0681032970157972,-0.0239421831746007,4.42947010178354e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40071,-0.0345080913441525,0.00844780583671909,-0.051065790784122,-0.0179503919041831,4.43237171887602e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,40233,-0.0101244650463624,0.00248081053828375,-0.0149868537013985,-0.00526207639132623,4.50413340922199e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37470,-0.0261929025078655,0.00644342602658041,-0.0388220175199631,-0.0135637874957679,4.83027319536729e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40065,-0.00817953448993211,0.0020187109136245,-0.0121362078806361,-0.0042228610992281,5.10579149464926e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,40100,-0.0342163431649822,0.00844911420385397,-0.050776607004536,-0.0176560793254285,5.15313579944497e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37362,-0.0177064855383075,0.00437687926263925,-0.0262851688930804,-0.00912780218353459,5.25246169580512e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,39727,-0.0317361884607595,0.00786372529217148,-0.0471490900334156,-0.0163232868881034,5.46886358947091e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37470,-0.0343054334682858,0.00850698116089644,-0.0509791165436428,-0.0176317503929287,5.54726421541867e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,37756,0.0139351210384507,0.00345925659998313,0.00715497810248376,0.0207152639744176,5.64800927372299e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37737,-0.0176023663772703,0.00437461329503401,-0.0261766084355369,-0.00902812431900362,5.75951843924098e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,39834,-0.0211022543046172,0.00524484138746216,-0.031382143424043,-0.0108223651851913,5.76308542600944e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,40186,-0.0258667991773969,0.00643927554729597,-0.038487779250097,-0.0132458191046968,5.92087109270685e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39746,-0.017478977990733,0.00436212834705283,-0.0260287495509566,-0.00892920643050946,6.17903190389835e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,37730,0.017847223204618,0.00445480389066564,0.0091158075789134,0.0265786388303227,6.20170179116903e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37697,-0.0143809943555159,0.00359021272826183,-0.021417811302909,-0.00734417740812267,6.21953954470455e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,37696,-0.0117353900168597,0.00293340404078776,-0.0174848619368037,-0.00598591809691564,6.35243727228925e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37697,-0.0153657994654944,0.00385114601456182,-0.0229140456540356,-0.00781755327695324,6.64487894126534e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,40095,-0.0127142966183554,0.00318906545179551,-0.0189648649038746,-0.00646372833283617,6.7263054732063e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37362,-0.0155553077725281,0.003903301641839,-0.0232057789905325,-0.00790483655452365,6.78034639308689e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37434,0.0185204529329616,0.00464851524128155,0.00940936306004972,0.0276315428058734,6.80875810718252e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40248,-0.0128144037218391,0.00321833048691067,-0.019122331476184,-0.00650647596749421,6.87324586076637e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,39955,-0.0130165031529711,0.00327004964961498,-0.0194258004662165,-0.00660720583972575,6.90775269349337e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37697,-0.0155000576816617,0.00389936342564191,-0.0231428099959198,-0.00785730536740353,7.07460085552378e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,37282,-0.0136293111151669,0.00342881420973217,-0.020349786966242,-0.00690883526409189,7.07843392830552e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,40248,0.0171675985335083,0.00432309945944018,0.00869432359300549,0.025640873474011,7.18489411988502e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40100,0.0151254897639638,0.00381595802472091,0.00764621203551083,0.0226047674924168,7.41104012773419e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40216,-0.00985388328513163,0.00248888258056778,-0.0147320931430445,-0.00497567342721879,7.55441763270776e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37362,-0.0238087048061678,0.0060152164676524,-0.0355985290827665,-0.0120188805295691,7.59595696115807e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37372,-0.0224446895991321,0.00567170391649744,-0.033561229275467,-0.0113281499227971,7.62040323343961e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,40248,0.0228432265076531,0.00578471675011983,0.0115051816774182,0.034181271337888,7.88541126432624e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39746,-0.0191609025389704,0.00486140487466871,-0.0286892560933211,-0.00963254898461974,8.13565522141516e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,37362,-0.0228061038783937,0.00578914772417648,-0.0341528334177796,-0.0114593743390078,8.20956613020317e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40233,0.0102435325709748,0.00260109746416167,0.00514538154121789,0.0153416836007316,8.24624578906163e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37376,-0.0186447694815733,0.00473731837399569,-0.0279299134946048,-0.00935962546854172,8.3381291675471e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37376,-0.0264506488859777,0.00672304081917671,-0.0396278088915641,-0.0132734888803914,8.38661138819425e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,39727,-0.0185125702485363,0.00471337247010047,-0.0277507802899332,-0.00927436020713934,8.61499542505492e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37470,0.0122250474788696,0.00311485782643349,0.00611992613906,0.0183301688186793,8.72654731875345e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39961,0.0126353805766256,0.00322131333192094,0.00632160644606057,0.0189491547071906,8.80374726062961e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,39727,-0.0196219702706859,0.00500938087503849,-0.0294403567857614,-0.00980358375561048,9.0031067113611e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,40033,-0.0149368126287039,0.00382185538362428,-0.0224276491806074,-0.00744597607680027,9.33556033160611e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39815,-0.0110413029447875,0.0028278930913019,-0.0165839734037392,-0.00549863248583575,9.48524323589594e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37515,-0.0161302631566859,0.00413158892309361,-0.0242281774459494,-0.00803234886742247,9.5039958206475e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,37343,0.0104035388006806,0.00266546840733345,0.00517922072230705,0.0156278568790542,9.54591886097463e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37696,-0.0192164772451242,0.00493604600321765,-0.0288911274114308,-0.00954182707881764,9.94603413746203e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,39783,-0.0179114992896924,0.00460653745370618,-0.0269403126989565,-0.00888268588042825,0.000101383503150738
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,37697,-0.0186370507130653,0.00480004974907343,-0.0280451482212492,-0.00922895320488137,0.00010381360402235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,39727,-0.0194882257693702,0.00502096464152084,-0.0293293164667511,-0.00964713507198938,0.000104305894143966
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37376,-0.0224285043409285,0.00578060021505385,-0.033758480762434,-0.0110985279194229,0.000104991571363116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,40233,-0.0125693188010257,0.00324309930822282,-0.0189257934451424,-0.006212844156909,0.000106743514659936
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37376,0.0139086572740097,0.00359009854065283,0.00687206413433017,0.0209452504136893,0.000107515991604774
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37430,-0.0240294992201195,0.00620785688023017,-0.0361968987053706,-0.0118620997348684,0.000109000933331843
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,37808,-0.00958651608430113,0.00248232701389666,-0.0144518770315386,-0.00472115513706369,0.000113036151877231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40186,0.0152013183610827,0.00393777730653197,0.00748327484028004,0.0229193618818854,0.00011366321675481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37515,-0.0278963946640373,0.00723604918273923,-0.0420790510622062,-0.0137137382658684,0.000116190635173831
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,40066,-0.0100043331727001,0.00259558839002079,-0.0150916864171409,-0.00491697992825936,0.000116497235474707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37376,0.0118543151891057,0.00309354257161809,0.00579097174873423,0.0179176586294771,0.000127730984983207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37282,0.0211203475663522,0.00552281077343995,0.0102956384504099,0.0319450566822945,0.00013181689043524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37784,-0.0231153951025232,0.00605155057899384,-0.0349764342373511,-0.0112543559676953,0.000134194085741884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40059,0.0174010371391454,0.00455887674755322,0.00846563871394112,0.0263364355643497,0.0001356293826034
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,37697,-0.0284205027183886,0.007451258356845,-0.0430249690978048,-0.0138160363389724,0.000137251420132561
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,40064,-0.0102666093763019,0.00270119837252304,-0.0155609581864471,-0.00497226056615679,0.000144800426089551
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40095,0.0117460936795848,0.00309162656259998,0.00568650561688886,0.0178056817422808,0.000145640136349474
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40095,0.0129456468848361,0.0034276050431126,0.00622754100033543,0.0196637527693368,0.00015939430593431
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,40233,-0.0127242036803414,0.00337318443619656,-0.0193356451752866,-0.00611276218539611,0.000162429231038144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40039,0.0216487437715358,0.00573928271800115,0.0103997496442536,0.0328977378988181,0.000162523884823053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,39770,-0.0224494648858417,0.0059521035209321,-0.0341155877868686,-0.0107833419848148,0.000162758235859046
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37430,-0.016289635294413,0.00432446478769429,-0.0247655862782938,-0.0078136843105322,0.000166047035266983
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,40032,-0.0194543071741213,0.00517650542674282,-0.0296002578105372,-0.00930835653770539,0.000171769218501028
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37791,-0.0210219765494977,0.00560044164214152,-0.0319988421680951,-0.0100451109309003,0.000175032768789531
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,40021,0.0149586146119494,0.00398936847552692,0.00713945239991659,0.0227777768239821,0.000177744067422403
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37697,-0.0131579308542119,0.00351182840450648,-0.0200411145270446,-0.0062747471813792,0.000179903202878819
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40095,-0.0122825724220689,0.0032786764786176,-0.0187087783201593,-0.00585636652397838,0.000180179278158684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37697,-0.0216915230400941,0.00579591351280832,-0.0330515135251984,-0.0103315325549898,0.000182928709040229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37403,0.015328585253074,0.00409916338878953,0.00729422501104656,0.0233629454951015,0.00018522354821533
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,37620,-0.0103992725082444,0.00279150010303424,-0.0158706127101915,-0.00492793230629726,0.000195871021710623
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,39727,-0.0199354063291277,0.00536076964082121,-0.0304425148251372,-0.00942829783311808,0.000200920635746239
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39967,-0.00856282916374226,0.00230383777477205,-0.0130783512022955,-0.00404730712518904,0.000202497198318684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,37808,0.0108467809193134,0.0029191576671936,0.00512523189161391,0.0165683299470128,0.000203450047007336
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37737,-0.0843347225774936,0.022789236716729,-0.129001626542282,-0.0396678186127048,0.000215926321068928
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,40100,-0.0350536670358174,0.00947497987037458,-0.0536246275817516,-0.0164827064898832,0.000216676148045439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37376,-0.0190751324390251,0.00515585679915654,-0.029180611765372,-0.00896965311267832,0.000216748229236858
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,40143,0.0115453392741974,0.00312576725998609,0.00541883544462466,0.0176718431037701,0.000221850467752571
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,37782,-0.0227985133761403,0.00618501153651428,-0.0349211359877082,-0.0106758907645723,0.000228628317784841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39691,-0.016776971096384,0.00455256239747989,-0.0256999933954446,-0.00785394879732343,0.000229341040608362
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37784,-0.00950688336480515,0.00258717776659827,-0.0145777517873378,-0.00443601494227253,0.000239141433969921
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,39810,-0.0156992032792627,0.00427843592893714,-0.0240849376999795,-0.0073134688585459,0.000243962895952653
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,37697,-0.0228358250639875,0.0062296411090409,-0.0350459216377076,-0.0106257284902673,0.000247653549576348
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,40117,-0.0137711542142309,0.00376622105909966,-0.0211529474900663,-0.00638936093839561,0.00025652811336697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40233,-0.0101413699767953,0.00278453685329254,-0.0155990622092487,-0.00468367774434194,0.0002713612385367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37696,-0.0393219624288778,0.0108040790214412,-0.0604979573109025,-0.0181459675468531,0.000274156533818108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37696,-0.0177468400198354,0.00487802539371887,-0.0273077697915244,-0.0081859102481464,0.000275679418636818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,37756,-0.0104584645626091,0.00287729316611299,-0.0160979591681905,-0.0048189699570276,0.000279215257269304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,37430,0.0242500928748926,0.0066782960054528,0.0111606327042051,0.0373395530455801,0.00028321488950374
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40213,-0.0228786201000562,0.00630111021566148,-0.0352287961227527,-0.0105284440773597,0.000283343655866875
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,39438,-0.00779784207011627,0.00215033458346194,-0.0120124978537017,-0.00358318628653087,0.000288421511331123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",40248,-0.025502612484797,0.00703767738747313,-0.0392964601642443,-0.0117087648053497,0.000291300890510106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37784,-0.0117008926997051,0.00324709468307298,-0.0180651982785281,-0.00533658712088203,0.000315108977530127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37343,0.011802603068425,0.00327682631901862,0.0053800234831485,0.0182251826537015,0.00031716128188038
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37515,0.0100448777795779,0.00278979088709557,0.00457688764087059,0.0155128679182852,0.000318679186294466
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40092,0.00765620212332478,0.00213095098496504,0.0034795381927933,0.0118328660538563,0.000328076114293127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37515,-0.0299666141281185,0.0083482491674072,-0.0463291824962366,-0.0136040457600004,0.000332438887863823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40083,-0.00829539573357592,0.00232089747654722,-0.0128443547876085,-0.00374643667954337,0.000352333002813555
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37737,-0.0157394150651036,0.00440708534617566,-0.0243773023436079,-0.00710152778659932,0.000356348335193167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,37777,-0.00500484967593602,0.00140214418675141,-0.00775305228196879,-0.00225664706990326,0.000359022509656149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40126,-0.0119076208676389,0.00334035971879124,-0.0184547259164697,-0.00536051581880802,0.000365255744453356
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,37479,0.00714111905915323,0.00200965878386393,0.00320218784277992,0.0110800502755265,0.00038163252185866
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,37343,0.0255489731228229,0.00721664449336851,0.0114043499158206,0.0396935963298252,0.00040110518412457
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39991,0.0169498991775135,0.00480887534381432,0.00752450350363746,0.0263752948513896,0.000425163186900166
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,40038,-0.0162897749708457,0.00464253755050799,-0.0253891485698414,-0.00719040137185004,0.000451387988882102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37403,-0.0131121106907615,0.00374458593879384,-0.0204514991307974,-0.00577272225072559,0.000463998939118775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,37756,-0.0229334824209984,0.00655883130785324,-0.0357887917843908,-0.0100781730576061,0.000472798682943006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40278,-0.00904107865384831,0.00258760956764948,-0.0141127934064413,-0.00396936390125532,0.000477161639272368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37403,-0.0128404965037173,0.0036861342223642,-0.0200653195795512,-0.00561567342788349,0.000496614270089192
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37756,-0.0256661094254789,0.00737532007236978,-0.0401217367673237,-0.0112104820836341,0.000503021082563652
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39991,-0.011494044478405,0.00330451009622109,-0.0179708842669984,-0.00501720468981169,0.000506004853843363
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,40055,-0.0359886923619849,0.0103477492038469,-0.0562702808015247,-0.015707103922445,0.000506688777060158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,40248,0.0148168396134135,0.00426771724929073,0.00645211380480367,0.0231815654220233,0.000518282821831923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,37343,0.0120281124078334,0.00347990037377521,0.005207507675234,0.0188487171404328,0.000549098718226853
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,37696,-0.0149871528279158,0.00433806387019227,-0.0234897580134926,-0.00648454764233894,0.000552421230861358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37403,-0.0102822043006229,0.00297995794837417,-0.0161229218794362,-0.00444148672180948,0.000561430971607785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,37470,-0.0105672288098237,0.00306257323132514,-0.016569872343221,-0.00456458527642642,0.000561445954243903
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,40100,0.0193974325772434,0.00563184340027399,0.00835901951270639,0.0304358456417804,0.000574162993990226
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37784,0.0111595674337328,0.00324224856695336,0.0048047602425042,0.0175143746249614,0.000579368385525472
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40126,-0.0159860303146744,0.00464810684349069,-0.0250963197279161,-0.00687574090143259,0.000584832547570359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37782,0.0472498695336014,0.0137831670175393,0.0202348621792243,0.0742648768879784,0.000609692330411573
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37515,-0.0146946933394455,0.00428881700712348,-0.0231007746734075,-0.00628861200548346,0.00061379024769643
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',37362,-0.0141735931237138,0.00413755503840771,-0.022283200998993,-0.00606398524843473,0.00061536107140242
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,39810,-0.0243702677625452,0.00712612088295337,-0.0383374646931338,-0.0104030708319566,0.000628184720282601
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,40095,0.0291417504040573,0.00852561133285858,0.0124315521916545,0.0458519486164601,0.00063210837757275
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,40100,-0.013084374201783,0.00383459491175152,-0.020600180228816,-0.00556856817475005,0.000646057744652933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,40095,0.00630439696787398,0.00184880854383932,0.00268073222194891,0.00992806171379905,0.000651321160566299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,37343,0.0143322957166602,0.00420831594284731,0.00608399646867948,0.0225805949646409,0.000661940144691944
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37697,-0.0147422312318571,0.00433140954210897,-0.0232317939343907,-0.00625266852932351,0.000667097517208784
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37697,-0.0167231325799405,0.0049144507845311,-0.0263554561176214,-0.00709080904225955,0.000668845697943193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,39783,-0.0129309770949383,0.00380337880792099,-0.0203855995584634,-0.00547635463141314,0.000675907714531489
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39967,0.0108603302522929,0.0031985813103634,0.00459111088398068,0.0171295496206052,0.000687105315173972
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37584,-0.0199297625551439,0.00588338959373595,-0.0314612061588663,-0.00839831895142139,0.000707493854228671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37430,-0.0308892576723771,0.00915118153125689,-0.0488255734736406,-0.0129529418711136,0.000739139752291805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40204,-0.00891958163297563,0.00265001748194966,-0.014113615897597,-0.00372554736835431,0.000764883893000299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39991,0.0189777058639895,0.00566168869175979,0.00788079602814036,0.0300746156998387,0.000804354671893165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,39781,-0.0231416241735601,0.00690698949069823,-0.0366793235753286,-0.00960392477179153,0.000808708415710489
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37515,-0.023695101180489,0.00708978017089077,-0.0375910703154349,-0.00979913204554314,0.000833657882281435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37470,-0.0249734961393018,0.00748165921203481,-0.03963754819489,-0.0103094440837136,0.000846318140375266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,37515,0.00939397862277553,0.00282514046932356,0.00385670330290134,0.0149312539426497,0.000886185592291564
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39746,-0.0150152882470754,0.00451910964212808,-0.0238727431456464,-0.00615783334850436,0.000893851820315164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37403,-0.00964219403498828,0.00290830508231052,-0.0153424719963169,-0.00394191607365967,0.000917636273539249
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37403,0.0139750710691813,0.0042322372211843,0.00567988611566009,0.0222702560227025,0.000962398207223695
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40194,-0.0230081567478403,0.00698910661467636,-0.0367068057126059,-0.00930950778307461,0.000996957565930007
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37430,-0.0286845302109023,0.00874272608008643,-0.0458202733278717,-0.0115487870939329,0.00103727539353072
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37403,-0.0176169020379927,0.00538335010301342,-0.028168268239899,-0.00706553583608638,0.00106887824136956
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37696,-0.00851337657602329,0.00260265705821083,-0.0136145844101165,-0.00341216874193007,0.00107429420292611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39746,-0.0109304535730274,0.00334352684968088,-0.017483766198402,-0.0043771409476529,0.00108113619573867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,37730,-0.00978650594922642,0.00300801246141351,-0.0156822103735969,-0.00389080152485595,0.00114286035127038
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,39954,0.0144797974675183,0.00446223092786237,0.00573382484890807,0.0232257700861285,0.00117712782922889
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,40153,0.012183646173049,0.00375868684111617,0.00481661996446131,0.0195506723816367,0.00119165601078925
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39991,0.00873323588649987,0.00269668567564073,0.00344773196224403,0.0140187398107557,0.00120409283998957
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37282,0.00937894537879215,0.00289705232480996,0.00370072282216464,0.0150571679354197,0.00120926477908126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37696,-0.0167181652348777,0.00516813557407242,-0.0268477109600596,-0.00658861950969576,0.00122003443701261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37430,-0.00885680909612737,0.00273943687777755,-0.0142261053765714,-0.00348751281568338,0.00122770748776384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,39815,-0.0255398806926831,0.00792362992382151,-0.0410701953433733,-0.010009566041993,0.00127007125480478
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37362,0.0101241573912691,0.00314181436884384,0.00396620122833514,0.016282113554203,0.00127440535314346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39815,-0.010930173841836,0.00339383965920611,-0.01758209957388,-0.00427824810979206,0.0012819216025801
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40065,-0.0118166530372818,0.0036780768419834,-0.0190256836475693,-0.00460762242699435,0.00131748427652373
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37756,0.0144661802982005,0.00450577164559613,0.00563486787283203,0.0232974927235689,0.00132777957006095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37362,-0.0170819190439216,0.00532508316780294,-0.0275190820528153,-0.00664475603502782,0.00134070599389427
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40065,-0.0105931442782821,0.00330325624187122,-0.0170675265123497,-0.00411876204421453,0.00134453671245274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37791,-0.00844808509491065,0.00264503783363259,-0.0136323592488305,-0.00326381094099078,0.00140672767181329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40297,0.00686544583396333,0.00215305063245546,0.00264546659435062,0.011085425073576,0.00143188964121482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37791,-0.0163189041612456,0.00512599121237068,-0.0263658469374921,-0.00627196138499905,0.00145809688046021
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37362,0.0134748019267412,0.00423420485723703,0.00517576040655666,0.0217738434469258,0.00146421755463755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,37808,0.0227335516427972,0.00714527364842413,0.00872881529188588,0.0367382879937085,0.00146788547795466
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39810,-0.0177317370215543,0.00557858813730706,-0.0286657697706761,-0.00679770427243242,0.00148314901630639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39815,-0.0192134561618772,0.00606916202990247,-0.0311090137404861,-0.00731789858326836,0.00154985199129914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,40283,-0.0101679944297021,0.00321584417414441,-0.0164710490110251,-0.00386493984837904,0.00157069827694282
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,37376,-0.00943829979314616,0.00299152341643364,-0.0153016856893561,-0.00357491389693624,0.0016085811174767
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37782,-0.00777135044860945,0.0024639938596152,-0.0126007784134552,-0.00294192248376365,0.00161426011155263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,39815,0.014995117992806,0.00475461660719242,0.00567606944270888,0.0243141665429032,0.00161468931696129
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37737,0.018181482993657,0.0057967975386692,0.00681975981786534,0.0295432061694486,0.00171368020004836
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,37362,0.011023654128408,0.00352191788364832,0.00412069507645728,0.0179266131803587,0.00175187320182848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,39718,-0.016778769819546,0.0053735315444129,-0.0273108916465953,-0.00624664799249673,0.0017966650946631
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,40213,0.00924673651559024,0.00297090815994367,0.00342375652210064,0.0150697165090798,0.001858873675814
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,39991,-0.0165653967761587,0.00532643371561275,-0.0270052068587597,-0.00612558669355773,0.00187403361611815
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,40126,-0.00821244034481,0.00264065234688482,-0.0133881189447042,-0.00303676174491576,0.00187420044489125
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37756,-0.0268961055530403,0.008669703924279,-0.0438887252446271,-0.00990348586145343,0.00192419050428848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39841,-0.010073851515006,0.00325085115688656,-0.0164455197825037,-0.00370218324750837,0.00194633330614075
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39746,-0.0167506424820157,0.00540986949701643,-0.0273539866961679,-0.00614729826786352,0.00196298541489772
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40050,0.0102589832366256,0.00331683675724115,0.00375798319243293,0.0167599832808182,0.00198492615462519
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,40126,0.0247485498096804,0.00800225146168301,0.00906413694478169,0.0404329626745791,0.00198694094229346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37362,0.0177752238092049,0.00575568041035381,0.00649409020491148,0.0290563574134984,0.00201737503937643
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39727,-0.0146694546627392,0.00476040140556558,-0.0239998414176478,-0.00533906790783069,0.00206286451162561
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37343,0.0181088101698047,0.00588014196506536,0.00658373191827664,0.0296338884213329,0.00207676231674279
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39991,0.010571091744511,0.00343330091337719,0.0038418219542917,0.0173003615347303,0.00208067280835985
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37362,0.00756007320829319,0.00245996482477877,0.00273854215172679,0.0123816042648596,0.0021218631719642
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,40100,0.0139755398155432,0.00454801178024714,0.00506143672625878,0.0228896429048276,0.00212360999320387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39727,-0.0112299585708549,0.00365458976664072,-0.0183929545134707,-0.00406696262823913,0.00212407597351624
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37515,-0.0173623231995829,0.00565194821518914,-0.0284401417013536,-0.00628450469781221,0.00213125350342258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37762,0.0309336099748426,0.0100734962347961,0.0111895573546421,0.050677662595043,0.00213922286092138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37737,0.00783479731386962,0.00255221722519419,0.002832451552489,0.0128371430752502,0.00214633993331067
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37362,0.00842836195809717,0.00274706979478813,0.00304410516031244,0.0138126187558819,0.00215850520445601
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,40065,-0.054789081087179,0.0178724333429671,-0.0898190504393945,-0.0197591117349634,0.00217631156415593
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37791,-0.0117695505695162,0.00384151882964027,-0.0192989274756112,-0.00424017366342129,0.00218998934215934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37376,-0.021316657868389,0.00695887586331899,-0.0349560545604942,-0.00767726117628381,0.00219410007849575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,39727,-0.0129166473355458,0.00421693618259435,-0.0211818422534308,-0.0046514524176609,0.00219481491059803
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37696,-0.0140072104633614,0.00458410205074163,-0.0229920504828149,-0.00502237044390776,0.0022505289313959
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,40215,0.0125067048279887,0.00410667915590479,0.00445761368241535,0.0205557959735621,0.0023271245782522
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37756,-0.0126725125685898,0.00416234202653427,-0.020830702940597,-0.00451432219658263,0.0023347399907464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39810,-0.0181064946192881,0.0059665675790158,-0.029800967074159,-0.00641202216441712,0.00241211047740483
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,40205,0.0122485820393134,0.00403855155633288,0.00433302098890093,0.0201641430897258,0.00242598271641254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,37791,0.0144758211155664,0.00478148973249085,0.00510410123988439,0.0238475409912485,0.00247080322905111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39477,0.0107759741549797,0.00356413524207889,0.00379026908050503,0.0177616792294543,0.00250334328020621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40100,0.00703219462266045,0.00233331827185243,0.00245889080982968,0.0116054984354912,0.00258396239861099
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,39713,-0.0248767685192498,0.00826031701013307,-0.0410669898591107,-0.00868654717938902,0.00260300453494106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,40106,-0.0148326504801314,0.00493124733907504,-0.0244978952647185,-0.00516740569554434,0.00263486138653919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,37430,-0.0151398142551536,0.00504140204332793,-0.0250209622600763,-0.00525866625023085,0.00267757346608934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40137,-0.0076968485978666,0.00256537274788298,-0.0127249791837172,-0.00266871801201597,0.0027015112475952
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37282,-0.0191268183754798,0.00638604354639221,-0.0316434637264086,-0.00661017302455109,0.00274881465505239
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37697,-0.0150976365936117,0.00505395164346714,-0.0250033818148073,-0.00519189137241611,0.00281974882121783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40248,0.0167501522845653,0.00561923939685867,0.00573644306672228,0.0277638615024083,0.0028788035764767
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,37808,-0.0056340970154161,0.00189620981386399,-0.00935066825058951,-0.00191752578024268,0.00297126772941508
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39810,-0.0159001468075311,0.00535237213048278,-0.0263907961832773,-0.00540949743178482,0.00297607927765408
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,39800,-0.0120779870903597,0.00406883714086582,-0.0200529078864567,-0.00410306629426273,0.00299804548730212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37362,-0.0106465764840521,0.00358717867397464,-0.0176774466850424,-0.00361570628306183,0.00300340595822979
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,39575,-0.00999602803101535,0.00336987372523281,-0.0166009805324717,-0.00339107552955904,0.00301885732442443
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,37343,-0.0129158170716184,0.00435669550822809,-0.0214549402677454,-0.00437669387549129,0.00303640983312786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40297,-0.00829314284604552,0.00279867416881573,-0.0137785442169243,-0.00280774147516669,0.00304871707104937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40097,-0.0088914822407973,0.00300340610659696,-0.0147781582097273,-0.00300480627186726,0.00307634642870169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39727,-0.0131242023625507,0.00443469139439424,-0.0218161974955634,-0.00443220722953795,0.00308671830548162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37258,-0.0252731568185914,0.00854308272472597,-0.0420175989590543,-0.00852871467812848,0.00309888132375009
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,40297,-0.00909600348441295,0.00308359843275595,-0.0151398564126146,-0.00305215055621129,0.00318442928406473
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40274,0.00733403938846225,0.00249145918266979,0.00245077939042946,0.012217299386495,0.00324814479958162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,37282,-0.0103145757651235,0.00350551688977107,-0.0171853888690748,-0.00344376266117215,0.00326278794744211
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37737,-0.0166650546686414,0.00567340021354646,-0.0277849190871924,-0.0055451902500903,0.00331543563565683
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37362,0.0106756596076924,0.0036361013064812,0.00354890104698925,0.0178024181683955,0.00333041281395294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,39815,-0.0144815080937535,0.00494590254792668,-0.0241754770876898,-0.00478753909981721,0.00341671714224834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,37343,0.013514695007268,0.00464380902508393,0.00441282931810348,0.0226165606964325,0.0036174522989938
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,37403,0.012391579865035,0.00427021542889106,0.00402195762440849,0.0207612021056615,0.00371575940947539
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,37343,0.0273366262415764,0.00944417588160508,0.00882604151363048,0.0458472109695224,0.00380341103133992
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,37808,-0.00405943653419164,0.00140629403709466,-0.00681577284689717,-0.0013031002214861,0.00390028457970937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37756,-0.0199324514015432,0.00692312138244585,-0.0335017693111371,-0.00636313349194938,0.00399430726430134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,37515,0.00973546664840558,0.00338200686776085,0.00310673318759431,0.0163642001092169,0.00400084655086421
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37775,-0.00667451697011079,0.00232610516419569,-0.0112336830919343,-0.00211535084828724,0.00411903234414607
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37756,-0.00760756047810174,0.00265200077988962,-0.0128054820066854,-0.00240963894951807,0.00412926224441983
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39596,0.0236839754636231,0.00826275429025506,0.00748897705472315,0.039878973872523,0.0041580241519197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,37362,0.0115735875528589,0.00405315850230422,0.0036293968883426,0.0195177782173751,0.0043044546031626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37403,-0.0121897793464983,0.0042712485551349,-0.0205614265145627,-0.00381813217843393,0.00432526220678537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37430,0.00713076798748617,0.00250219959008254,0.0022264567909244,0.0120350791840479,0.00438156446133214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37282,-0.015017507280421,0.00527099500681289,-0.0253486574937743,-0.00468635706706775,0.00439150923201082
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40174,0.00648823997772508,0.00227758987682167,0.00202416381915461,0.0109523161362956,0.00439510109918546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,37515,0.00941232090117683,0.00331062053587372,0.00292350465086434,0.0159011371514893,0.00447507811704788
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37362,-0.010100478038217,0.00356504287020612,-0.017087962063821,-0.00311299401261301,0.00461560322712401
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39815,0.0166545885575704,0.00589103479134729,0.0051081603665297,0.0282010167486111,0.0047031261705689
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,37343,0.0258121406245008,0.00913071291538748,0.00791594331034138,0.0437083379386603,0.0047064879124532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37756,-0.0131066330637029,0.00463988111386969,-0.0222008000468875,-0.00401246608051835,0.00473838197178436
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,37696,-0.0162536036389055,0.00575600174846562,-0.0275353670658981,-0.00497184021191291,0.00475338348836794
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37376,0.0139912076293804,0.00497222168759202,0.00424565312170002,0.0237367621370608,0.0049022276321517
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,39991,0.00945622485815298,0.00336888068855106,0.00285321870859291,0.0160592310077131,0.00500778020712329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,40186,-0.0115469518260034,0.00411773113236918,-0.019617704845447,-0.00347619880655984,0.00505030248865357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37362,-0.0122225253720551,0.00436101097369476,-0.0207701068804968,-0.00367494386361338,0.00507552094220918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39991,-0.0109081870937405,0.00389508279335222,-0.0185425493687108,-0.00327382481877015,0.00510861975003162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39730,0.0075098105516179,0.00268379414619321,0.0022495740250792,0.0127700470781566,0.00514515753383531
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40233,0.0122812204357391,0.00439807380496856,0.00366099577800072,0.0209014450934775,0.00523801469281898
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,37362,0.0107379135254189,0.00385855982093482,0.00317513627638669,0.0183006907744512,0.00539568125965624
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37376,0.0130714004767064,0.0046978377937907,0.00386363840087659,0.0222791625525361,0.00540319141180698
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,37447,-0.0152474353078943,0.00548383932315947,-0.0259957603812869,-0.00449911023450178,0.00543649502327554
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37696,-0.0104498400218695,0.00375903194352023,-0.0178175426311691,-0.0030821374125698,0.00544475765939151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,37403,0.00890831389287737,0.00321611493581569,0.00260472861867862,0.0152118991670761,0.00561535125632444
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40126,0.00743614802533812,0.00268821748625775,0.00216724175227293,0.0127050542984033,0.00567800973788058
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37343,0.0112873008760195,0.00408915121490642,0.00327256449480288,0.0193020372572361,0.00578291736199263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40297,-0.00748520028015019,0.00272214183095799,-0.0128205982688279,-0.00214980229147252,0.00597089808047735
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37470,0.00657528641310096,0.00239371537113752,0.00188360428567143,0.0112669685405305,0.00602449811880185
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,37808,0.00865385140391279,0.00315322986218148,0.00247352087403709,0.0148341819337885,0.00606951260705561
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39922,-0.0154459379634571,0.00563031836281338,-0.0264813619545713,-0.00441051397234292,0.00608857220682803
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39746,-0.0209317842030361,0.00763131448542174,-0.0358891605944627,-0.0059744078116095,0.00609737264120274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,40100,0.0150656653115915,0.00549392438303232,0.00429757352084819,0.0258337571023349,0.00610908978764365
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,40153,0.00732211338254884,0.00267257617082724,0.00208386408772746,0.0125603626773702,0.0061560770909454
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39529,-0.0169523739099717,0.00620368859882193,-0.0291116035636627,-0.00479314425628074,0.00629044292994315
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,40037,-0.0155096148597194,0.00568391338880586,-0.0266500851017789,-0.00436914461765991,0.00636585146456348
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,40100,-0.0163463327527441,0.00599223520862641,-0.0280911137616519,-0.00460155174383635,0.00638063418617165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40256,-0.0136515765773501,0.00502089596384429,-0.0234925326664849,-0.00381062048821528,0.00655605392035086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,37403,-0.00852928238169365,0.00313936560835092,-0.0146824389740615,-0.00237612578932584,0.00659878682893594
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37697,-0.00738574502666367,0.00272187532132828,-0.0127206206564671,-0.00205086939686024,0.006666736637665
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37697,-0.0123945286709657,0.00458172873358515,-0.0213747169887926,-0.00341434035313879,0.00683489671451424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,40248,-0.00734787684360388,0.00271862416321446,-0.0126763802035042,-0.00201937348370355,0.00688331726224544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37376,0.0170532531488235,0.0063147701141792,0.00467630372503223,0.0294302025726147,0.00693183881291926
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37343,0.0130100664500543,0.0048183884194732,0.00356602514788684,0.0224541077522218,0.00694118939726754
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39746,-0.0106769514430664,0.00395579668470779,-0.0184303129450936,-0.00292358994103909,0.0069611037645762
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37430,-0.0159609844122347,0.0059308467997852,-0.0275854441398137,-0.00433652468465572,0.00712907008208244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37282,-0.00751901424076394,0.00279573724924874,-0.0129986592492915,-0.00203936923223642,0.00716609773539489
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37791,0.00758680001810475,0.00282345949788965,0.00205281940224104,0.0131207806339685,0.0072173756571343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,37696,-0.0273834510086022,0.0101923809399015,-0.0473605176508091,-0.00740638436639535,0.00722606782299575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40065,-0.00561680489302154,0.00209634592063614,-0.00972564289746838,-0.00150796688857471,0.00738467321849588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40126,0.00445011810562076,0.00166418424088984,0.00118831699347668,0.00771191921776483,0.00750181418134457
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,37362,-0.0159905633832052,0.00598478309371465,-0.0277207382468859,-0.00426038851952444,0.00755245087272795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,37377,0.0176041079211121,0.00659256784912116,0.00468267493683466,0.0305255409053896,0.00758792097597595
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,36008,-0.0266862414382254,0.00999683327983687,-0.0462800346667056,-0.00709244820974508,0.00760773701320798
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,37343,-0.0222596551121999,0.00834796213933919,-0.0386216609053047,-0.00589764931909514,0.00767463467208916
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,37362,0.0105043689270664,0.00394269257345734,0.00277669148308998,0.0182320463710428,0.00772531390982416
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40186,-0.00668286067765779,0.00250935989470044,-0.0116012060712707,-0.00176451528404493,0.00774862957620171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,37791,-0.0229281068588897,0.0086389711285225,-0.0398604902707938,-0.00599572344698563,0.00796305921121648
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,40248,-0.00515114522901815,0.00194147942407643,-0.00895644490020795,-0.00134584555782835,0.00798109154451814
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40070,-0.0174525884404562,0.00657809141065444,-0.0303456476053389,-0.00455952927557348,0.00798277946937435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40065,-0.00603850347171221,0.00228121691971069,-0.0105096886343452,-0.00156731830907926,0.00812779864050022
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37696,-0.00658153915013863,0.00248961909520809,-0.0114611925767465,-0.00170188572353077,0.00821278959176311
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37362,-0.0213962154536839,0.00809919226686176,-0.037270632296733,-0.00552179861063489,0.00825730855169367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37282,0.00664220732681958,0.00251867778370729,0.00170559887075328,0.0115788157828859,0.00836991653676288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,37042,0.0175916721581796,0.00668272155528167,0.0044935379098275,0.0306898064065316,0.00848846157546726
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,39976,0.0319811999581909,0.0121495818325711,0.00816801956635158,0.0557943803500303,0.00848958341691293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40065,-0.0142072327064636,0.00543801255114188,-0.0248657373067016,-0.00354872810622549,0.00899482300784106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,37403,0.00680669539761832,0.00261082652394968,0.00168947541067694,0.0119239153845597,0.0091416380366603
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C5,Complement C5,37808,-0.00380741575666467,0.00146141854329611,-0.00667179610152506,-0.000943035411804291,0.00918989237740633
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37343,0.0143746614938836,0.00551953149067232,0.00355637977216587,0.0251929432156014,0.00921606573717588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40274,0.00718275466196111,0.00276213178993901,0.00176897635368065,0.0125965329702416,0.00931911879515777
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,40138,-0.0164538732888671,0.00632746284592816,-0.0288557004668863,-0.00405204611084792,0.00932050928851114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40081,0.00696570745815829,0.00269174793816969,0.00168988149934571,0.0122415334169709,0.00966801716966731
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39991,-0.0257430834964632,0.00995519512030767,-0.0452552659322663,-0.0062309010606602,0.00972168069105335
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,39810,-0.00739947332266722,0.002882034275509,-0.0130482605026649,-0.00175068614266959,0.0102543909185552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37714,-0.00936951304264413,0.00365124777026481,-0.0165259586723632,-0.0022130674129251,0.0102954241082114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40065,-0.00755788441745472,0.00295319328399763,-0.0133461432540901,-0.00176962558081938,0.0104999372929973
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39810,0.00738494667802304,0.00289382394306388,0.00171305174961784,0.0130568416064282,0.010721225829716
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,37737,0.00895560307850768,0.00351315129637054,0.00206982653762142,0.0158413796193939,0.0108092532737273
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37362,0.00995991191198552,0.00391541117857838,0.0022857060019719,0.0176341178219991,0.0109778304543287
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37470,-0.00622728777334697,0.0024491818976373,-0.0110276842927161,-0.00142689125397786,0.0110146173954065
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37737,-0.00688348029490531,0.00270810989792791,-0.012191375694844,-0.0015755848949666,0.0110395109404039
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37343,0.0196835716882169,0.00776203877102532,0.00446997569700728,0.0348971676794265,0.0112283351783599
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37737,-0.0172340739074005,0.00680066905995342,-0.0305633852649092,-0.00390476254989177,0.0112826853243852
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,40297,0.00967444247811886,0.00383071462494408,0.00216624181322846,0.0171826431430093,0.0115632810693821
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,40095,-0.00852253641521111,0.00337915563147434,-0.0151456814529008,-0.00189939137752141,0.0116758096572909
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,37737,0.00637419870771565,0.00253328379318462,0.0014089624730738,0.0113394349423575,0.011875135953434
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37403,0.00708443581721764,0.00281616761134053,0.00156474729899021,0.0126041243354451,0.0118939821805969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,40100,-0.0161941868245152,0.0064394678319588,-0.0288155437751544,-0.00357282987387595,0.0119188160918428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37737,-0.0090094259011935,0.00358545008984364,-0.016036908077287,-0.00198194372509996,0.011990347708135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,37376,-0.0125279045284116,0.004990495685642,-0.0223092760722699,-0.00274653298455323,0.0120731758889684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,40027,-0.0159053556970083,0.00635086693005625,-0.0283530548799186,-0.00345765651409807,0.0122747291397695
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37784,0.00598554179422044,0.00239270068633576,0.00129584844900234,0.0106752351394385,0.0123758007655306
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,39991,-0.0125482290474936,0.00502295023067483,-0.0223932114996162,-0.00270324659537091,0.0124935629204866
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37362,0.00763802782819809,0.00305844678021093,0.00164347213898466,0.0136325835174115,0.0125247097613509
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37430,-0.0100682751603081,0.0040445162747171,-0.0179955270587536,-0.00214102326186259,0.0128095958394712
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37675,-0.0207261120964712,0.00834582918770825,-0.0370839373043794,-0.00436828688856304,0.0130254343948357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40248,-0.00892465674629815,0.00360135271303395,-0.0159833080638447,-0.00186600542875161,0.0132172951407277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39815,-0.00990182925532043,0.00399913695525084,-0.0177401376876121,-0.00206352082302879,0.0132973660763454
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40100,-0.0174521729397862,0.00706847597176481,-0.0313063858444452,-0.00359796003512716,0.0135591548341323
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,37697,-0.0124419378267173,0.00504114024869394,-0.0223225727141575,-0.0025613029392772,0.013596531594487
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,37515,0.00992548730910086,0.00402335438137745,0.00203971272160106,0.0178112618966007,0.013638978842019
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,37343,0.0215298436632092,0.00873593961883143,0.00440740201029961,0.0386522853161188,0.0137328745041682
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37376,-0.0127397855873501,0.00517188981661498,-0.0228766896279155,-0.00260288154678476,0.0137803720436367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,40100,0.0154233217623719,0.00626748047701453,0.00313906002742345,0.0277075834973204,0.0138715950375025
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37362,-0.00943591489100256,0.00383909544407086,-0.0169605419613814,-0.00191128782062368,0.0139902577796571
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39727,-0.00902106880831681,0.00367791722500081,-0.0162297865693184,-0.00181235104731523,0.0141873689854565
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37362,0.0124171362461823,0.00507591566593395,0.00246834154095176,0.0223659309514129,0.0144469352362283
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,37327,-0.0223848500453314,0.00916152348162789,-0.0403414360693221,-0.00442826402134076,0.0145647709918343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,37430,-0.0066645982317301,0.00273244623600677,-0.0120201928543034,-0.00130900360915684,0.014738861065308
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,37362,0.0119465858918423,0.00489966132166561,0.00234324970137768,0.0215499220823069,0.0147720657019427
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,39667,-0.0108834682395362,0.0044661566088783,-0.0196371351929377,-0.00212980128613478,0.0148261564361397
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37791,0.00901421231008468,0.0037004890270583,0.00176125381705041,0.016267170803119,0.0148656702301313
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40121,-0.067836414502075,0.0278682464552657,-0.122458177554396,-0.0132146514497543,0.0149365355587505
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40164,-0.0147731049606356,0.00607960889435598,-0.0266891383935734,-0.0028570715276979,0.0151123088323566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40143,-0.00770525753770038,0.00317599373440859,-0.0139302052571412,-0.00148030981825954,0.015273535964806
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37376,0.0184139604053552,0.00759644779655994,0.00352492272409767,0.0333029980866126,0.0153632839278699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37343,0.0133723208005053,0.00553574114184064,0.00252226816249766,0.024222373438513,0.0157216849103046
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37362,-0.0109063468809688,0.00454490864475222,-0.0198143678246832,-0.00199832593725449,0.0164232869686732
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,37362,0.010936815300903,0.00456268089596071,0.00199396074482005,0.019879669856986,0.016543366761225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,40186,-0.00747340539225764,0.00311888959763618,-0.0135864290036246,-0.00136038178089073,0.0165787803655718
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37376,-0.0238052279359572,0.00994526049192482,-0.0432979385001298,-0.0043125173717845,0.0166969508820819
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,40065,0.00346699889423923,0.00145014376964071,0.000624717105743451,0.00630928068273502,0.0168236339337523
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37362,0.0128820422969552,0.00539904858371605,0.00229990707287172,0.0234641775210386,0.0170478278260323
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37756,-0.00704947921068716,0.00295558239833359,-0.012842420711421,-0.00125653770995333,0.0170865162035655
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,37470,0.0117516550891247,0.0049333496223976,0.00208228982922543,0.021421020349024,0.0172292279035622
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,37343,0.0124461910978405,0.00523755461165106,0.00218058405900442,0.0227117981366766,0.0175000383893524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37403,0.00676041722320504,0.00284529414631105,0.00118364069643538,0.0123371937499747,0.0175159491911521
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40041,0.00579299738655274,0.00244054839888759,0.00100952252473306,0.0105764722483724,0.0176254856404391
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40122,0.00898607134491542,0.003788818291804,0.00155998749297958,0.0164121551968513,0.017716816837575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39746,-0.00766033914138806,0.00323342716475091,-0.0139978563842999,-0.00132282189847628,0.0178433791425428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39727,-0.0124874653138441,0.00527395584965094,-0.0228244187791599,-0.00215051184852822,0.0179084913819746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,37513,-0.00869042600631988,0.00367685537228029,-0.0158970625359892,-0.00148378947665051,0.0181154153645151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39892,0.0393858311625223,0.0166713573773801,0.00670997070285729,0.0720616916221873,0.0181652085648439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,40100,0.00786357364780211,0.00332903863153634,0.00133865792999089,0.0143884893656133,0.0181831538944904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,37343,0.0119706094121738,0.00508035134029154,0.00201312078520235,0.0219280980391452,0.0184750619573098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37282,0.00679703412951081,0.00289092141781469,0.00113082815059401,0.0124632401084276,0.01872976258962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,39815,-0.0157038209977504,0.00668683403463797,-0.0288100157056409,-0.00259762628986001,0.0188633840469156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,40177,-0.0251542658175098,0.0107400793023344,-0.0462048212500853,-0.00410371038493431,0.0191883389192771
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,40074,0.0152157687028529,0.00650463518745741,0.00246668373543633,0.0279648536702694,0.019336616100412
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37403,-0.00841127083439671,0.00359618090072235,-0.0154597853998125,-0.00136275626898091,0.0193533823660434
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37362,0.0117163972207644,0.00501171548494232,0.00189343487027747,0.0215393595712513,0.0194127273296867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37739,-0.00493504169827124,0.00211673292012909,-0.00908383822172425,-0.000786245174818225,0.0197448962898311
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39815,-0.00801682273947228,0.00344069199559296,-0.0147605790508345,-0.00127306642811007,0.019818876064406
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,37282,0.0106825480891071,0.00459406213499278,0.00167818630452121,0.0196869098736929,0.0200717243768887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37362,0.0139726018501377,0.00600969757942238,0.00219359459446984,0.0257516091058056,0.0200868940568192
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,37282,0.00797802413158348,0.00343208968925038,0.00125112834065275,0.0147049199225142,0.0201121859332413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37403,-0.00733293748140257,0.00316086871988217,-0.0135282401723716,-0.00113763479043351,0.0203611004933635
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37403,-0.0136717687966117,0.00590847727377802,-0.0252523842532166,-0.00209115334000678,0.0206874514068042
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37808,-0.00717082698089302,0.00309910526003161,-0.013245073290555,-0.00109658067123106,0.0206917220805827
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,40065,-0.0093601055966972,0.00404956424841468,-0.01729725152359,-0.00142295966980443,0.020824506171574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,37430,-0.0187749388551506,0.00812492615854893,-0.0346997941259065,-0.00285008358439471,0.0208604574142235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39746,-0.0109271918071656,0.0047342825813863,-0.0202063856666828,-0.00164799794764848,0.0210069193931721
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,37362,0.00701985819212802,0.00304213198038615,0.00105727951057118,0.0129824368736849,0.0210401622066255
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37376,-0.0120414274434292,0.00522467574243342,-0.0222817918985987,-0.00180106298825972,0.0211978944845179
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,39746,0.0185220924414065,0.00803718502477457,0.00276920979284831,0.0342749750899646,0.0212051348925678
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37343,0.015646598172643,0.00679543350699091,0.00232754849894084,0.0289656478463452,0.0213219102344696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37808,0.00429565180593906,0.00186850412357947,0.000633383723723296,0.00795791988815482,0.0215214909692795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,37282,-0.0157112723384439,0.00685017423132874,-0.0291376138318482,-0.00228493084503955,0.0218319856864365
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39727,-0.00602119245604649,0.00262749571910325,-0.0111710840654889,-0.000871300846604118,0.0219417671965975
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,39810,-0.0258019561628528,0.0112835510502604,-0.0479177162213631,-0.00368619610434244,0.0222276088213518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,40248,-0.00544118910568903,0.00239202621646289,-0.0101295604899563,-0.000752817721421759,0.0229360954694529
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37282,-0.0168422256384275,0.00741293871386286,-0.0313715855175987,-0.00231286575925625,0.0231027534189599
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,37470,0.0195891660961888,0.00862857021871119,0.00267716846751486,0.0365011637248627,0.0232076039425696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37756,0.00917464642953434,0.00404454433807255,0.00124733952691215,0.0171019533321565,0.0233207607408769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37470,-0.0184349008242013,0.00812828699838961,-0.0343663433410449,-0.00250345830735763,0.0233459238956936
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37515,0.0160271857131771,0.00706807503796274,0.00217375863877012,0.0298806127875841,0.0233731517878521
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39995,-0.0125720787785287,0.00555295062017771,-0.023455861994077,-0.00168829556298038,0.0235856358159755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,40095,-0.00844905429800028,0.0037343493865048,-0.0157683790955497,-0.00112972950045087,0.0236787161572147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,40233,0.00665597346790199,0.00294269739963203,0.000888286564623222,0.0124236603711808,0.0237195171627813
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,37697,-0.00963157538452469,0.00425832244744617,-0.0179778873815192,-0.0012852633875302,0.0237244267047461
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37756,-0.00708189563147929,0.00313261445208512,-0.0132218199575661,-0.00094197130539246,0.0237940439902326
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,37782,0.00481309968802568,0.00213613138444027,0.000626282174522748,0.0089999172015286,0.0242636583311659
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39815,-0.00684273102928433,0.00303785589182215,-0.0127969285772557,-0.00088853348131292,0.0243055652363517
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37515,0.00666941574465324,0.00296474862826006,0.000858508433263533,0.012480323056043,0.0244927030039616
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37376,-0.00634926896900808,0.00282805987830423,-0.0118922663304844,-0.000806271607531783,0.0247787398185241
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37362,-0.0105244647609401,0.00469042790084805,-0.0197177034466023,-0.00133122607527792,0.0248610180477866
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40121,-0.00630808109562782,0.00281767049983542,-0.0118307152753052,-0.0007854469159504,0.0251856773411882
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,37443,-0.0302377541955968,0.0135070934420924,-0.056711657342098,-0.00376385104909563,0.0251950843338988
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,37403,0.0124617443982038,0.00562262802805817,0.00144139346320982,0.0234820953331978,0.0266844535720123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37362,0.0103013849975745,0.0046509540417266,0.00118551507579037,0.0194172549193587,0.0267845145318811
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37791,-0.00974419443048972,0.00441362442476066,-0.0183948983030206,-0.00109349055795883,0.0272784206923222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERVV_1,,37362,0.0101607682167625,0.00463006849668639,0.00108583396325721,0.0192357024702679,0.0282159476187549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,37362,0.00725286906668185,0.0033147247768961,0.000756008503965492,0.0137497296293982,0.0286819431413799
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37696,0.0115355859646256,0.00527614854334001,0.00119433481967915,0.021876837109572,0.0288063599667496
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,37343,0.0164804144228819,0.00760012647429632,0.00158416653326112,0.0313766623125027,0.0301434920626141
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,39727,-0.00732919792349085,0.00339201984088021,-0.0139775568116161,-0.000680839035365635,0.0307326344914478
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40052,-0.00709346511794181,0.00328373491020105,-0.0135295855419359,-0.000657344693947752,0.0307737617992163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37376,0.00665828100151622,0.00308230113971273,0.000616970767679271,0.0126995912353532,0.0307781735500419
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,37362,0.00754601479447809,0.00349418180634111,0.000697418454049515,0.0143946111349067,0.0308224509649308
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,37737,-0.00797681185843672,0.00370304796929814,-0.0152347858782611,-0.00071883783861237,0.0312486433338435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37362,0.0101371206352557,0.00471682172969792,0.000892150045047769,0.0193820912254636,0.0316416617078904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37343,0.0134438454942825,0.00625713045248899,0.00117986980740404,0.0257078211811609,0.031687544231456
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40117,0.00739300703866109,0.00344692995835336,0.000637024320288505,0.0141489897570337,0.0319834400574848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37737,-0.0115768812832562,0.00540773967887535,-0.0221760510538519,-0.000977711512660554,0.0323084335335351
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,37362,0.00926082749128182,0.00432671937573775,0.000780457514835842,0.0177411974677278,0.03234267828539
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37376,0.00920703270626071,0.00431861107378931,0.000742555001633675,0.0176715104108878,0.033030334677251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37376,-0.0068538788307202,0.00322472721741718,-0.0131743441768579,-0.000533413484582527,0.0335710355560303
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40065,-0.00910184544808642,0.0042862999700165,-0.0175029933893188,-0.000700697506854073,0.0337298552774089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37343,0.00642313532518558,0.00303388276997863,0.000476725096027464,0.0123695455543437,0.0342676052399256
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37515,-0.0143783586473023,0.00679755984592406,-0.0277015759453135,-0.0010551413492912,0.0344297781783867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37362,0.0073256804645844,0.00346783477831978,0.000528724299077633,0.0141226366300912,0.034665712172984
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,37362,0.0108344439782025,0.00513471626034196,0.00077040010793226,0.0208984878484727,0.0348743129117064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,39815,-0.00994698142684324,0.00471907757724818,-0.0191963734782497,-0.000697589375436796,0.0350624367679638
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,40262,-0.0122637955585978,0.00581935932621282,-0.0236697398379749,-0.000857851279220664,0.0350974693899615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37362,0.0109448151517264,0.0051954178460265,0.000761796173514455,0.0211278341299383,0.0351690420891722
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,37515,-0.00889986548320482,0.00423673633981462,-0.0172038687092415,-0.000595862257168164,0.035691538276502
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,37343,0.00680620701465991,0.00324780603655113,0.000440507183019693,0.0131719068463001,0.0361342819927113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40066,-0.00717704334249426,0.00342567038038533,-0.0138913572880495,-0.000462729396939005,0.0361802140123644
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37282,0.00691927001587901,0.00331194350218951,0.00042786075158757,0.0134106792801704,0.0367105264780144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,39810,-0.0101735670895537,0.00487431968203856,-0.0197272336663493,-0.000619900512758117,0.0368885981882256
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,39991,-0.00690028487457326,0.00330945785611171,-0.0133868222725522,-0.000413747476594311,0.0370837933469002
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39471,0.00932931707112392,0.00450214768580976,0.000505107606936792,0.0181535265353111,0.0382645075591315
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,37403,-0.00829159697098878,0.00401444394324065,-0.0161599070997405,-0.000423286842237103,0.038901144791266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39815,-0.00958859435608533,0.00465064978780364,-0.0187038679401805,-0.000473320771990186,0.0392459252655102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40169,-0.00999562712822446,0.00485211611192846,-0.0195057747076042,-0.000485479548844682,0.0394096875963469
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,39815,0.0285628749872184,0.013865865268593,0.00138577906077618,0.0557399709136606,0.0394209138221964
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,40297,-0.00962704931144827,0.00468567522086893,-0.0188109727443514,-0.000443125878545159,0.0399368864459977
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37282,0.0187985533231283,0.00915043556593285,0.000863699613899916,0.0367334070323567,0.0399582772638721
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37756,-0.00689773406556795,0.00336067159854952,-0.013484650398725,-0.000310817732410902,0.0401418976475812
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37470,-0.00745449654104451,0.00363199997433583,-0.0145732164907427,-0.000335776591346286,0.0401459474853044
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37362,0.010226425483146,0.00501207906353821,0.000402750518611116,0.0200501004476809,0.0413351874665346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37403,-0.00612978229277185,0.00300725126720738,-0.0120239947764983,-0.000235569809045386,0.0415368200561899
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40054,-0.0348874751607887,0.0171201084027978,-0.0684428876302724,-0.00133206269130496,0.0415860807062117
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39815,-0.00811673758414322,0.00398618088486411,-0.0159296521184769,-0.000303823049809573,0.0417454766955807
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,37282,0.00890893841860879,0.00438275500099214,0.000318738616664189,0.0174991382205534,0.0421007993410876
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37784,-0.00752479896849213,0.00370372806361509,-0.0147841059731777,-0.000265491963806564,0.0422056135365613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37343,-0.00906789018508464,0.00447489585264232,-0.0178386860562636,-0.000297094313905687,0.0427452463425829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,37515,-0.00574287650031946,0.00283951000885282,-0.011308316117671,-0.000177436882967926,0.0431462405919568
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,37343,0.0070672114558687,0.0034949972655881,0.000217016815316032,0.0139174060964214,0.0431873007439736
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37343,0.0176733571681237,0.00874121194357994,0.000540581758707054,0.0348061325775404,0.0432132029749286
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37343,0.013787030716314,0.00682215402738451,0.000415608822640384,0.0271584526099877,0.0433086296600486
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39727,-0.00580805433295976,0.00288861881626551,-0.0114697472128402,-0.000146361453079357,0.0443780433274911
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40095,-0.00710545194242393,0.00354038118881458,-0.0140445990725005,-0.000166304812347362,0.0447696362846112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40297,0.0056379423630439,0.00281469552984916,0.000121139124539539,0.0111547456015483,0.0451902014653568
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39727,-0.027219824628401,0.0135952236129456,-0.0538664629097744,-0.000573186347027705,0.0452850802607043
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37343,0.0118487257372892,0.00592991408776131,0.000226094125277057,0.0234713573493014,0.0457237843135902
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,37560,-0.0119620316290173,0.00598725418062411,-0.0236970498230405,-0.000227013434994044,0.0457463803271072
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,39727,-0.00746218486919215,0.00373658192213823,-0.0147858854365831,-0.000138484301801222,0.0458361841542265
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,37376,-0.0147207488447634,0.00737885765988002,-0.0291833098581283,-0.000258187831398596,0.0460649084636697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37515,-0.0131393739912182,0.00659252540763927,-0.0260607237901912,-0.000218024192245231,0.0462743928384906
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,39815,0.00643273921892915,0.00322826691680614,0.000105336061989107,0.0127601423758692,0.0463197177339139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,39638,0.0132996816795074,0.00667980153805987,0.000207270664910079,0.0263920926941048,0.0464955360470816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40126,-0.00600141675419987,0.00302280176063381,-0.0119261082050421,-7.67253033575974e-05,0.0471193648296016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37362,0.0135507699423496,0.00685444350424204,0.000116060674035235,0.026985479210664,0.0480705398821063
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,39727,-0.00827106803259053,0.00418446915816879,-0.0164726275826013,-6.95084825797065e-05,0.0481035685060146
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37515,-0.0112562499791699,0.00571356863967526,-0.0224548445129334,-5.7655445406448e-05,0.0488490351267463
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39727,-0.0091377631935608,0.00464391573246305,-0.0182398380291884,-3.56883579332237e-05,0.0491223598097688
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40100,0.00853624972476543,0.00435072671538829,8.82536260438105e-06,0.0170636740869265,0.0497768663494613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37782,0.0117428434838773,0.00598705945514588,8.20695179141323e-06,0.0234774800159633,0.0498565700106239
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,39746,-0.00998024278250247,0.00509061433092637,-0.0199578468711182,-2.63869388678062e-06,0.0499533609288373
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,39815,0.00553343359486391,0.00282368470311608,-9.88423243610675e-07,0.0110678556129714,0.0500547721443256
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40032,0.00432795102989088,0.00221090558524172,-5.42391718288352e-06,0.00866132597696465,0.0503010477381242
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37362,0.00712074043334366,0.00364215470933021,-1.78827969435471e-05,0.0142593636636309,0.0505939888988036
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,39727,0.00614441990202615,0.00314448434020215,-1.87694047700639e-05,0.0123076092088224,0.0507157728860769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37403,0.00944280967949718,0.00483721687194211,-3.81353895093552e-05,0.0189237547485037,0.0509459224361999
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37362,0.00713208237525226,0.00365390374225131,-2.95689595603129e-05,0.0142937337100648,0.0509707690575275
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,37343,0.00937841855410916,0.00480760443031187,-4.4486129302107e-05,0.0188013232375204,0.0511088204465589
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40186,0.00516139776361234,0.00264762404312658,-2.79453609157597e-05,0.0103507408881404,0.0512600328991536
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37343,0.0106792148588479,0.00548072442666483,-6.30050174151141e-05,0.021421434735111,0.0513763239231552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39974,-0.00748586585887833,0.00384541259822474,-0.0150228745513988,5.11428336421637e-05,0.0515886906271742
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,37430,-0.0127397311640774,0.00654633229471708,-0.0255705424617229,9.10801335680927e-05,0.0516658631298998
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,40121,0.00430096953894538,0.0022118730331806,-3.4301606088593e-05,0.00863624068397936,0.05185401299272
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37515,-0.00859795247737516,0.00445312063907769,-0.0173260689299674,0.000130163975217118,0.0535330958787377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,37403,0.007674563539205,0.00398478897272499,-0.000135622847335986,0.015484749925746,0.0541306252638169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,40095,-0.00746567308788686,0.00387740128976123,-0.0150653796158189,0.000134033440045144,0.0541934238892994
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39746,-0.00657675762061477,0.00342028612442804,-0.0132805184244937,0.000127003183264177,0.0545152183296807
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37403,-0.00801008753064386,0.00417198454487134,-0.0161871772385917,0.000167002177303954,0.0548835576653262
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,40126,-0.0216115285296146,0.0112827686729085,-0.0437257551285153,0.000502698069286163,0.0554538886553384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37737,-0.00995501074092673,0.00519747661437825,-0.0201420649051081,0.000232043423254644,0.055468742521497
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39940,0.00483132602910873,0.00253096912102005,-0.000129373448090572,0.00979202550630802,0.05629554232951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37376,-0.0096515950920376,0.00505972264745272,-0.0195686514810449,0.000265461296969726,0.0564735611908072
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37737,-0.00484419276021764,0.0025401124896355,-0.00982281323990323,0.00013442771946794,0.056532028285967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37376,0.0143443613560992,0.00752858410206811,-0.000411663483954317,0.0291003861961527,0.056760665995846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,39375,-0.00507069971879842,0.00267210525417581,-0.010308026016983,0.000166626579386163,0.0577625118105631
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,40072,-0.00489249541863299,0.00258521821063298,-0.00995952311147364,0.000174532274207651,0.0584444134510073
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,37696,-0.0105653020252943,0.00558376238551651,-0.0215094763009067,0.000378872250318053,0.0584931222515374
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,37376,-0.00879829185859835,0.00465314425604794,-0.0179184546004523,0.000321870883255618,0.0586697574292599
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,40040,-0.00601311204688559,0.00318200223766739,-0.0122498364327137,0.000223612338942507,0.0588131662456468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,39622,0.0119487374297038,0.00633611146069782,-0.000470041033263943,0.0243675158926715,0.0593389051401359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40065,-0.0047271846856489,0.00251458527886708,-0.00965577183222838,0.000201402460930577,0.0601394546504705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37362,0.00761481194512934,0.00407126642229916,-0.000364870242577022,0.0155944941328357,0.0614537908023694
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40248,0.00577674637719622,0.0030894041302651,-0.000278485718123367,0.0118319784725158,0.0615220522281745
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37696,-0.00472161539164717,0.00252565383433789,-0.00967189690694943,0.000228666123655094,0.0615805313055127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37515,0.0065743551844978,0.00351804199568345,-0.000321007127041763,0.0134697174960374,0.0616794050247644
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37585,0.00747451793272733,0.00400068501973261,-0.00036682470594859,0.0153158605714032,0.0617411882829564
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,40119,-0.00697306311422435,0.00373892628074987,-0.0143013586244941,0.0003552323960454,0.0622013747959101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37697,-0.00961771143823567,0.0051589764820066,-0.0197293053429686,0.000493882466497259,0.0623062738079236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40297,0.00616344016120024,0.00332050168763858,-0.000344743146571368,0.0126716234689719,0.0634468283897589
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,39093,0.00855093146915242,0.00460810986456156,-0.000480963865388232,0.0175828268036931,0.0635268741970986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37515,-0.012653391709464,0.00686007869162191,-0.026099145945043,0.000792362526114927,0.0651334296791867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,37376,-0.010775833804555,0.0058432513588574,-0.0222286064679155,0.000676938858805456,0.0651841111004448
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,37791,0.00404243957232398,0.0021925158393187,-0.000254891472740668,0.00833977061738862,0.0652425136936805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39700,0.00942209624210316,0.00511737984465168,-0.000607968253414132,0.0194521607376205,0.0656123425096311
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37403,-0.00570152311053641,0.00310852533638731,-0.0117942327698555,0.00039118654878272,0.0666536411585594
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37362,0.00858821606329896,0.00469489618692613,-0.000613780463076259,0.0177902125896742,0.0673827555120937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39930,-0.00560582610368758,0.00306630795734893,-0.0116157897000915,0.000404137492716313,0.0675386853527933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40274,-0.0101828734859196,0.00556991965134385,-0.0210999160025535,0.000734169030714379,0.0675398042363041
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40297,0.00725716159242373,0.0039748343839695,-0.000533513800156494,0.0150478369850039,0.0679026556062698
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37362,0.0125741925921349,0.00690208457951529,-0.000953893183715058,0.0261022783679849,0.068509017541212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37697,0.00991787602568269,0.00545041452654838,-0.000764936446352138,0.0206006884977175,0.0688340684494914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39810,0.00569931709886004,0.00313461306684772,-0.000444524512161492,0.0118431587098816,0.0690548145313833
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LXN,Latexin,39946,0.0114710563113893,0.00631831135887698,-0.000912833952009555,0.0238549465747882,0.0694624905086756
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40160,-0.015310734734815,0.00843457702199719,-0.0318425056979295,0.0012210362282995,0.0695069496426742
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40226,0.00697615030749927,0.0038595108517796,-0.000588490961988744,0.0145407915769873,0.070699988414109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40100,0.00947133348572294,0.00525249694016014,-0.000823560516990932,0.0197662274884368,0.0713751125940598
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,40062,-0.0135906723637498,0.0075388432254272,-0.0283668050855871,0.0011854603580875,0.0714462909841898
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39746,0.00556973861064762,0.00309263246105232,-0.000491821013014915,0.0116312982343102,0.071727283271104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37343,0.00937477532252403,0.00521370515654515,-0.000844086784304456,0.0195936374293525,0.0721841836330874
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,37282,0.00643497194548356,0.00358266239579454,-0.00058704635027374,0.0134569902412409,0.0724953853853034
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,37696,-0.0194186549296295,0.0108228848404006,-0.0406315092168146,0.00179419935755563,0.0728005880522477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,37791,-0.0155802230422477,0.00869309566438221,-0.0326186905444368,0.00145824445994145,0.0731151715072342
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,37403,0.00737177811209718,0.00412613116199377,-0.000715438965410605,0.015458995189605,0.0740242833298973
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37362,-0.00706289590706452,0.00395354834042077,-0.0148118506542892,0.000686058840160197,0.0740466323644489
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40100,-0.00571731735399695,0.00320236314161361,-0.0119939491115596,0.000559314403565738,0.0742250228117118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,37737,0.00668533327256597,0.00374919469941993,-0.000663088338297079,0.014033754883429,0.0745865911975965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39947,0.00488260271398118,0.00274117021824928,-0.000490090913787403,0.0102552963417498,0.0748975602526211
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37430,0.00640608122846355,0.0035965174672274,-0.000643093007302158,0.0134552554642293,0.0749047851387951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,37282,0.00441185703569609,0.00247828431244307,-0.000445580216692329,0.00926929428808451,0.0750658846128272
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,37403,0.0175777476517347,0.00989754701929478,-0.00182144450608305,0.0369769398095525,0.0757613183229791
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_A,,37756,0.00554450586475315,0.00312588321252095,-0.000582225231787902,0.0116712369612942,0.0761289422642001
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,37756,-0.013955535295499,0.00788426088077314,-0.0294086866218144,0.00149761603081634,0.0767417252235011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37376,-0.00621291802849964,0.00351153065276679,-0.0130955181079225,0.000669682050923264,0.076868976978778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37697,-0.0109754181787486,0.00620620561530865,-0.0231395811847536,0.00118874482725634,0.0770072682731049
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37430,-0.0131883715510855,0.00746284156194326,-0.0278155410124943,0.00143879791032328,0.0772173860496986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37343,0.0133172570581392,0.00754369309747466,-0.00146838141291108,0.0281028955291896,0.0775286667621087
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,37403,0.00478820016836516,0.00272010773154876,-0.000543210985470406,0.0101196113222007,0.078380896680013
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37343,0.00571640062085091,0.00325538259221584,-0.00066414925989214,0.012096950501594,0.0791148399137157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,40126,-0.0131437584768389,0.00750727104602885,-0.0278580097270555,0.0015704927733776,0.0799992781414301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,39662,-0.00510673787424949,0.00292331913611279,-0.0108364433810306,0.000622967632531579,0.080675363241955
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,40100,0.0114121626551581,0.00654245752921942,-0.00141105410211195,0.0242353794124282,0.0811223238175442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,39815,0.00534451742685034,0.00306581772092793,-0.000664485306168408,0.0113535201598691,0.08130821236018
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,39815,-0.00981994818706087,0.00566541012713444,-0.0209241520362444,0.00128425566212263,0.083059514800414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40095,-0.00802274681175012,0.00463033638509113,-0.0170982061265287,0.0010527125030285,0.083177817724577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,37357,-0.0113562881621193,0.0065666831759999,-0.0242269871870791,0.00151441086284056,0.083765085121991
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39815,-0.0109719973780317,0.00634648801636974,-0.0234111138901163,0.00146711913405305,0.0838596576575164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37343,0.0105677917302904,0.00611299140708214,-0.00141367142759061,0.0225492548881714,0.0838790266593552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37696,-0.0167615364282385,0.00972530477179962,-0.0358231337809658,0.00230006092448872,0.0848219738805742
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37376,0.0114924440586612,0.00671262136023229,-0.00166429380739412,0.0246491819247165,0.0869086812831066
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37696,-0.0134569452267316,0.00786302833787511,-0.0288684807689668,0.00195459031550359,0.0870269921533349
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37282,-0.0134564294292486,0.00787239369775403,-0.0288863210768465,0.00197346221834933,0.0874161216979116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,40248,-0.00477784450418293,0.00279640889204039,-0.0102588059325821,0.000703116924216245,0.0875513250521825
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37403,0.00353940528386788,0.00209445957330748,-0.000565735479814785,0.00764454604755054,0.0910731601156877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37343,0.0104521372292455,0.00620585295215456,-0.00171133455697749,0.0226156090154684,0.0921597707246172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,37430,0.00288059955474562,0.00171340936704552,-0.000477682804663594,0.00623888191415483,0.0927463532385649
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37756,0.00858748045557581,0.00511628046387412,-0.00144042925361747,0.0186153901647691,0.0932805002351839
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,37282,0.00725510549322613,0.00432367752701502,-0.00121930245972331,0.0157295134461756,0.0933726012929596
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,40186,0.00326181909174996,0.00194737177130711,-0.000555029580011975,0.0070786677635119,0.0939569880374774
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,37282,0.00678699044902434,0.00405637137806623,-0.00116349745198547,0.0147374783500342,0.0943186232472083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37403,0.00935173369377456,0.00560146660495796,-0.00162714085194304,0.0203306082394922,0.0950394867194451
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40274,0.00579514077981282,0.00347719883877455,-0.00102016894418529,0.0126104505038109,0.0956114049657078
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,37343,0.00734537672606766,0.00441074201364294,-0.00129967762067249,0.0159904310728078,0.0958696206549996
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37282,-0.0141183830060374,0.00854449581352407,-0.0308655948005446,0.00262882878846977,0.0984904252701416
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40202,0.00357193054483126,0.00216394651716566,-0.000669404628813434,0.00781326571847595,0.0988288468594907
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37696,-0.00338938181158594,0.00205455590744202,-0.00741631139017229,0.000637547767000418,0.0990299239858809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,37403,-0.00265750687060497,0.00161435664678584,-0.00582164589830521,0.000506632157095281,0.0997528509159282
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39815,-0.0094219473746281,0.00574612829356515,-0.0206843588300158,0.00184046408075959,0.10108727954736
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37515,0.0064738326765307,0.00396200384064913,-0.0012916948511416,0.014239360204203,0.102287272801577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,39810,0.0200070401645894,0.0122478745586127,-0.00399879397029151,0.0440128742994703,0.102382026789951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,37258,-0.00550362632816769,0.00337310424867845,-0.0121149106555775,0.00110765799924207,0.102784027715094
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,37282,0.0146527583276963,0.0090421641538025,-0.00306988341375657,0.0323754000691492,0.1051511198534
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,37376,0.00610103788397061,0.00376877600130629,-0.00128576307858972,0.0134878388465309,0.105506519883107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,37362,0.00817099667556949,0.00506483199264878,-0.00175607403002211,0.0180980673811611,0.10670793704566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39727,-0.00606311217827528,0.00378237165309817,-0.0134765606183477,0.00135033626179714,0.108957056774132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,37376,0.00911329334195399,0.00569266873449425,-0.00204433737765473,0.0202709240615627,0.109427403576757
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,37343,0.014032444158815,0.00879319868144423,-0.00320222525681573,0.0312671135744456,0.110551420992773
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37696,-0.00641453779657649,0.00402239870340619,-0.0142984392552526,0.00146936366209964,0.110802165717608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40065,-0.00589699367335101,0.00370051483741675,-0.0131500027546878,0.00135601540798583,0.11105478630614
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,37376,0.00573952682252218,0.0036084498240535,-0.00133303483262268,0.012812088477667,0.111728668061593
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40233,-0.0109241987502116,0.00687087579908881,-0.0243911153164257,0.00254271781600243,0.111871036185328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39991,0.0105549339045526,0.00664463165446276,-0.00246854413819437,0.0235784119472997,0.112195824698202
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,37756,-0.00458388564171855,0.00290616530388182,-0.0102799696373269,0.00111219835388982,0.114750991794987
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,37282,0.00480240638260428,0.0030458745977711,-0.00116750782902707,0.0107723205942356,0.114891046179627
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37343,0.00453945233268794,0.00288312159838433,-0.00111146600014535,0.0101903706655212,0.115398254152248
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,40202,-0.00730175220848546,0.00464405945836644,-0.0164041087468837,0.00180060432991276,0.115906195083526
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37430,0.00587467886072825,0.0037516436804056,-0.00147854275286672,0.0132279004743232,0.11739765783295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,37282,0.00897109215548441,0.00573229389267959,-0.00226420387416758,0.0202063881851364,0.117605436312992
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39727,0.00597886545843229,0.00382910093889565,-0.00152617238180319,0.0134839032986678,0.118443513634092
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37282,0.00378388668076651,0.00243608069382142,-0.000990831479123475,0.00855860484065649,0.120383738721254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,37697,0.00865999777149289,0.00558204080052385,-0.00228080219753385,0.0196007977405196,0.120828903516271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37696,0.00485767524689084,0.00313622029258526,-0.00128931652657626,0.0110046670203579,0.121430909287524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,40126,-0.00514085918243642,0.00331953111588912,-0.0116471401695791,0.00136542180470624,0.121481191261276
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,40025,-0.00357583451638386,0.0023098641545506,-0.00810316825930304,0.000951499226535325,0.121625439717933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39727,0.00963998893118139,0.00623709837824142,-0.00258472389017179,0.0218647017525346,0.122224642021059
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,39746,0.0247665314082031,0.0160698126384353,-0.00673030136313001,0.0562633641795362,0.123292800898526
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37362,0.0103091207881847,0.00674907791108523,-0.00291907191754234,0.0235373134939118,0.126664749682358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37403,0.0067063383398381,0.00439639023318684,-0.00191058651720811,0.0153232631968843,0.127178976184701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,37403,-0.00435525998287647,0.00285524985588726,-0.00995154970041551,0.00124102973466257,0.12719583829042
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37343,0.00602583749824988,0.00395945320741179,-0.00173469078827723,0.013786365784777,0.128062106246929
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,37376,-0.00954718029248399,0.00627665381083681,-0.0218494217617241,0.00275506117675615,0.128268715692783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,37282,0.00761364915400177,0.00501200816000173,-0.00220988683960163,0.0174371851476052,0.128766609293504
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40297,-0.00356364666474384,0.00234616715332618,-0.00816213428526316,0.00103484095577548,0.128801893643344
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,40126,0.00384067663677613,0.00253051887975653,-0.00111914036754666,0.00880049364109892,0.1290994352638
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39991,-0.00876605187574143,0.00578261658745707,-0.0200999803871573,0.00256787663567444,0.12955696111043
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37515,0.00936121298012711,0.00617904305724329,-0.00274971141206973,0.021472137372324,0.129798125904632
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37430,-0.00476139369851024,0.00314991032143183,-0.0109352179285166,0.00141243053149616,0.130660867824602
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37756,0.00500689174422949,0.003318715702935,-0.00149779103352312,0.0115115745219821,0.131403420996063
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,37515,-0.0106185044470143,0.00704409298009824,-0.0244249266880069,0.00318791779397824,0.131723660820494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,39815,-0.00465952038032705,0.00309539372761275,-0.010726492086448,0.00140745132579393,0.132265514304187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37343,0.00553207198559586,0.00368630444522931,-0.00169308472705358,0.0127572286982453,0.133455213996338
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,39599,-0.00841826745656764,0.00562498502144631,-0.0194432380986024,0.00260670318546713,0.134522145842049
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37697,-0.00719784333894811,0.00481822412940538,-0.0166415626325826,0.00224587595468643,0.135231096741046
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,40095,0.00794936422862298,0.00533009000025615,-0.00249761217187907,0.018396340629125,0.135873324989359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40194,-0.0047922396144529,0.00321494714486713,-0.0110935360183925,0.00150905678948668,0.136083360793634
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37430,-0.00697512415377342,0.00468501139657163,-0.0161577464910538,0.00220749818350697,0.136559888629545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,37343,-0.00922190438197441,0.00619860197701828,-0.0213711642569302,0.00292735549298143,0.136844092313396
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,40274,-0.00646203508537356,0.00434379397139816,-0.014975871269314,0.00205180109856682,0.136863756711095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40174,-0.00522897008894923,0.00351758151686371,-0.0121234298620021,0.00166548968410364,0.137160570258737
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39746,-0.00675767132365382,0.00456164165997574,-0.0156984889772063,0.00218314632989863,0.138517383583902
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40126,0.00394916750238331,0.00266709965326564,-0.00127834781801734,0.00917668282278395,0.138707329255598
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39727,-0.0120038202551671,0.00810799373755408,-0.0278954879807731,0.00388784747043893,0.138762605933162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,37756,-0.00673506335711524,0.00455144611664961,-0.0156558977457485,0.00218577103151801,0.138960078723874
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37376,-0.00551227215697268,0.00372899485719488,-0.0128211020770746,0.00179655776312928,0.139373459933288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,37376,0.00495224332376982,0.00335486526032572,-0.00162329258646859,0.0115277792340082,0.13993127425334
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,37515,0.00500967054173903,0.00340880481262665,-0.0016715868910092,0.0116909279744873,0.141686969431603
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37430,-0.00965881836861121,0.0065761153074854,-0.0225480043712826,0.00323036763406016,0.141918699424252
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40065,0.00315763305112845,0.00215028733086559,-0.0010569301173681,0.00737219621962499,0.141996667845549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,37213,-0.00616150829721909,0.00420346274840146,-0.0144002952840859,0.00207727868964777,0.142722713321976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,37258,0.0115331530322736,0.00786848599561221,-0.00388907951912635,0.0269553855836735,0.142743740980277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,37362,0.0118940150586112,0.00812376663401989,-0.00402856754406783,0.0278165976612902,0.143190695477916
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37362,0.00716470992513673,0.00489898569165293,-0.00243730203050301,0.0167667218807765,0.143631753135675
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,40274,-0.00569422580031855,0.00389796792207854,-0.0133342429275925,0.0019457913269554,0.144084963348498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,37343,0.0104787092271653,0.00717430014273698,-0.0035829190525992,0.0245403375069297,0.144152432896867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37784,0.0145736735287833,0.0100296651580479,-0.00508447018099054,0.0342318172385571,0.146231509983278
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37784,-0.00461477749267445,0.0031802516516333,-0.0108480707298757,0.00161851574452682,0.146783045547607
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39815,-0.00555478274818579,0.00383703781921747,-0.013075376873852,0.00196581137748045,0.147728441605731
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39727,-0.00449654183127778,0.00311202863815865,-0.0105961179620687,0.00160303429951317,0.148509048104756
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40229,-0.00403720529922678,0.00280029260711406,-0.00952577880917033,0.00145136821071677,0.149404508806336
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37403,-0.00391292804706975,0.00272217544397467,-0.00924839191726011,0.00142253582312061,0.150620906242978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,39810,-0.00834772888401017,0.00581806746708075,-0.0197511411194884,0.00305568335146811,0.151366141667311
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,37362,-0.00525242246579463,0.00366972528873987,-0.0124450840317248,0.0019402391001355,0.152372780278205
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40284,-0.00746163112140704,0.00525559214632655,-0.0177625917282071,0.00283932948539299,0.155699934384524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,37430,0.00304972436223189,0.00214956999001716,-0.00116343281820173,0.00726288154266552,0.155992951849929
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37282,0.00863535680636781,0.00610910409793287,-0.00333848722558061,0.0206092008383162,0.157526377815834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,37515,0.00533513345957946,0.00379667640667046,-0.00210635229749465,0.0127766192166536,0.15998216717603
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,39810,-0.0044340486057279,0.00315839340928567,-0.0106244996879278,0.00175640247647202,0.160370726461055
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,37282,0.00770971244870257,0.00550203161322092,-0.00307426951321044,0.0184936944106156,0.161164023028778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37515,-0.00713187865902077,0.00512068743452541,-0.0171684260306906,0.00290466871264905,0.163716670030083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37515,-0.0103977295199534,0.00746907850534301,-0.0250371233904257,0.00424166435051892,0.163914790039261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,37756,-0.00339390350629551,0.00244343553580402,-0.0081830371564714,0.00139523014388037,0.164859540380972
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37430,0.00453064465387859,0.00327123186880067,-0.00188096980897073,0.0109422591167279,0.166077347329354
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40100,-0.0112034658696809,0.00811015821580717,-0.0270993759726629,0.00469244423330117,0.16717219429289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,40164,0.00611061044582735,0.00442795272309595,-0.00256817689144072,0.0147893977830954,0.167603798843347
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,37403,-0.00388383735169377,0.00282686336444637,-0.00942448954600866,0.00165681484262111,0.169495433885709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,39815,-0.0112719341342199,0.008206068233046,-0.0273558278709901,0.00481195960255025,0.169582956838109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37697,-0.00579679831322138,0.00423447995785672,-0.0140963790306205,0.00250278240417778,0.171037604365866
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37403,-0.00267601167445879,0.00196104358310632,-0.00651965709734717,0.00116763374842959,0.172407067415922
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,37282,0.00818666442745518,0.00600716720202635,-0.00358738328851646,0.0199607121434268,0.172964381090057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,39815,-0.0053336833885181,0.00392572372912994,-0.0130281018976128,0.00236073512057657,0.174277564048967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,40223,0.00386741743728848,0.00285104181924018,-0.00172062452842227,0.00945545940299923,0.174961871542844
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39810,-0.00645022574322214,0.0047561699666664,-0.0157723188778883,0.002871867391444,0.175061630266744
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37343,0.00753335598424148,0.00557898595393597,-0.00340145648547302,0.018468168453956,0.176940532353299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39727,0.00430660140732751,0.00319334949290838,-0.00195236359877291,0.0105655664134279,0.17748041449411
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,39810,-0.00643596853852398,0.00478134276800263,-0.0158074003638091,0.00293546328676117,0.178303420289237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40233,0.00293690325238748,0.00219391076982504,-0.0013631618564696,0.00723696836124456,0.180700272577304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39746,-0.00689605774565109,0.00515791203376679,-0.017005565331834,0.00321344984053182,0.181246993246069
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37282,-0.00338511512765551,0.00253393431789841,-0.00835162639073639,0.00158139613542538,0.181601492821057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,37470,0.00550930843367714,0.00413762550973685,-0.00260043756540708,0.0136190544327614,0.183043085849569
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37576,0.0010305970098376,0.000776454683448011,-0.000491254169720498,0.00255244818939571,0.184428844144434
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,37230,-0.00443385883059058,0.00334820626888546,-0.0109963431176061,0.00212862545642491,0.185444045216952
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,37697,-0.00468617234844648,0.00354714350450594,-0.0116385736172781,0.00226622892038516,0.186486985827715
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37808,-0.00224501184333749,0.00169985423619578,-0.00557672614628122,0.00108670245960624,0.186621226481355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,37784,-0.00464964457877191,0.00352218119155495,-0.0115531197142196,0.0022538305566758,0.186823047123009
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39955,-0.00391533624455576,0.00297131795480321,-0.00973911943597005,0.00190844694685852,0.187620120241399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37362,0.00850538583050098,0.00646284319546026,-0.00416178683260113,0.0211725584936031,0.188182651098482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,37343,0.00565065778846319,0.00429760209985489,-0.00277264232725239,0.0140739579041788,0.188587176866047
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37515,-0.00666561775486679,0.00510219866516695,-0.016665927138594,0.00333469162886042,0.191432544206566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37403,0.00604344826324636,0.0046279164210067,-0.00302726792192677,0.0151141644484195,0.191620622548346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,37362,0.00626913347372237,0.00481834194705993,-0.00317481674251508,0.0157130836899598,0.193248246069558
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37343,0.0062150769794213,0.00477990556926316,-0.0031535379363345,0.0155836918951771,0.193538203420257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,37343,0.00787426265345857,0.00607022682541599,-0.00402338192435677,0.0197719072312739,0.194587612163282
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40297,-0.00383719799385953,0.00296865196855965,-0.00965575585223644,0.00198135986451738,0.196177792795625
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40248,0.00310794409605312,0.0024116836226904,-0.00161895580442006,0.0078348439965263,0.197520207305682
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37697,-0.00761598848659035,0.00591714109818151,-0.0192135850390261,0.0039816080658454,0.198079796794064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,40100,0.00476932596363448,0.00370658751262246,-0.00249558556110554,0.0120342374883745,0.19821228142927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,37791,-0.00576951401823025,0.00449184492604524,-0.0145735300732789,0.00303450203681844,0.199009671952341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37403,-0.0107392572831283,0.00838613368295488,-0.0271760793017199,0.00569756473546321,0.200358202378464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,39815,-0.0054036329554559,0.00422057763944522,-0.0136759651287685,0.00286869921785674,0.2004566952611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37782,-0.00313729271624233,0.00245042895299272,-0.00794013346410806,0.00166554803162341,0.200460702441566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,37403,-0.00630747261819965,0.00492839279067091,-0.0159671224879146,0.00335217725151534,0.200630162887473
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,39991,-0.0014852412579698,0.00116221564070583,-0.00376318391375324,0.000792701397813634,0.201289854079304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,37343,0.00606961885407568,0.00476473620859347,-0.00326926411476752,0.0154085018229189,0.20273511102528
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39746,-0.0094486957496084,0.00742796992316781,-0.0240075167990173,0.0051101252998005,0.203377249156388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39727,-0.00524377975539575,0.00412249159891474,-0.0133238632892686,0.00283630377847714,0.203395031178215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37716,-0.00468853656009291,0.00369217207400349,-0.0119251938251398,0.00254812070495392,0.204157269851711
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37403,0.00511692741052163,0.0040297247549873,-0.00278133310925348,0.0130151879302967,0.204180205872175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,37515,0.0052352747031315,0.00412348597097525,-0.00284675779997998,0.013317307206243,0.204241390481134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37756,-0.00834431402486426,0.00662246469032431,-0.0213243448178999,0.00463571676817138,0.207690999518765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37403,-0.00774913945719188,0.00616302666246475,-0.0198286717156228,0.00433039280123902,0.208646199596067
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,40126,0.0047893707568425,0.00381642079447555,-0.00269081400032958,0.0122695555140146,0.209520047402095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37343,0.00910176459093071,0.00725518789811172,-0.00511840368936827,0.0233219328712297,0.209676493539523
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,37282,0.00551851762067235,0.00440068893156364,-0.00310683268519237,0.0141438679265371,0.209860417412257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37376,0.00356511601612848,0.00284566478274731,-0.00201238695805625,0.00914261899031322,0.210292575674021
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37376,0.00469386441448789,0.00376108392170832,-0.00267786007206042,0.0120655889010362,0.212050582483905
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37515,-0.00429359658883766,0.0034428295173489,-0.0110415424428415,0.00245434926516619,0.212378517107423
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37403,-0.00937254150536109,0.00753354702421187,-0.0241382936728164,0.00539321066209418,0.213482558531755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39815,0.0045582038682287,0.00366565181523867,-0.00262647368963909,0.0117428814260965,0.213706047984134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,40035,0.00406548695843971,0.00328240242997982,-0.00236802180432074,0.0104989957212002,0.215523239819174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40135,-0.00668779004372347,0.0054326986041866,-0.0173358793079292,0.00396029922048227,0.218331820497091
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39810,-0.00931083478194947,0.00760791055005351,-0.0242223394600543,0.00560066989615541,0.221032877293514
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39746,0.00414295141099835,0.00340458499897121,-0.00253003518698522,0.0108159380089819,0.223670887104526
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39811,0.00480395426669218,0.0039635042902385,-0.00296451414217529,0.0125724226755596,0.225512959208207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40053,-0.0031588076378597,0.00261020426126503,-0.00827480798993916,0.00195719271421977,0.226229540868258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37697,0.00493422308358377,0.00409155076349203,-0.0030852164128606,0.0129536625800281,0.22785666799888
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39810,-0.00968316158618777,0.00809364550643708,-0.0255467067788045,0.0061803836064289,0.231562628096515
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,39746,-0.00353071315901873,0.00295549261592412,-0.00932347868623,0.00226205236819254,0.232251072396264
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,37376,-0.00399339904564323,0.00334959560856353,-0.0105586064384277,0.00257180834714129,0.23320341692574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37362,0.00471230601601499,0.00395450589495547,-0.00303852553809772,0.0124631375701277,0.23342844481646
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,39815,0.00325042399701499,0.00273315518276074,-0.00210656016119606,0.00860740815522604,0.234356921659383
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37343,0.00629222202082427,0.00529199147966344,-0.00408008127931608,0.0166645253209646,0.234458285177955
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,40178,-0.00378761139584198,0.00318737368547138,-0.0100348638193659,0.00245964102768193,0.234726356812175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37756,-0.00304802416914934,0.00257600919870378,-0.00809700219860874,0.00200095386031006,0.236737179795408
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37282,0.00464377537815955,0.00393625626898717,-0.00307128690905531,0.0123588376653744,0.23812385543206
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,39727,-0.00682711545052429,0.00578722278854136,-0.0181700721160654,0.00451584121501678,0.238142826163388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37362,0.0109875928727375,0.00934732335902061,-0.00733316091094293,0.0293083466564179,0.239824359962778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,37343,0.00389822114369986,0.00332268819087085,-0.002614247710407,0.0104106899978067,0.240732057384156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,37606,-0.00339985488868243,0.00289823310723813,-0.00908039177886916,0.0022806820015043,0.240785577045378
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSND,Barttin,37282,0.0038020171077632,0.00326408491518008,-0.00259558932598975,0.0101996235415162,0.244120251489691
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37696,-0.0143015596471839,0.0123135117217632,-0.0384360426218397,0.0098329233274719,0.245478838863881
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,37737,-0.00762120142015088,0.00657263522730181,-0.0205035664656624,0.00526116362536066,0.246258966567706
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37376,0.00460407045767656,0.00397451808297465,-0.00318598498495377,0.0123941259003069,0.246723402577082
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,37362,0.00728876353414319,0.00629226264055445,-0.00504407124134353,0.0196215983096299,0.246734811239109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37282,0.00521868070513159,0.00450664859644241,-0.00361435054389552,0.0140517119541587,0.246887255406903
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40065,-0.00395492639672378,0.00342255334979347,-0.010663130962319,0.00275327816887141,0.247883565929883
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,37754,0.00398547225908226,0.00345487827553073,-0.00278608916095797,0.0107570336791225,0.248693867166208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37515,0.00499441523463041,0.00433771162573781,-0.0035074995518157,0.0134963300210765,0.249591245447863
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39727,-0.00758720334997886,0.00661667639369634,-0.0205558890816237,0.00538148238166597,0.251532306631118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,37403,0.00613338853064216,0.00537702292237684,-0.00440557639721645,0.0166723534585008,0.254029932327821
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,40118,0.0199943142455824,0.0175417036468479,-0.0143874249022396,0.0543760533934044,0.254380398543254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39815,-0.00666295102147922,0.00585847365176416,-0.018145559378937,0.00481965733597853,0.255422861806888
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37282,0.00473445668501361,0.00416360075446174,-0.00342620079373141,0.0128951141637586,0.255515083186245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37282,-0.0064605686199016,0.00569375327441407,-0.0176203250377532,0.00469918779794999,0.256532042516587
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37697,-0.00738028059944273,0.00651769386758148,-0.0201549605799024,0.00539439938101698,0.257509753256155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,37362,0.00681231807619152,0.00601629999992027,-0.00497962992365221,0.0186042660760353,0.257525057981155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,37756,-0.00395579248633195,0.00350357907338412,-0.0108228074701648,0.00291122249750092,0.258887885520295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,40297,0.00283511897004896,0.0025188997979193,-0.00210192463387286,0.00777216257397079,0.260377914781532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,39727,-0.00486193664858166,0.00432138535889713,-0.01333185195202,0.00360797865485671,0.260569635842746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,37343,-0.00791536559855223,0.00704320601513744,-0.0217200493882216,0.00588931819111715,0.261106116427193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,40297,0.00765814319750561,0.0068190175696539,-0.00570713123901604,0.0210234176340273,0.261430440865947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39305,-0.00306543406754343,0.00273731558709144,-0.00843057261824266,0.00229970448315579,0.26278782325843
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,39691,-0.00357838856619509,0.0032363871738295,-0.00992170742690091,0.00276493029451072,0.268885180983773
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37782,0.00272285974070171,0.00247017318986697,-0.00211867971143755,0.00756439919284098,0.270353311087856
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,37282,0.00441423362649272,0.00401253075668786,-0.00345032665661549,0.0122787939096009,0.271303924103974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37362,0.00486841429084222,0.00445046220294598,-0.0038544916269319,0.0135913202086163,0.274013957326188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,37343,-0.0120438427392189,0.0110387661964544,-0.0336798244842695,0.00959213900583174,0.275271398498331
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,37282,-0.00768076415549433,0.00705195490823248,-0.02150259577563,0.00614106746464134,0.276100231539244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37515,-0.0095038349631582,0.00879443933023916,-0.0267409360504269,0.00773326612411054,0.2798665032983
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,37376,0.00444021473164973,0.00411008158574015,-0.00361554517640097,0.0124959746397004,0.280018631868554
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,37282,0.00479949745459616,0.004446256063822,-0.00391516443049496,0.0135141593396873,0.280408831977414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,37282,0.0120786862934899,0.0112121181184742,-0.00989706521871965,0.0340544378056994,0.281371637944712
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37258,0.00531607486166384,0.00493883583860531,-0.00436404338200256,0.0149961931053303,0.281776648218562
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,37756,0.00217123558385816,0.00203910355514568,-0.00182540738422737,0.00616787855194368,0.286986187374683
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,37430,-0.00693844394228461,0.00652595431004845,-0.0197293143899796,0.00585242650541034,0.287707618311377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37403,-0.00293407733896661,0.00276669756057743,-0.00835680455769838,0.00248864987976517,0.288937857950615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37362,0.00395840546316476,0.00373571206325566,-0.00336359018081633,0.0112804011071459,0.28934095980204
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,37403,0.0106068837193935,0.0100399621364407,-0.00907144206803029,0.0302852095068173,0.290774841507905
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,37808,-0.0019220448030882,0.00182019301979892,-0.00548962312189409,0.00164553351571769,0.291007150746178
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37282,0.00643351182163967,0.00610542704107689,-0.00553312517887103,0.0184001488221504,0.2920233791779
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37515,0.00700960411698013,0.00667539197911573,-0.00607416416208669,0.020093372396047,0.293707059791398
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,37403,0.00582721680369416,0.00555450561221512,-0.00505961419624748,0.0167140478036358,0.2941529182181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,40065,0.00877005942280019,0.00838082175053194,-0.00765635120824242,0.0251964700538428,0.295372353724978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,40174,-0.00790779952655858,0.00755831806750847,-0.0227221029388752,0.00690650388575802,0.295467250150113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37489,0.00509114762123253,0.00486709738074022,-0.0044483632450183,0.0146306584874834,0.295564891661621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,39810,0.0107152387917859,0.0102515276599195,-0.00937775542165641,0.0308082330052281,0.2959315752474
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,37697,-0.00354266313415904,0.00339252057140616,-0.0101920034541151,0.00310667718579703,0.296385589615976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,37737,0.00535773604870897,0.00513479515666263,-0.00470646245834979,0.0154219345557677,0.296773874831626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37737,0.00396296952837635,0.00382059548023709,-0.00352539761288834,0.011451336669641,0.299631305428659
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37515,-0.00661292073495351,0.00638382976080336,-0.0191252270661281,0.00589938559622108,0.300274442155366
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37362,-0.00403319392497737,0.00391421453410585,-0.0117050544118248,0.00363866656187009,0.30284310265526
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,40079,-0.0124935112132698,0.0121682130711445,-0.0363432088327131,0.0113561864061735,0.304561892661685
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37403,-0.00474419799204302,0.00462441649473415,-0.0138080543217219,0.00431965833763591,0.304956954622947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,37362,0.00461139180571452,0.00452277503191348,-0.00425324725683591,0.013476030868265,0.307940418005253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,37362,0.00455399024147893,0.00450308934804161,-0.00427206488068264,0.0133800453636405,0.311890120894902
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37282,0.00619262383008138,0.00614915009583546,-0.00585971035775612,0.0182449580179189,0.313920187998726
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37697,-0.00342792657938321,0.00340660227966891,-0.0101048670475343,0.00324901388876786,0.31430904454975
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,37362,0.0106909238953589,0.0106257755270532,-0.0101355961376654,0.0315174439283833,0.314371336648299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37376,-0.00503511039416212,0.00502133595283347,-0.0148769288617157,0.00480670807339148,0.316003562461191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37282,0.00312038082766186,0.00311912640784675,-0.00299310693171777,0.0092338685870415,0.317134787126767
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,39571,0.00249562259459812,0.00250328030887086,-0.00241080681078877,0.00740205199998501,0.318809138972538
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40248,-0.00336190627920026,0.00337475802457533,-0.00997643200736791,0.00325261944896739,0.319172221456621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,39746,0.0135816419852476,0.0136364475900279,-0.0131457952912071,0.0403090792617023,0.319275159971375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,39815,-0.00365111701848093,0.00369144768336136,-0.0108863544778692,0.00358412044090735,0.322642237063004
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37782,-0.00331231002211996,0.00335387636021043,-0.00988590768813239,0.00326128764389248,0.323363337780666
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37403,-0.00572356556262563,0.00579740508239176,-0.0170864795241135,0.00563934839886222,0.323531996466078
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37376,0.00662512525061246,0.0067289481841375,-0.00656361319029705,0.019813863691522,0.324853416945472
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37403,0.00401538427403015,0.00408401574910153,-0.00398928659420885,0.0120200551422691,0.325529792461141
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37470,-0.00500415661521947,0.00511725258980719,-0.0150339716912416,0.00502565846080263,0.328142410558844
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,37515,0.00534251804379866,0.00552725955516282,-0.00549091068432045,0.0161759467719178,0.33377378529301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,39786,-0.00513927700643403,0.00532210657067099,-0.0155706058849492,0.0052920518720811,0.334236005548756
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37791,0.00230359391779999,0.00238639256262498,-0.00237373550494498,0.00698092334054495,0.33441014618658
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37515,0.00702694099996552,0.00730628711756044,-0.00729338175045293,0.021347263750384,0.336184793106282
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37791,0.00237376858324594,0.00247046329115452,-0.00246833946741691,0.0072158766339088,0.336640139636212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37403,0.00850139954380274,0.00885195953897978,-0.00884844115259763,0.0258512402402031,0.336873140487455
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39727,-0.00281930598647238,0.00293845681405054,-0.00857868134201143,0.00294006936906667,0.337346666585465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,39815,0.00465966676788809,0.00487742053444513,-0.00490007747962436,0.0142194110154005,0.339413372066564
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37282,0.0129748282771135,0.0135912702884138,-0.0136640614881775,0.0396137180424044,0.339775608345848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37343,-0.00564972260509339,0.00592757840052437,-0.0172677762701212,0.00596833105993437,0.340544659422164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37756,0.00388711030984481,0.00408111708050367,-0.00411187916794237,0.011886099787632,0.340879862007269
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,37403,-0.00447034375055611,0.00469627426880412,-0.0136750413174122,0.00473435381629997,0.341169754157993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,37445,-0.00757163488344116,0.00795841354225408,-0.0231701254262592,0.00802685565937684,0.341419042264087
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37376,0.00353983912490761,0.00372456763826457,-0.00376031344609095,0.0108399916959062,0.341925446785224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37791,0.0124567120531764,0.0131749094369248,-0.0133661104431963,0.0382795345495491,0.344427180572232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37362,0.00354258266645578,0.00375763250665152,-0.0038223770465812,0.0109075423794928,0.345816273698428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40075,-0.00362560391139287,0.00384904675893074,-0.0111697355588971,0.00391852773611138,0.346233560113118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37737,0.0023497383028824,0.00249554807360092,-0.00254153592137541,0.00724101252714021,0.346428908384552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37515,-0.00508461652969431,0.00540112481217896,-0.0156708211615651,0.00550158810217645,0.34651754650527
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,37499,0.00882954787452651,0.00940261856589023,-0.00959958451461834,0.0272586802636714,0.347721424959118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40097,-0.00432847774803797,0.00462705389636415,-0.0133975033849117,0.00474054788883577,0.349559725072181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,39727,0.00467198773365228,0.005011636911164,-0.00515082061222917,0.0144947960795337,0.351233495804225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40226,-0.00566312980294037,0.00608674359332194,-0.0175931472458514,0.00626688763997062,0.352176253264743
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,40248,0.00526714854689975,0.00568335025466289,-0.00587221795223952,0.016406515046039,0.35406103455328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37737,0.00314887793959686,0.00340260967859581,-0.00352023703045093,0.00981799290964464,0.354758957399229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39815,0.0025787238664795,0.00278742971031297,-0.00288463836573391,0.00804208609869292,0.354914869732823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,37343,0.00575255760647287,0.00624307764434392,-0.00648387457644121,0.017988989789387,0.356843334897321
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37362,0.00312837357204473,0.00339533516871222,-0.00352648335863123,0.00978323050272069,0.356872411358611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,40148,0.00494269574578113,0.00538681898157837,-0.00561546945811247,0.0155008609496747,0.358866659569982
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,40237,-0.00187858293134522,0.00206288086179456,-0.00592182942046255,0.00216466355777211,0.362488491119249
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37260,0.00425427592466089,0.00467675675168201,-0.00491216730863584,0.0134207191579576,0.363017002627345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,39746,0.00486839435334352,0.00536621495961881,-0.00564938696750935,0.0153861756741964,0.364299165217816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,39746,0.00808064719382747,0.0089164444309653,-0.00939558389086451,0.0255568782785194,0.364810733147776
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39746,-0.00260529624317486,0.0028747973360283,-0.00823989902179033,0.0030293065354406,0.364815767015621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,37782,0.00221250849834304,0.00244491311933869,-0.00257952121556079,0.00700453821224686,0.365511618268225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37480,-0.00568696016456658,0.00630463955947724,-0.018044053701142,0.00667013337200881,0.367058774908628
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39746,-0.0065856062982238,0.00730774365482135,-0.0209087838616736,0.00773757126522605,0.367505804553854
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37784,-0.00227030716944688,0.00251928308004467,-0.00720810200633443,0.00266748766744067,0.367513197323639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37362,-0.00569913691106641,0.00632869690870139,-0.0181033828521211,0.00670510902998832,0.367858806886621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37362,0.00425549270628441,0.00475838500912683,-0.00507094191160417,0.013581927324173,0.371170316378582
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37808,-0.00229932526857502,0.0025740423229329,-0.0073444482215235,0.00274579768437345,0.371726513952433
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,40095,-0.00371150346392327,0.00417839795183745,-0.0119011634495247,0.00447815652167814,0.374414607096347
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,40160,-0.0069677966438062,0.00788099236014005,-0.0224145416696807,0.00847894838206829,0.376641293343714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37470,-0.00238475114849275,0.00269939452259197,-0.00767556441277301,0.0029060621157875,0.377015290848064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37282,0.00309107513283782,0.00350205390678816,-0.00377295052446697,0.00995510079014261,0.37744390897323
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37343,0.00417141033601775,0.00474473219358739,-0.00512826476341354,0.013471085435449,0.379327308196126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37362,0.00512382595338357,0.00584001783218941,-0.00632260899770767,0.0165702609044748,0.38030486379543
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37489,0.00440759423508263,0.00503504718977648,-0.00546109825687927,0.0142762867270445,0.381381725385965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40297,0.00580665075983883,0.00668977184045765,-0.00730530204745816,0.0189186035671358,0.38541330448336
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,39941,-0.0027756362877791,0.00321508808576906,-0.00907720893588645,0.00352593636032825,0.387977236385823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,37567,0.00272967835038365,0.00316369856625691,-0.00347117083947988,0.00893052754024719,0.388256397745154
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37430,-0.00303383425855888,0.00353199154146966,-0.00995653767983941,0.00388886916272166,0.390379260934965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,37697,0.0033082478091824,0.00385488023249517,-0.00424731744650812,0.0108638130648729,0.390799055788827
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37376,0.00347584116568516,0.00406305838992456,-0.00448775327856697,0.0114394356099373,0.392304603032641
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37756,-0.00300728130535575,0.00352008808576643,-0.00990665395345795,0.00389209134274644,0.39294314613441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39815,-0.00445474933274237,0.00521448408194043,-0.0146751381333456,0.00576563946786087,0.392950452845738
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37403,-0.00239121734793202,0.00280711543554239,-0.00789316360159511,0.00311072890573106,0.394317835222451
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37493,-0.00453076947669661,0.0053414279377217,-0.0149999682346311,0.00593842928123792,0.396324412780046
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37696,0.00396854115510379,0.00469176761750605,-0.00522732337520807,0.0131644056854157,0.39765057840941
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39810,0.00271412389015419,0.0032245329812146,-0.00360596075302643,0.00903420853333481,0.399963017346376
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,37258,0.00326374774821337,0.00389492601695967,-0.00437030724502758,0.0108978027414543,0.402075218612945
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,37403,0.00465234226319399,0.00557607965388217,-0.00627677385841507,0.015581458384803,0.404105214053226
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,40095,0.0038228274640212,0.00459780327442284,-0.00518886695384756,0.01283452188189,0.405734127608864
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36990,0.00388651533905773,0.00468119622819904,-0.00528862926821239,0.0130616599463279,0.406419034609061
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,37515,-0.00183259400434296,0.00220849244748186,-0.00616123920140741,0.0024960511927215,0.406670370242063
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,37282,-0.00428504795109399,0.00516728238194252,-0.0144129214197013,0.00584282551751335,0.406969731873382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40121,0.00209809802525381,0.0025304403948792,-0.00286156514870941,0.00705776119921704,0.407035882113193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37362,-0.00360147197655722,0.0043828060109616,-0.012191771758042,0.00498882780492752,0.411247211532197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37376,0.00393620094603283,0.00480623702195933,-0.00548402361700745,0.0133564255090731,0.412814237296566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,39810,-0.00380542964129706,0.00466430984043851,-0.0129474769285566,0.00533661764596242,0.414592151955843
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37696,0.0134637710202123,0.0165630647493988,-0.0189998358886094,0.0459273779290341,0.416301926097287
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39746,0.00980093163895279,0.0120594025146471,-0.0138354972897555,0.0334373605676611,0.416390595190094
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,37376,-0.00472098201166368,0.00584197268182953,-0.0161712484680495,0.00672928444472219,0.419039626022276
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37403,-0.00217172988244887,0.00269474974863449,-0.00745343938977248,0.00310997962487473,0.42030866174927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37282,0.00343268280415704,0.0042870408957805,-0.00496991735157275,0.0118352829598868,0.423313529365069
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,39815,-0.00229228780341763,0.00287708555022044,-0.0079313754818497,0.00334679987501443,0.425614630127016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37343,0.0038684091111517,0.00486086763979723,-0.00565889146285087,0.0133957096851543,0.426147321730579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37697,0.0035492684319911,0.0044619363116063,-0.00519612673875725,0.0122946636027395,0.426363277613732
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37343,-0.00435288738442752,0.00547419699143104,-0.0150823134876324,0.00637653871877732,0.426532430292935
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,37697,0.00257310403023346,0.00324208727883767,-0.00378138703628837,0.00892759509675528,0.427409578872452
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39727,0.00388006907865968,0.00489329798159345,-0.00571079496526347,0.0134709331225828,0.427827790240004
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37515,-0.00340884549009171,0.00430736305075294,-0.0118512770695675,0.00503358608938406,0.42872519955655
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37737,-0.0025000660364056,0.00316558039911401,-0.00870460361866905,0.00370447154585786,0.429678854077874
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40212,0.00259813156383002,0.00330219113561006,-0.0038741630619657,0.00907042618962575,0.431416532668427
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,40160,-0.0021934686524379,0.00279032098867121,-0.00766249779023347,0.00327556048535768,0.431821324232182
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,40248,-0.00235279336981527,0.0029943080773486,-0.00822163720141852,0.00351605046178799,0.432022658759887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37282,-0.00312023779071863,0.00397122710287343,-0.0109038429123506,0.0046633673309133,0.432051183537262
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39810,-0.00202845321970676,0.00258630925803303,-0.00709761936545149,0.00304071292603798,0.432873730681925
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37282,0.00422393275587625,0.00541648394022224,-0.00639237576695933,0.0148402412787118,0.435505756163157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37343,0.0041685241126653,0.00542129555786019,-0.00645721518074068,0.0147942634060713,0.441956912957753
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,37282,0.0030712099629111,0.00405181942518633,-0.00487035611045411,0.0110127760362763,0.448475123276626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39746,0.00239124626310716,0.0031551292403455,-0.00379280704797003,0.00857529957418434,0.44852749700915
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37343,0.00786024246678895,0.0103952851998002,-0.0125145165248194,0.0282350014583973,0.449581874893356
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,37362,0.00396823072600705,0.00524944071745214,-0.00632067308019914,0.0142571345322132,0.449702559347199
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39746,0.00356648873149979,0.00473330987547326,-0.00571079862442779,0.0128437760874274,0.451168757734666
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37791,-0.00159997196228335,0.00213210609172943,-0.00577889990207305,0.00257895597750634,0.453015898345389
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,37362,0.00533536474492017,0.0071232289701656,-0.0086261640366044,0.0192968935264447,0.453865246484544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37784,-0.00523482954372403,0.0070124658369123,-0.0189792625840721,0.00850960349662408,0.455376545722929
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37697,-0.00314778241316067,0.00421937912434033,-0.0114177654968677,0.00512220067054638,0.455662675303551
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37782,-0.0020014184105531,0.00269966723161036,-0.00729276618450942,0.00328992936340321,0.458489797621163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37282,-0.00455058259791061,0.00614727911235059,-0.0165992496581178,0.00749808446229654,0.459156013704489
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40036,-0.00236910407045501,0.00320354576930525,-0.00864805377829331,0.00390984563738328,0.459599046738395
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37362,0.00228577107614201,0.00309504906251622,-0.00378052508638978,0.0083520672386738,0.460208912693925
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,37791,0.00314763007699801,0.00426677790558193,-0.00521525461794258,0.0115105147719386,0.460705757969155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,37784,-0.00204994944570926,0.00277979333651735,-0.00749834438528326,0.00339844549386475,0.46086371817394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,37455,0.00259988109544574,0.00354460163971776,-0.00434753811840108,0.00954730030929256,0.463281235585332
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37515,-0.00593980243370225,0.00810572333078632,-0.0218270201620434,0.00994741529463893,0.463698959878555
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37362,-0.00329772728369004,0.00451259454184567,-0.0121424125857076,0.00554695801832747,0.464924983474502
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37376,0.00252850272926785,0.00346684176229515,-0.00426650712483063,0.00932351258336634,0.465807569498329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37808,0.00132428518274047,0.00181786816802561,-0.00223873642658973,0.00488730679207067,0.466331037805353
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37376,0.00353895057024236,0.00485948970569286,-0.00598564925291564,0.0130635503934004,0.466470333148763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37430,-0.00180673718171813,0.00248483489302263,-0.00667701357204249,0.00306353920860622,0.467174429181458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,37282,-0.00376032656993982,0.00520298919390309,-0.0139581853899899,0.00643753225011024,0.469862474968789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,40010,0.00350062572909995,0.0048501047979472,-0.00600557967487656,0.0130068311330765,0.47045110649623
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37784,-0.00202683961433868,0.00282360344470996,-0.0075611023659702,0.00350742313729284,0.472880728647785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39727,-0.00404438653979406,0.00566611207160963,-0.0151499662001489,0.00706119312056083,0.475370961989938
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,37655,-0.00485772408106245,0.00684565004734401,-0.0182751981738567,0.0085597500117318,0.477960147068972
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37376,-0.00527727184139842,0.00749655026654728,-0.0199705103638311,0.00941596668103424,0.48147034091089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,39991,0.00286828007107426,0.00412705063809854,-0.00522073917959889,0.0109572993217474,0.487068749012102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,39815,0.00311200187474207,0.00448567487531221,-0.00567992088086985,0.011903924630354,0.487840413813825
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,37515,-0.00350011337714925,0.0050491993503858,-0.0133965441039054,0.00639631734960693,0.488195330149525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37697,0.00269868433863411,0.00392748828976351,-0.00499919270930236,0.0103965613865706,0.49201455638618
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,39648,0.0045985214302941,0.0067059228108379,-0.00854508727894818,0.0177421301395364,0.492887358514784
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37697,-0.00252110732154995,0.00368898028161821,-0.00975150867352165,0.00470929403042174,0.494356108684047
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37362,0.00340125784507271,0.0050262845214481,-0.00645025981696557,0.013252775507111,0.498612087901064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37362,0.00217572750983143,0.00321777982876627,-0.00413112095455046,0.00848257597421332,0.498952460439791
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,37791,0.00583892555309043,0.0086477979261251,-0.0111107583821148,0.0227886094882956,0.499565376270626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,37376,-0.00271385550274508,0.00402704664901666,-0.0106068669348177,0.00517915592932758,0.500382402724026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,37470,0.00246154025520457,0.00365792839305107,-0.00470799939517553,0.00963107990558467,0.501001943819158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37343,0.00390936681367661,0.00581228431279221,-0.00748271043939612,0.0153014440667493,0.50121118770749
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37376,0.00275333030274191,0.00411735661170901,-0.00531668865620774,0.0108233492616916,0.503690453116916
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,37282,0.0051656983680787,0.00776036117045329,-0.0100446095260098,0.0203760062621672,0.505645656407598
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,37343,0.00467166423809147,0.00702363790568792,-0.00909466605705685,0.0184379945332398,0.505976337165552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37696,-0.00276267302653343,0.00415471994701289,-0.0109059241226787,0.00538057806961184,0.506095284059214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,39761,-0.0030002978811254,0.00455934222551111,-0.0119366086431272,0.00593601288087637,0.510512694658573
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,40143,-0.00150255818345717,0.00229414157246182,-0.00599907566548234,0.002993959298568,0.512506695840392
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,39746,-0.00525183455123348,0.0080846253367851,-0.0210977002113323,0.0105940311088653,0.515955439442286
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,40065,0.00198871777775097,0.0030758923844517,-0.00404003129577437,0.00801746685127631,0.51793282427607
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40126,-0.00270173617520206,0.00420053790309608,-0.0109347904652704,0.00553131811486625,0.520111435067175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37343,0.00370381903010797,0.00579458691932393,-0.00765357133176693,0.0150612093919829,0.522713273845974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,39727,-0.004176929773281,0.00654784265423688,-0.0170107013755853,0.00865684182902328,0.523542280884496
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40095,0.0018917835222768,0.00299565603732756,-0.00397970231088522,0.00776326935543883,0.527717043455128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37782,0.00285878638768861,0.00453981189746443,-0.00603924493134167,0.0117568177067189,0.528892041372473
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40233,0.00282468523966281,0.00448854173266569,-0.00597285655636194,0.0116222270356876,0.529155083594501
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37515,0.00379531513860966,0.0060636433841946,-0.00808942589441177,0.0156800561716311,0.531382735359559
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,39815,0.00471636924852732,0.0075550979986311,-0.0100916228287896,0.0195243613258443,0.53246405227257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39815,-0.00351604559962653,0.00567411009075267,-0.0146373013775018,0.00760521017824872,0.535487765241492
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37515,0.00500207188029212,0.00815295596757091,-0.0109777218161469,0.0209818655767311,0.539537542806153
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37515,0.00375181011968445,0.00612137870127926,-0.00824609213482289,0.0157497123741918,0.539951284468429
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,40143,-0.00172062313427007,0.00281921416534651,-0.00724628289834922,0.00380503662980909,0.541658608909828
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,37403,-0.00186455454499049,0.00305569062561596,-0.00785370817119777,0.00412459908121678,0.541746078339534
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,40168,0.00233784784959075,0.00383742977603265,-0.00518351451143323,0.00985921021061474,0.542385897919197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39815,0.00696930327493573,0.0114438859637857,-0.0154607132140842,0.0293993197639557,0.54253479200684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37376,0.00214131169761907,0.00353711074827568,-0.00479142536900126,0.0090740487642394,0.544934238358177
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37515,-0.00314658049932636,0.00522308820677492,-0.0133838333846052,0.00709067238595248,0.546893883188763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39810,0.0036208945378681,0.00607158845127797,-0.00827941882663673,0.0155212079023729,0.550938920345371
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,37282,0.00175957173183126,0.00297088695443819,-0.0040633666988676,0.00758251016253012,0.553679221136629
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40126,-0.00279112355585924,0.00471440991889397,-0.0120313669968914,0.00644911988517293,0.553831731027047
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37697,-0.00252001393808421,0.00426981960965452,-0.0108888603730071,0.00584883249683866,0.555071915225933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37470,-0.00177038805624858,0.00300312955317136,-0.00765652198046445,0.00411574586796728,0.555526499201328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,37515,0.00483285554011701,0.00821176717191009,-0.0112622081168268,0.0209279191970608,0.556188069344804
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,37403,0.00305803320024534,0.00521284115108499,-0.00715913545588125,0.0132752018563719,0.557459336580915
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37343,-0.00438998120314395,0.0074857370416991,-0.0190620258048742,0.0102820633985863,0.557586049209962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,39991,-0.00734646980633773,0.0125303646597143,-0.0319059845393777,0.0172130449267023,0.557686897314137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,40065,-0.0010675598705415,0.00182223159128623,-0.00463913378946251,0.00250401404837951,0.557982762518226
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40140,0.00124800126698424,0.00214020330059455,-0.00294679720218108,0.00544279973614956,0.559819041441913
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40233,-0.00712255579231752,0.0122305698364425,-0.0310944726717448,0.0168493610871098,0.560334678021467
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,37697,0.00254094034558251,0.00436405008505821,-0.00601259782113159,0.0110944785122966,0.560412502208591
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37403,-0.00124566041548656,0.00214475504051542,-0.00544938029489679,0.00295805946392366,0.561389544789637
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40066,0.00123301954862188,0.00212512245525819,-0.00293222046368416,0.00539825956092793,0.56178066993651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37362,-0.00490314085085397,0.00853137765938019,-0.0216246410632391,0.0118183593615312,0.56549168598372
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,37282,0.00230579433782987,0.00401298405437223,-0.00555965440873969,0.0101712430843994,0.565583102410105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39727,0.00307175916975376,0.00534752183017773,-0.0074093836173946,0.0135529019569021,0.56568756710903
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37403,0.00298447538302753,0.00522164975849265,-0.00724995814361806,0.0132189089096731,0.567631415231947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37362,-0.00209802978958294,0.00368096511244668,-0.00931272140997844,0.00511666183081256,0.568709787141848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,39810,-0.00392670980636442,0.00691274629886261,-0.0174756925521351,0.00962227293940631,0.57001676012385
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37403,0.0022270176169302,0.00392259091790169,-0.00546126058215712,0.00991529581601752,0.570220355401143
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,37697,-0.00268679597227313,0.00473684981784173,-0.0119710216152429,0.00659742967069666,0.570580068118539
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39727,-0.00262899916806024,0.00466758288615006,-0.0117774616249144,0.00651946328879388,0.57327539153516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37362,0.00280358490832514,0.00499748833341492,-0.0069914922251681,0.0125986620418184,0.574808098520671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37362,0.00353192074492641,0.00630068219464085,-0.00881741635656966,0.0158812578464225,0.575106135628137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37343,0.0038937885411833,0.00699526720465679,-0.009816935179944,0.0176045122623106,0.577788649119765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,37697,0.00572302035425933,0.0103775653185685,-0.0146170076701349,0.0260630483786536,0.581313934617225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37403,0.00324962277199573,0.00596116918093287,-0.0084342688226327,0.0149335143666242,0.585672273460439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,39700,-0.00186483845678662,0.00342904485832959,-0.00858576637911262,0.00485608946553939,0.58656220069447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40174,0.00140707249921979,0.00258857876784981,-0.00366654188576583,0.00648068688420542,0.586745451260232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,37696,-0.0133788109538475,0.0248368086012694,-0.0620589558123355,0.0353013339046405,0.59012454054907
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,39815,-0.00460313749606587,0.00856663592719805,-0.021393743913374,0.0121874689212423,0.59104529094961
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37403,0.00356364057461128,0.00665870443450057,-0.00948742011700983,0.0166147012662324,0.592530935262416
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37777,0.000944231453985073,0.00177681710333946,-0.00253833006856026,0.0044267929765304,0.595138452506352
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37515,-0.0041021667050557,0.00791261420113737,-0.0196108905392849,0.0114065571291735,0.604164413264541
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,37515,-0.00850701005118085,0.0164173329391564,-0.0406849826119274,0.0236709625095657,0.604346712905775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,37677,-0.00252075247109395,0.00489166358630663,-0.0121084131002549,0.00706690815806706,0.606340839297728
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37403,-0.00182243195699034,0.00353858694337265,-0.00875806236600074,0.00511319845202006,0.606550023997543
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37343,-0.00213724757495842,0.0041511757918269,-0.0102735521269391,0.0059990569770223,0.606664192128001
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,37343,0.0024922500292196,0.00486580340014711,-0.00704472463506874,0.0120292246935079,0.608521899285002
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39746,-0.00589511050119874,0.011526105580392,-0.028486277438767,0.0166960564363695,0.609038285085136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40297,0.00131651276585273,0.00258228319296396,-0.00374476229235664,0.00637778782406209,0.610181105914202
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37343,-0.00419804893777198,0.00825840590828852,-0.0203845245180175,0.0119884266424735,0.611226093858473
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,40126,0.00217352750358799,0.00428871001461572,-0.00623234412505883,0.0105793991322348,0.612300769117756
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,39815,-0.00258287405512352,0.00514477808734657,-0.0126666391063228,0.00750089099607575,0.61564799229823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37515,0.00217450811337041,0.00433488617585477,-0.00632186879130494,0.0106708850180458,0.615936402521343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37343,-0.00262284623059633,0.00527573617738171,-0.0129632891382645,0.00771759667707181,0.619089886474918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37430,0.00203085109042254,0.00408787594019982,-0.00598138575236911,0.0100430879332142,0.619339489576868
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37697,-0.00268941307328537,0.00551484610591575,-0.0134985114408802,0.0081196852943095,0.625793208356304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,37282,-0.00290662113675068,0.00597950155413221,-0.0146264441828498,0.00881320190934845,0.62690629629473
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37362,0.00278439045016302,0.00576707185238398,-0.00851907038050958,0.0140878512808356,0.629240007472406
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37362,-0.00551062401510716,0.0114536769977083,-0.0279598309306154,0.0169385829004011,0.630437448638464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39942,-0.00198605484955911,0.00413558388002254,-0.0100917992544033,0.00611968955528507,0.631066615191745
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37697,-0.00432696986294936,0.00908242275570876,-0.0221285184641385,0.0134745787382398,0.633789163720288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39727,-0.00298406956243786,0.00628304413929407,-0.0152988360754542,0.00933069695057851,0.634836464406757
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37362,0.0022065529079065,0.00464848485419553,-0.00690447740631674,0.0113175832221297,0.635021553016387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37515,0.00229103091404389,0.00486140602267854,-0.00723732489040606,0.0118193867184938,0.637456379450666
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37430,-0.00360370588079998,0.00790354159269227,-0.0190946474024768,0.0118872356408769,0.648425729570565
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37430,0.00177018213634217,0.0038950545747541,-0.00586412483017587,0.00940448910286022,0.649498793270591
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37282,0.00218507545251254,0.00483028370873056,-0.00728228061659936,0.0116524315216244,0.651010101902139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,37343,-0.00203195230718775,0.00450273842674161,-0.0108573196236013,0.0067934150092258,0.651802308979021
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,37403,0.00149714373135427,0.00332277128212621,-0.0050154879816131,0.00800977544432164,0.652306454890965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,39810,-0.00118804330231665,0.00264481802509139,-0.00637188663149578,0.00399580002686247,0.65329616814709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37403,0.00155323671954773,0.00347399093228485,-0.00525578550773057,0.00836225894682602,0.654807140791912
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,40233,-0.00110399891179704,0.00246955750623006,-0.00594433162400795,0.00373633380041388,0.654849997489486
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,37331,0.00372623301008223,0.00844660150738831,-0.0128291059443989,0.0202815719645633,0.659110548808405
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,39810,-0.0022858026544605,0.00520884545375018,-0.0124951397438109,0.00792353443488986,0.660790197915119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,37756,-0.00183887982365543,0.00419516060487902,-0.0100613946092183,0.00638363496190746,0.661151594194801
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37343,0.00357204409709293,0.00821427094703289,-0.0125279269590915,0.0196720151532774,0.663672546289086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37282,0.00205840325953779,0.00474546101621856,-0.00724270033225059,0.0113595068513262,0.664468174268942
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,37362,-0.0019783791482409,0.00456582543312983,-0.0109273969971754,0.00697063870069357,0.664802965654372
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37362,0.00196274896133056,0.00453651164130362,-0.00692881385562453,0.0108543117782857,0.665271929873692
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37362,-0.00165141455107269,0.00387192784633645,-0.00924039312989213,0.00593756402774676,0.669743636752481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37376,0.00147752727254153,0.00346649402825873,-0.00531680102284558,0.00827185556792865,0.66994661740389
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37403,0.00112337684572754,0.0026904435279891,-0.0041498924691311,0.00639664616058618,0.676287933375925
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39810,0.0012946803936984,0.00315333535127006,-0.00488585689479093,0.00747521768218772,0.681389988489439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,40174,0.00118552351857459,0.00290818334118409,-0.00451451583014623,0.00688556286729541,0.683535549779892
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,37343,0.00226698107136059,0.0056150576119573,-0.00873853184807571,0.0132724939907969,0.686416157609315
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37696,-0.00210778191618797,0.00524615689011533,-0.012390249420814,0.00817468558843808,0.687855090934636
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37343,0.0017628158965051,0.00441067012914441,-0.00688209755661794,0.0104077293496281,0.689405650564527
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37403,-0.000817766032153468,0.0020543077060674,-0.00484420913604557,0.00320867707173863,0.690582363397822
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37376,0.00255090938025578,0.00645042664040883,-0.0100919268349455,0.0151937455954571,0.692507256877461
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,37784,0.000960142554404069,0.00247038528801527,-0.00388181261010586,0.00580209771891399,0.697533101116656
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTN,Titin,37362,0.0024327991561197,0.00630933815754724,-0.0099335036326729,0.0147991019449123,0.699808870594366
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37376,-0.00130454795567489,0.00339613023892689,-0.0079609632239716,0.00535186731262181,0.700890065079101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,37376,0.00176771502665935,0.00467992829524513,-0.00740494443202111,0.0109403744853398,0.705642825484072
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37403,-0.00100407546970772,0.00266725323651507,-0.00623189181327725,0.00422374087386181,0.706591894423843
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37515,0.00129184201331981,0.00345121104788602,-0.0054725316405368,0.00805621566717642,0.708175628880355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37362,-0.00206012788051214,0.00550951537026478,-0.0128587780062311,0.00873852224520682,0.708468640682974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37282,0.00206812375109826,0.00554726120349355,-0.0088045082077491,0.0129407557099456,0.709289403095637
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37737,-0.00142306992896477,0.00382548686175753,-0.00892102417800952,0.00607488432007999,0.70990095922996
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39815,-0.0016404210003665,0.00441779213576476,-0.0102992935864654,0.00701845158573242,0.710403240671415
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,40248,0.00158003423950265,0.00428363665824879,-0.00681589361066498,0.00997596208967028,0.712241891688377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37403,0.0032924467901752,0.00895475181631562,-0.0142588667698034,0.0208437603501538,0.713120891247894
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,39718,0.00310747914961457,0.00848164561496244,-0.0135165462557118,0.019731504554941,0.714088920910998
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,37376,-0.00324691368727092,0.00886709635247203,-0.0206264225381161,0.0141325951635743,0.714240095647544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,40095,0.00176864460504258,0.00483127705672544,-0.00770065842613928,0.0112379476362244,0.714308678858296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37680,-0.00145448466272493,0.00400250970842648,-0.00929940369124083,0.00639043436579097,0.716317015356732
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37515,0.00260185116705009,0.00716997962531624,-0.0114513088985697,0.0166550112326699,0.716699465151901
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37376,0.00299822470004988,0.00829285055915729,-0.0132557623958984,0.0192522117959982,0.717699239521704
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37756,0.00130161227744262,0.0036154734079665,-0.00578471560217171,0.00838794015705695,0.718844191949217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,37362,0.00139806218984447,0.00389185830433115,-0.00622998008664459,0.00902610446633353,0.719430845919814
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,40159,-0.00509416300346127,0.0142172312898388,-0.0329599363315454,0.0227716103246228,0.720116842178548
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,37403,0.00103876385479546,0.00291925486800875,-0.00468297568650169,0.00676050339609261,0.72197229229954
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_DRA,,40047,0.00122220238293329,0.00343535866510483,-0.00551110060067219,0.00795550536653876,0.722016576560986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,37282,-0.00210625022011936,0.00597905245567886,-0.0138251930332499,0.00961269259301119,0.72464039018138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,37791,-0.0014592074443786,0.00417009197114937,-0.00963258770783138,0.00671417281907417,0.7264026666521
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37362,-0.00210451937426052,0.00602803138206701,-0.0139194608831119,0.00971042213459081,0.727003289948371
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,37282,0.00267268834653193,0.00775182353044116,-0.0125208857731327,0.0178662624661966,0.730264002426537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,39998,-0.00226844105575795,0.00659297260875568,-0.0151906673689191,0.0106537852574032,0.730798642762955
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,37737,-0.00194594762600472,0.00571777707107589,-0.0131527906853135,0.00926089543330402,0.733611228123851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,37791,-0.00186012658193051,0.0054776304014738,-0.0125962821688192,0.00887602900495813,0.734173671157066
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37282,0.00182394662862023,0.00539549982957115,-0.00875123303733923,0.0123991262945797,0.735331331622588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,37515,-0.00132163949199747,0.00397538188425406,-0.00911338798513542,0.00647010900114048,0.739550306262621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37343,0.00211193432157004,0.0063909361169488,-0.0104143004676496,0.0146381691107897,0.741059487761527
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,39669,-0.00134074867149289,0.00407970280612535,-0.00933696617149859,0.0066554688285128,0.74243323280768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37369,-0.00119842257302935,0.00365730741446362,-0.00836674510537804,0.00596989995931935,0.743159748069865
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37756,-0.00115032253188839,0.00351970299769491,-0.00804894040737042,0.00574829534359363,0.7438063367219
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37343,-0.00125114832778001,0.00384716431871375,-0.00879159039245896,0.00628929373689895,0.745025054158498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37784,0.000853228754021753,0.00263935432469555,-0.00431990572238152,0.00602636323042503,0.746494498811933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,37403,-0.00195850543900123,0.00607068119939849,-0.0138570405898223,0.00994002971181981,0.746990465152232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,37697,-0.000851030680735342,0.00264767173279827,-0.00604046727701995,0.00433840591554927,0.747892612466896
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37403,-0.00287029048121673,0.00894623816302872,-0.020404917280753,0.0146643363183196,0.748338564271829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,37362,0.00223793979057038,0.00697865057073548,-0.0114402153280712,0.0159160949092119,0.748455258344198
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39746,-0.00141518833378688,0.00444099670412398,-0.0101195418738699,0.00728916520629612,0.749985230682334
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37470,-0.00117029959758114,0.00368113805070194,-0.00838533017695695,0.00604473098179467,0.750552330313383
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40095,0.00357721531725268,0.0113399693041558,-0.0186491245188928,0.0258035551533981,0.752422743878846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,39746,-0.0012150145960276,0.00389237190286005,-0.00884406352563329,0.00641403433357809,0.754928694121052
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,37737,0.00282355451793002,0.00907402645398562,-0.0149615373318818,0.0206086463677418,0.755677132859062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,37376,0.00257735090854378,0.00835200637823295,-0.0137925815927928,0.0189472834098804,0.75763792332294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36783,-0.0014714097803852,0.004794285310188,-0.0108682089883537,0.00792538942758327,0.758917746173146
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39727,-0.00145172754558479,0.00473582141731298,-0.0107339375235182,0.00783048243234865,0.759196284899136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39815,0.00193864468636197,0.00634236734067523,-0.0104923953013615,0.0143696846740854,0.759863268899062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39810,-0.00177452986301621,0.00581968293849158,-0.0131811084224597,0.00963204869642728,0.760432243237164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,37376,0.00135858054445096,0.00447315387520873,-0.00740880105095815,0.0101259621398601,0.761347088280245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,37756,-0.00463401186915523,0.0153794934056323,-0.0347778189441946,0.0255097952058841,0.763181996726885
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37403,-0.00192123967019342,0.00640609705857905,-0.0144771899050084,0.0106347105646215,0.764252155438451
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37362,-0.00112598724803833,0.00376575601510884,-0.00850686903765166,0.006254894541575,0.764939549995546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40251,0.00128083661668783,0.00430730793305443,-0.00716148693209884,0.00972316016547451,0.766192835884849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,37403,0.00136562289903551,0.00462438782059021,-0.0076981772293213,0.0104294230273923,0.767762649213414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,40251,0.000756901432763937,0.00256516230302458,-0.00427081668116424,0.00578461954669211,0.76794458388281
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,39727,0.00104112024573901,0.00359547390227283,-0.00600600860271575,0.00808824909419376,0.772153647676969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37282,0.000916508724710572,0.0032180591649657,-0.0053908872386222,0.00722390468804334,0.775800665547006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,37282,-0.00214782582201674,0.00756381158607329,-0.0169728965307204,0.0126772448866869,0.776445020784514
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37515,0.00182315512072582,0.00646004562746808,-0.0108385343091116,0.0144848445505633,0.777779170748574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37515,0.00109409238353107,0.00388130515132138,-0.00651326571305884,0.00870145048012098,0.778034046843355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37697,0.00208088813987578,0.00743274986168222,-0.0124873015890214,0.0166490778687729,0.779510966748135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37362,-0.00257443919809505,0.00926981837381036,-0.0207432832107634,0.0155944048145733,0.781229663427774
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,39815,0.00167960149594565,0.00609493558824651,-0.0102664722570175,0.0136256752489088,0.782879527818176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37349,0.00104351851335352,0.00386806889963128,-0.00653789652992379,0.00862493355663084,0.787335639261658
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,37403,0.000999377023078513,0.00371603511851148,-0.00628405180920398,0.00828280585536101,0.787982926693514
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,39946,-0.00177269442314573,0.00661569957443337,-0.0147394655890351,0.0111940767427437,0.788739310867503
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,37343,-0.0024905975220876,0.00934696062225531,-0.020810640341708,0.0158294452975328,0.789888696469751
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37430,0.00148234778452067,0.0055640050733006,-0.0094231021591485,0.0123877977281898,0.789921995908017
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40274,-0.000877938054916143,0.00332455836766955,-0.00739407245554845,0.00563819634571617,0.791724337465409
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37697,0.00214829661431259,0.00814852644321284,-0.0138228152143846,0.0181194084430098,0.792059627844819
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37282,0.00215405731968712,0.00819475372049676,-0.0139076599724865,0.0182157746118608,0.792664179832835
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37362,0.000860152080502444,0.00327349275862388,-0.00555589372640037,0.00727619788740526,0.792737612455526
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,40258,0.00074142046183008,0.0028464175810335,-0.00483755799699559,0.00632039892065575,0.794500832834988
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37282,0.00103442972377921,0.00398192235597225,-0.00677013809392639,0.00883899754148481,0.795036497878083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,37403,0.00149924372143442,0.00597629593538131,-0.010214296311913,0.0132127837547818,0.801922433663874
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37343,-0.002783574507763,0.0114430236163393,-0.025211900795788,0.019644751780262,0.807811611073918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,40174,0.000855241219985054,0.00353478397193168,-0.00607293536500104,0.00778341780497115,0.808822009937014
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,37403,-0.00204451549139282,0.00849394896804598,-0.0186926554687629,0.0146036244859773,0.80978944375646
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37515,-0.00157201151427121,0.00653137232676076,-0.0143735012747223,0.0112294782461799,0.809802073588972
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37282,0.00111886730756791,0.0047221375687134,-0.00813652232711035,0.0103742569422462,0.812706458309976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39746,-0.00132054898031634,0.00558889150018379,-0.0122747763206766,0.00963367836004389,0.813217778557466
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,37734,-0.000524899829717603,0.00223105399362621,-0.00489776565722498,0.00384796599778977,0.81400288992438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39746,0.000837230863565848,0.00358375059187512,-0.00618692029650939,0.00786138202364109,0.815284198664503
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37362,0.00198982009218065,0.00852598394174105,-0.0147211084336318,0.0187007486179931,0.81546767818392
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37362,0.0012765133731081,0.00555277614150665,-0.00960692786424493,0.0121599546104611,0.818182895173076
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,37403,0.000581001447410053,0.00254356933794557,-0.00440439445496325,0.00556639734978336,0.819323550901214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,39727,0.00115699286764922,0.00507539378528013,-0.00879077895149984,0.0111047646867983,0.819679453991795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,40174,0.000628125631702159,0.00278648105595682,-0.00483337723797321,0.00608962850137753,0.821656301489523
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,37376,0.00146347518052289,0.00667130014759905,-0.0116122731087713,0.014539223469817,0.826366227925128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39946,-0.000852281026575389,0.00389391635562071,-0.00848435708359197,0.00677979503044119,0.826750287452139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37343,-0.00154752995988504,0.00707269862167876,-0.0154100192583754,0.0123149593386053,0.826806722169234
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40212,0.000598168559969688,0.00283614375253783,-0.00496067319500446,0.00615701031494384,0.832960920644234
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40065,-0.000897937254758453,0.00427262371107789,-0.00927227972847111,0.0074764052189542,0.833545054978144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37784,0.00100177992306029,0.0047668949484333,-0.00834133417586898,0.0103448940219896,0.833551038650809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39746,-0.00176884388611407,0.00851099592528289,-0.0184503958996685,0.0149127081274404,0.835364144118588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37756,-0.000582362212738021,0.00281313883401028,-0.00609611432739817,0.00493138990192213,0.836001235240483
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37362,0.000939768983923133,0.0046561640357179,-0.00818631252608395,0.0100658504939302,0.840050222436183
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,37441,0.000615456969778863,0.00305542161388864,-0.00537316939344287,0.0066040833330006,0.840364644986277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37362,0.00090789260808604,0.00456459784248592,-0.00803871916318637,0.00985450437935845,0.84234511324033
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37282,-0.00169150168023818,0.00870594491583395,-0.0187551537152727,0.0153721503547964,0.845949765109574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,37403,0.000780268809722075,0.00415075961341248,-0.00735522003256638,0.00891575765201053,0.850893571397829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,37756,0.000677670690475148,0.00365162288511716,-0.00647951016435449,0.00783485154530479,0.852776427674428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37403,-0.00188545943800422,0.0102871715163849,-0.0220483156101186,0.0182773967341102,0.854579163392168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,37403,0.000604535931732832,0.00331629757968512,-0.00589540732445,0.00710447918791567,0.855356095273366
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39967,0.000788967228707281,0.00432849878397705,-0.00769489038788773,0.0092728248453023,0.85537109099359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,37376,0.00100426449327832,0.00575549731162163,-0.0102765102375001,0.0122850392240567,0.861484792365146
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37376,0.000698019237358797,0.00401098013215434,-0.00716350182166371,0.0085595402963813,0.861846890787249
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,40100,0.000924981844620325,0.00532009980347516,-0.00950241377019098,0.0113523774594316,0.861973410929418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,37756,-0.00104435644738547,0.0060824530897184,-0.0129659645032335,0.0108772516084626,0.863676093955885
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,37403,-0.000771422489924085,0.00453919219335517,-0.00966823918890021,0.00812539420905204,0.865054404232707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,39815,-0.000708511807053447,0.00424697189239288,-0.0090325767161435,0.0076155531020366,0.86750795639056
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,39746,-0.00166135553842883,0.0102305872863232,-0.0217133066196223,0.0183905955427646,0.871000084717625
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37282,-0.000874590929817369,0.00541011461041132,-0.0114784155662236,0.00972923370658882,0.871577344379105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40233,-0.000428366388400632,0.00266556972795962,-0.0056528830552015,0.00479615027840023,0.872328988588805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40100,-0.000909405547818823,0.00576446032578562,-0.0122077477863586,0.010388936690721,0.87464736880532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37376,0.000812133870090136,0.00545828983846968,-0.00988611421331043,0.0115103819534907,0.881722396744183
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,37282,0.00103901512328403,0.00707563533581199,-0.0128292301349075,0.0149072603814755,0.883257402437976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,37515,0.000774024312708841,0.00530196078397784,-0.00961781882388773,0.0111658674493054,0.883932866705923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,37282,0.000849917717230356,0.00585108718789028,-0.0106182131710346,0.0123180486054953,0.884509389160679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37343,0.000449485966665045,0.00312129030767729,-0.00566824303638245,0.00656721496971254,0.885497619800953
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37782,0.000494830619024489,0.00375904594953422,-0.00687289944206259,0.00786256068011157,0.895273176249447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,40150,0.00037621866639028,0.0028930275020323,-0.00529411523759303,0.00604655257037359,0.896533883699281
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37282,-0.000742464399208046,0.00581503936835905,-0.0121399415611918,0.0106550127627757,0.89840419575884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37376,0.000812530502154656,0.00639020190216266,-0.0117122652260842,0.0133373262303935,0.898821633849272
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40297,-0.000733467721472397,0.00580916181472936,-0.0121194248783419,0.0106524894353971,0.899527318104208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,39815,0.000634265432448204,0.00508588448997562,-0.00933406816790402,0.0106025990328004,0.900754028288208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,39815,0.000568449531063368,0.00458794052182107,-0.00842391389170593,0.00956081295383266,0.901395435238987
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37376,0.00120676611158318,0.00976521364731787,-0.0179330526371598,0.0203465848603262,0.90165129035958
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,37403,-0.000571182280992049,0.00462420364529195,-0.00963462142576426,0.00849225686378017,0.901697143895631
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,37362,-0.000429989374825435,0.00349627983247781,-0.00728269784648194,0.00642271909683107,0.902121026448577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39727,0.000580431392235873,0.00476582259540123,-0.00876058089475054,0.00992144367922229,0.903066627086922
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,37376,0.000315389614979232,0.00260258193291676,-0.00478567097353762,0.00541645020349608,0.903547690235723
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37756,-0.000896644125597036,0.00751358020686861,-0.0156232613310595,0.0138299730798654,0.905010594298361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40297,-0.000256943821985353,0.00218200697457346,-0.00453367749214933,0.00401978984817863,0.90626270111921
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37305,-0.000378933751400745,0.00330309901769759,-0.00685300782608802,0.00609514032328653,0.908668317224266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37756,-0.000808111629772885,0.00705329893537098,-0.0146325775431,0.0130163542835542,0.908785983664821
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,37376,-0.000725871652427338,0.00663298437381505,-0.0137265210251048,0.0122747777202502,0.912860248737426
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,37515,0.000639690206834927,0.00591012282638133,-0.0109441505328725,0.0122235309465423,0.913809862247939
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,39815,0.000322149819409476,0.00298854449686256,-0.00553539739444114,0.00617969703326009,0.914159805667879
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40248,0.000589041430098157,0.00577767445000332,-0.0107352004919083,0.0119132833521047,0.918796623385849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37260,-0.000246051762956213,0.002421414141866,-0.00499202348101357,0.00449991995510115,0.919063940499727
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,37282,-0.000559187768166172,0.00553505715186063,-0.011407899785813,0.0102895242494807,0.919530957021396
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39815,0.000360712534539401,0.00358308282583054,-0.00666212980408847,0.00738355487316727,0.919812945951686
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37756,-0.00032194973756115,0.00323945536593226,-0.00667128225478837,0.00602738277966607,0.920834955586824
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37499,-0.000956351278550916,0.00969875835783893,-0.0199659176599152,0.0180532151028134,0.921452988167172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37376,0.000679092656963994,0.00698843873470128,-0.0130182472630505,0.0143764325769785,0.922589936730681
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,40215,-0.000394257915249298,0.00417254998880827,-0.00857245589331351,0.00778394006281492,0.924722332388684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37376,-0.000389171877532333,0.00412663922589392,-0.00847738476028442,0.00769904100521975,0.92486657590964
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,37403,-0.000648331095466302,0.00728539286459332,-0.0149277011100692,0.0136310389191366,0.929090798799833
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,40174,0.000179278819135547,0.00204633309315309,-0.0038315340434445,0.0041900916817156,0.930187934026078
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37403,0.000568786690597665,0.00653145436645226,-0.0122328638676488,0.0133704372488441,0.930605904725846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37403,-0.000292809786637883,0.00337512218844576,-0.00690804927599158,0.00632242970271581,0.930867348766188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,39815,0.000401103742826356,0.00470407192073884,-0.00881887722182177,0.00962108470747448,0.932049959679506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,37376,-0.000466669766903267,0.00555878978271684,-0.0113618977410283,0.0104285582072217,0.933096146403841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37756,0.000189576349958444,0.00225971208328542,-0.00423945933328099,0.00461861203319788,0.933141949617679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,37756,-0.000284229668433659,0.00359653576221201,-0.00733343976236919,0.00676498042550188,0.937010956601234
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39727,0.000480926442272275,0.00647671205819394,-0.0122134291917878,0.0131752820763324,0.940808677813589
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,37154,-0.000275495139929925,0.00371109457289799,-0.00754924050280998,0.00699825022295013,0.940824129502062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,37697,-0.000550120560324727,0.00772556940659114,-0.0156922365972434,0.0145919954765939,0.943233473583757
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37282,-0.00037625621987243,0.00535033054708724,-0.0108629040921634,0.0101103916524186,0.943936939882023
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,37403,0.000174372537836976,0.00250812177259457,-0.00474154613644838,0.00509029121212233,0.944574275872639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37403,-0.000312334387964512,0.00451293672045948,-0.0091576903600651,0.00853302158413608,0.944824583469584
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37430,-0.000382900001313377,0.00602960896568405,-0.0122009335740541,0.0114351335714274,0.949366718203293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37559,-0.000256338844573998,0.00426702890968745,-0.0086197155075614,0.0081070378184134,0.952097361483892
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37430,0.000152159726969454,0.00255637896114683,-0.00485834303687834,0.00516266249081724,0.952537590266425
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37362,0.000266626827666454,0.00465047976259562,-0.00884831350702097,0.00938156716235387,0.954280671404275
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37376,-0.000273315919304828,0.00477118308852107,-0.00962483477280613,0.00907820293419648,0.954319272274282
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,37376,0.000231251885809189,0.00408535905220283,-0.00777605185650836,0.00823855562812674,0.954860699901299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40193,-0.000149216710180893,0.00266058586822861,-0.00536396501190896,0.00506553159154718,0.955275478373175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39727,-0.000425040068652598,0.00774921183251833,-0.0156134952603885,0.0147634151230833,0.956259115250699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37515,0.000195559356908022,0.00362213841750248,-0.00690383194139684,0.00729495065521288,0.95694393426135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37376,-0.000406211128620701,0.00803875424026779,-0.0161621694395456,0.0153497471823042,0.959699547830615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37697,-0.000216215745987548,0.00432267395843488,-0.00868865670451992,0.00825622521254482,0.960108016939485
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37756,-0.00054066425482835,0.0109102682230069,-0.0219247899719218,0.0208434614622651,0.960477319347193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37430,0.00120673257569569,0.0251958100871969,-0.0481770551952103,0.0505905203466017,0.961801317502769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37376,-0.000279755144078189,0.00611862427009483,-0.0122722587134641,0.0117127484253077,0.963532612571221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37515,0.00023867073569746,0.00522310701772004,-0.00999861901903381,0.0104759604904287,0.963553916236435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37282,-0.00038507877554458,0.00854226554009212,-0.0171279192341251,0.016357761683036,0.964044856107486
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,40297,7.70636091722233e-05,0.00184729410050319,-0.00354363282781402,0.00369776004615847,0.966724809569976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39815,-0.000220451288764971,0.00547294145295366,-0.0109474165365541,0.0105065139590242,0.967870246109251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,37515,-0.000233499471981958,0.00583571419747223,-0.0116714992990275,0.0112045003550636,0.968084051195867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39727,0.000117891248495794,0.0033653718490565,-0.00647823757565494,0.00671402007264653,0.972055738259419
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,37376,-7.73181138678742e-05,0.00223541032250649,-0.0044587223459806,0.00430408611824485,0.972408896701097
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,37376,-0.000211668549730878,0.00634841948907573,-0.0126545707483193,0.0122312336488575,0.973402432980155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37282,0.000160167902082549,0.00485267742092449,-0.00935107984292944,0.00967141564709454,0.973670245521594
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,37670,0.000167302147178536,0.00544773721450786,-0.0105102627932569,0.010844867087614,0.975500966851008
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37376,-9.27802029715071e-05,0.00318686024893523,-0.00633902629088455,0.00615346588494154,0.976774631785258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,37737,-6.21747527093902e-05,0.00222445777456246,-0.00442211199085181,0.00429776248543303,0.977702034433274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,37737,7.42790811299289e-05,0.00291723070223796,-0.00564349309525647,0.00579205125751632,0.979686689491504
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,39727,-0.00010253468386289,0.00462834842097753,-0.00917409758897886,0.00896902822125308,0.982325701724579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40164,8.0353118911045e-05,0.00405122875043328,-0.00786005523193819,0.00802076146976028,0.98417584065092
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,40034,-4.76513371634381e-05,0.00355060841055434,-0.00700684382184994,0.00691154114752307,0.989292394293266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,37282,8.58912683196631e-05,0.00688265522622668,-0.0134041129750846,0.013575895511724,0.990043348033695
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,37362,-4.15955640923988e-05,0.00413354605318778,-0.00814334582834046,0.00806015470015566,0.991971238464687
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,37282,-5.89625643416605e-05,0.0065500687953374,-0.012897097403203,0.0127791722745196,0.992817820830835
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,40117,3.60827445075753e-05,0.00429282029354965,-0.00837784503084974,0.00845001051986489,0.993293670754213
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39810,2.9777077146603e-05,0.00415774891089137,-0.00811941078820049,0.0081789649424937,0.994285830921103
